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Introduction: In July 2011, The Malawi government started implementing an innovative 
PMTCT policy known as Option B+ strategy that provides universal lifelong ART for all 
HIV-infected pregnant and breastfeeding women regardless of clinical or immunological 
stage. Even though Option B+ strategy is a good choice for Malawi, there is fear that the 
programme may be affected by poor access, utilisation, adherence and retention. 
Aim: The aim of this study was to explore the lived experiences of HIV-positive women on 
Option B+ strategy in a selected district hospital in Malawi. 
Methodology: A Hermeneutics phenomenological approach was used in this study to explore 
the lived experiences of HIV-positive women on Option B+ strategy through in-depth 
interviews of five purposely sampled information rich sources. Interviews were audio-taped 
and transcribed, then manual data analysis using Giorgi’s approach was employed to identify 
meaningful segments and develop categories, themes and sub-themes. 
Results: The lifelong commitment was described as the most challenging aspect of Option 
B+ strategy. Participants demonstrated lack of knowledge and understanding of Option B+ 
strategy and its implications which rendered them poorly prepared and unready for the task. 
The un optional Opt-out HIV testing resulted in participants feeling left out in their own care, 
as health professionals dominated the care from HIV testing throughout the process. The 
importance of male involvement in PMTCT was revealed in promoting partner HIV testing, 
disclosure, support, and prevention of further HIV spread. Barriers to participation were 
described in terms of attitudes of health care workers, stigma and discrimination. Despite the 
overemphasised need for women to be supported on Option B+ strategy participants were not 
willing to seek available sources of formal support.  
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Recommendations: Suggestions made included that; emphasise comprehensive Option B+  
strategy information in the hospital and community; promote male involvement in PMTCT; 
implement Opt-out HIV testing in reality; facilitate policy change to include ART preparatory 
classes for women; ensure nurses’ curricula reflect new responsibilities related to ART 
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Chapter 1  Introduction 
1.1 Background 
1.1.1 Global overview of HIV and Women 
The HIV and AIDS pandemic continues to be a global public health concern. Of the 
estimated 35.3 million people worldwide living with HIV by 2012, 47% were women (United 
Nations Joint Programme on AIDS [UNAIDS], 2013) and half of all new infections occurred 
among women. The vulnerability of women to HIV remains particularly high in sub-Saharan 
Africa where 76% of all HIV-positive women live. In 2011, an estimated 92% of pregnant 
women living with HIV resided in this region. With the increasing evidence of HIV infection 
among women of reproductive age, there is high incidence of perinatal transmission. Mother-
to-child transmission (MTCT) of HIV accounts for 14% of all new HIV infections worldwide 
(UNAIDS, 2012), and may occur during pregnancy, labour and delivery, or breastfeeding.  
In September 2000, the Millennium Development Goals (MDG) framework was adopted by 
world leaders from 189 nations during the United Nations Millennium Summit, and three of 
its eight goals (goals 6, 5, 4) are concerned with combating HIV and AIDS and reducing the 
high rates of maternal and infant mortality attributed to HIV infection (United Nations 
Development Programme [UNDP], 2010). These goals were framed on the principle that 
primary health care must ensure access to health services for the most disadvantaged 
populations and focus on interventions that directly and significantly impact on the major 
causes of mortality, morbidity and disability for those populations (Kekki, 2003). Globally, 
there has been some progress towards achieving the MDGs. The incidence of new HIV 
infection was reduced from 3.3 million in mid-to late 1990s to 1.9 million in 2012, largely 
due to expansion of HIV prevention programmes (UNAIDS, 2013). In the absence of 
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prevention, rates of MTCT are estimated to be 25–35 percent (United Nations [UN], 2007). 
Prevention of mother to child transmission (PMTCT) is currently a global priority in the 
management of HIV. Since the programme was introduced in 2001 many countries have 
incorporated it into their HIV programmes (Druce and Nolan, 2007), one of them being 
Malawi. 
1.1.2 The situation in Malawi 
Malawi has one of the highest HIV prevalence rates in Africa. In 2011 prevalence among 
pregnant women was 12.6%, above that of the general population (10.6%), and 
approximately 63,500 pregnant women were living with HIV. Mother-to-child transmission 
was identified as the major route of transmission (Van Lettow, et al., 2011), and without 
intervention about 15% babies born to women living with HIV are infected at birth; an 
additional 15% acquire the virus through breastfeeding.  
1.1.3 HIV and PMTCT in Malawi 
Since 2003, the primary prophylaxis regimen in the WHO-recommended PMTCT 
programme has been the Option A ‘opt-in’ strategy. In the Option A programme, women 
attending antenatal care are advised to go for HIV testing should they so wish (Perez, 
Zvandaziva,  Engelsmann, and Dabis, 2006); if found HIV-positive they were originally 
given single-dose Nevirapine (SD-NVP) to be taken when labour starts, and this has 
subsequently been revised to a short course of ARVs (Zidovudine) from 28 weeks gestation 
until 1 week after delivery and NVP syrup for the infant to minimise the risk of HIV 
transmission (Ministry of Health [MOH], 2008). In 2006, Malawi approved HIV testing and 
counselling (HTC) for all women in antenatal care clinics (ANC), with the option to refuse or 
‘opt out’ (Center for Disease Control [CDC], 2004). The aim was to enable all pregnant 
women to be screened for HIV infection. The guidelines recommended that HIV-infected 
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women have their WHO clinical staging determined and that they be initiated in the national 
antiretroviral therapy (ART) programme on highly active antiretroviral treatment (HAART) 
if in stages III or IV, or if in stages I and II and CD4 count <350, (MOH, 2008). By 2010, 
PMTCT services were available in all ANC facilities (World Health Organization [WHO], 
UN and United Nations International Children Emergency Funds [UNICEF], 2011), but even 
though HIV testing coverage among pregnant women rose from 10% in 2005 to 66% in 2010 
it still remains low. In 2011 only 53% of pregnant women received more efficacious ARV 
regimes for PMTCT (WHO, UN and UNICEF, 2011). According to the ACCESS year end 
project report (2010), despite the introduction and scale-up of PMTCT services, the number 
of women accessing these services has not come close to the estimated need. Policies have 
been updated, space created and supplied with medicine, supplies and equipment, providers 
have been trained, and yet women accessing high-quality services remain low. National 
statistics also indicated minimal progress in the reduction of MTCT, as evidenced by the 
increasing trend of HIV-positive children needing ART each year (MOH, 2009). 
Van Lettow, et al. (2011) highlighted issues of the PMTCT programme uptake and outcomes 
in Malawi and concluded that there was low PMTCT programme efficiency and effectiveness 
under routine programme conditions in Malawi. Poor uptake may in part be related to an 
unwillingness of mothers to reveal their HIV status; in this study HIV-infected mothers who 
denied their status were among the least likely to comply with the recommended strategies. 
This is confirmed by other qualitative study findings by Chinkonde (2009) and O’Gorman, 
Nyirenda and Theobald (2010) which reveal that low uptake, or drop-out of PMTCT services 
in Malawi was related to avoidance of involuntary HIV disclosure, fear of negative 
community reactions and lack of support from husbands. 
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Since the initial publication of WHO guidelines in 2006, important new evidence has 
emerged on the value of antiretroviral (ARV) prophylaxis for prevention of mother to child 
transmission of HIV. The Kesho Bora randomised controlled clinical trial (2011) which was 
conducted in five sites in Burkina Faso, Kenya and South Africa is one of the studies that 
informed WHO on the use of triple ART prophylaxis during pregnancy and breastfeeding as 
compared to short-course ARV prophylaxis to prevent MTCT. The Kesho Bora results 
showed that in HIV-positive mothers with CD4 200–500 cells/mm
3
, triple-ARV prophylaxis 
given during pregnancy and continued during breastfeeding significantly reduces risk of HIV 
transmission to infants and improves HIV-free survival, compared with the standard 
recommended short-course regimen. These findings led the WHO to issue revised guidelines 
in 2010 to support a global scale-up of PMTCT interventions in resource-limited settings 
(WHO, 2010).These recommendations have two prophylaxis options; 
Option A: Ante partum AZT (from 14 weeks), sd-NVP at onset of labour, AZT + 
 3TC during labour and delivery, and AZT + 3TC for 7 days postpartum 
Option B: Triple ARV (from 14 weeks until one week after all exposure to breast 
 milk has ended) 
The 2010 guidelines recommend initiation of lifelong ART for all pregnant women with 
severe or advanced clinical disease (stage 3 or 4), or with a CD4 count at or below 350 
cells/mm3, regardless of symptoms or gestation and continue throughout pregnancy, delivery, 
breastfeeding and thereafter. The new ART eligibility criteria emphasise the need for access 
to CD4 testing (WHO, 2010). 
1.1.4 Changing from Option A to Option B+ 
Following WHO recommendations, and drawing on a decade of experience and monitoring 
data from the HIV programmes in Malawi, a group of physicians and researchers argued that 
practical realities in Malawi prevented widespread implementation of either Option A or 
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Option B (Schouten, Jahn, Midian, Makombe and Mthambalala, 2011). The team concluded 
that complicated protocols and reliance on CD4 counts created an obstacle for the majority of 
women trying to access PMTCT interventions, resulting in low uptake and high losses in 
follow-up. In July 2011, the Ministry of Health started implementing a modified version of 
WHO Option B, in which all HIV-positive pregnant women are initiated on lifelong 
treatment regardless of clinical or immunological stage. This new PMTCT approach is 
formally known as Option B+ strategy (Schouten, et al., 2011) 
Table 1-1 Three options for PMTCT 
 Treatment 










Option A Triple ARVs starting as 
soon as diagnosed, 
continued for life 
Antepartum: AZT 
starting as early as 14 
weeks gestation. 
Intrapartum: at onset of 
labour, single-dose 
NVP and first dose of 
AZT/ 3TC. Postpartum: 
daily AZT/3TC through 
7 days  
Daily NVP from birth 
until 1week after 
cessation of all 
breastfeeding; or, if not 
breastfeeding or if 
mother is on treatment, 
through age 4–6weeks 
Option B Triple ARVs starting as 
soon as diagnosed, 
continued for life 
Triple ARVs starting as 
early as 14 weeks 
gestation and continued 
intrapartum and through 
childbirth if not 
breastfeeding or until 1 
week after cessation of 
all breastfeeding 
Daily NVP or AZT 
from birth through age 
4–6 weeks regardless of 
infant feeding method 
Option B+ Triple ARVs starting as 
soon as diagnosed, 
continued for life 
Triple ARVs starting as 
soon as diagnosed, 
continued for life 
Daily NVP or AZT 
from birth through age 
4–6 weeks regardless of 
infant feeding method 
Source: WHO programmatic update, 2012 
Malawi is the only country to have embarked in such a way on bold expansion of the 
established global guidelines. The Malawi Ministry of Health takes the view (MOH, 2010) 
that lifetime treatment is not very risky to the women, is practical and has far-reaching health 
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benefits. Although a feasibility appraisal conducted prior to policy implementation (MOH, 
2009) recommended that the proposed implementation be done in phases, the actual 
implementation in fact took place on a massive country-wide scale, and the projected yearly 
increase of people to be started on ARVs has major implications for government’s capacity to 
sustain the initiative - involving, as it does, a steep rise in requisite quantities of drugs and 
supplies and sharply intensified pressure on health personnel availability, infrastructure, 
transport and logistics. Notwithstanding these difficulties, the new measures will clearly 
benefit client health; more clients will have earlier access to more expensive ARVs, which 
will continue throughout their lives. For a woman initiated on lifetime ARVs there is 
protection in subsequent pregnancies and reduced HIV transmission to sexual partners.  
According to UNICEF (2012), implementation of Option B+ strategy in Malawi has been 
positive, with a more than 5-fold increase since its commencement in the number of pregnant 
and breastfeeding women initiating ART. This research investigates the lived experiences of 
women who are on Option B+. 
 
Figure 1-1 Number of new antiretroviral treatment (ART) initiations, 2008–2012 
Source: Chimbwandira, Mhango, Makombe, Midiani, Mwansambo, et al. (2013)  
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The success of the Malawi initiative prompted the WHO to endorse Malawi’s approach as a 
third PMTCT Option in its executive summary document, Programmatic update: use of 
antiretroviral drugs for treating pregnant women and preventing HIV infection in infants, 
released in April, 2012. So far, Uganda and Swaziland have adopted Option B+ strategy, 
while other countries like South Africa are still discussing it (Mnyani, 2012), but even though 
it is evident that Option B+ is a good choice for Malawi, there is fear that the programme 
may be affected by poor utilisation, adherence and retention. Currently all efforts are directed 
towards rolling out the programme to increase access, and less attention is being directed 
towards the primary user: pregnant and breastfeeding women. Nothing is known about the 
experiences of women on the programme so far. 
1.1.5 Integration of ART and PMTCT services 
Increasing access to ART among pregnant women has frequently been a challenge, mainly 
because PMTCT services and ART services have often functioned separately (UNICEF, 
2012). Pregnant women were normally managed within family health units where routine 
antenatal care and ARV prophylaxis were provided to mothers and infants together with 
follow-up during postnatal care, while other HIV-infected individuals went through the 
national ART programme. The public approach to ARV provision taken by Malawi requires 
an integration of ART and PMTCT so that nurses administer ART to pregnant women in all 
health care facilities. Malawi’s integrated guidelines for HIV service provision, issued in 
2011, include antenatal care, maternity care, under-5 clinics, family planning clinics, exposed 
infant/pre-ART clinics and ART clinics (MOH, 2011). Although the national ART 
programme and PMTCT are integrated, their operating systems are still slightly different, 


















Figure 1-2 Essential steps in PMTCT and ART 
Source: Ministry of Health (2008) 
What happens in practice is that a pregnant woman who walks into an antenatal clinic for 
routine care is tested for HIV without much choice, and if tested positive she is started on 
lifelong ARV treatment immediately, an approach described by Dieffecbach and Fauci 
(2009) as ‘test and treat’. The woman’s thoughts, fears and concerns are seldom addressed in 
this scenario, as clinic staff are trained to seize every opportunity for identifying and treating 
HIV-infected women.  
Brinkhof, et al. (2008) give an insight on an existing problem with patient retention strategies 
on ART programmes in Africa. They carefully analysed 15 ART treatment centres and 
observed that early client loss was increasingly common when programmes were scaled up. 
 
Screened for eligibility for ART e.g. 
WHO stage III or IV, low CD4-
lymphocyte count or low CD4% 
 HIV testing and 
counselling 
 HIV positive 
 
HIV positive eligible for 
ART -opportunistic 
infections stabilised 
 Group counselling with guardian 
    Individual counselling for ART 
Patient understands implications of 
ART 
 
 START ART 















HIV pre-test information  
(Group) 




ARV treatment for life  
(start same day) 
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With the increased numbers of women enrolled on the Option B+ strategy, issues of loss to 
follow-up can be anticipated. On the other hand, ART preparatory classes that are 
prerequisite in the national ART programme have a major influence on the outcome of clients 
(only those who understand the implications, are started on treatment) which is not the case 
with PMTCT. This may result in initiation of a long-term treatment therapy to women who 
are not psychologically prepared. Chisha (2010) found that readiness for lifetime 
commitment taking ARVs was a determinant in adherence. 
In the Option B+ strategy, healthy HIV-positive women are asked, without choice or 
preparation, to make a lifelong drug commitment. The practicality of this demand is 
debatable. Statistics indicate that out of 6,094 females who were pregnant from April to June 
2012, 97% were started on Option B+ in WHO clinical stage 1 or 2 (MOH, 2012). Although 
these are healthy pregnant mothers who may not see the need for a lifelong treatment, the 
benefits of the Option B+ strategy may motivate them to access and adhere to the programme 
for their own health and that of their partners and children.  With many pregnant and lactating 
women being enrolled on ART, and with ART requiring consistent adherence for the rest of 
ones’ life, it is essential to explore the experiences of these women on the programme to 
determine what lifelong treatment means to them. It is not known whether women taking the 
Option B+ strategy see it as a benefit for improvement of health, or as just another burden to 
be endured.  
1.2 Problem statement 
Worldwide, it is women rather than men who are the most affected by HIV and AIDS. With 
increasing evidence of HIV infection among women of reproductive age, incidence of 
mother-to-child transmission of HIV is high. At the same time, there has also been significant 
progress in the global scale-up of PMTCT of HIV, including in high-burden and resource-
10 
 
limited settings (WHO, 2010) such as Malawi, and elimination of MTCT of HIV is now 
considered to be a realistic public health goal. In July 2011 the Department of HIV and AIDS 
in the Malawi Ministry of Health, began implementing an innovative policy for pregnant 
women living with HIV which came to be known as the Option B+ strategy, formally defined 
as “universal lifelong ART for all HIV-infected pregnant and breastfeeding women 
regardless of clinical or immunological stage” (MOH, 2011), and this resulted in an 
astounding 88% increase in the total number of all patients initiating ART in the national 
programme after implementation of the new strategy for just one quarter (MOH, 2012). 
The benefits of the new protocol are undeniable both therapeutically and in terms of access, 
but it also has enormous consequences for the health system; and while major implications 
such as programme sustainability have been reported in the literature, but little attention has 
been given to how the programme is experienced by the participants themselves, even though 
this is a situation where healthy women are asked to make a lifelong drug commitment. 
Schouten et al. (2011) point out that PMTCT Option B+ is untried and untested as a public 
health model, and that no assessment has yet been made of community acceptability for this 
approach. Participating women’s experiences should be high on the list of issues still to be 
explored because they could well have a positive or negative influence on their participation.  
A review by Graham and Hussein (2003) of HIV and AIDS and maternal mortality 
recommended assessment also of the effects of HIV and AIDS on the uptake of maternal 
health services. In areas where PMTCT is a component of maternity care, women might 
avoid maternal health facilities because of HIV-related fears, and a few studies have 
examined the impact of these fears on women’s decisions about where to deliver (Etiebet, 
Fransman, Forsyth, Goetzee, and Hussey, 2004). For maximum reduction in MTCT of HIV, 
the maternal regimen needs to commence antenatally and continue consistently throughout 
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breastfeeding (Chasela et al., 2010). If women’s experiences on Option B+ strategy are 
negative it may lead to poor adherence (with increased MTCT) and avoidance of health 
facilities for antenatal care and delivery (with increased pregnancy complications and 
maternal and infant HIV morbidity and mortality). At this early stage of Option B+ 
implementation little or nothing is known about how pregnant women understand, accept, 
utilise or adhere to the long-term regime. Coutsoudis et al.  (2013) argue that with there still 
being so many unknowns the push for countries to switch to Option B+ is premature. The 
purpose of the present study is to help build a fuller understanding of the public health 
potential of Option B+ strategy through an exploration of pregnant women’s experiences in 
utilising the service. 
1.3 Aims and objectives of the research 
1.3.1 Aim of the study 
To explore the lived experiences of HIV-positive women receiving care on PMTCT Option 
B+ strategy in a selected hospital in Malawi. 
1.3.2 Specific objectives in the study 
1) Describe and interpret the experiences of  HIV-positive women receiving care on 
PMTCT Option B+ strategy 
2) Describe and interpret sociocultural factors that affect HIV-positive women receiving 
care on PMTCT Option B+ strategy. 
1.3.3 Research questions 
1) What are the experiences of HIV-positive women when participating on PMTCT 
Option B+ strategy? 
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2) What sociocultural factors affect HIV-positive women receiving care on PMTCT 
Option B+ strategy? 
1.4 Significance of the study 
The PMTCT Option B+ strategy is a bold initiative by the Malawi government to minimise 
mother-to-child transmission of HIV and prevent maternal and infant mortality by providing 
universal lifelong ARV drugs for all HIV-infected pregnant and breastfeeding women, 
regardless of clinical or immunological stage (MOH, 2011). According to Bobrow (2008), 
the PMTCT programme continues to face obstacles to participation by the women concerned, 
resulting in low uptake and loss to follow-up of women and their newborns at different stages 
of the programme (Peltzer, Jones, Weiss and Shikwane, 2011). Issues of participation are 
becoming more critical since there has been a huge increase in Malawi in the number of 
women being tested for HIV during pregnancy (Bobrow, 2008). Factors that affect 
participation in PMTCT programmes have been discussed but are not conclusive in 
predicting a similar trend in the Option B+ strategy. The purpose of this study is therefore to 
investigate how Option B+ strategy is experienced by HIV-positive pregnant and 
breastfeeding women and to understand the individual meanings attached to the experience. 
The findings of this research will highlight experiences of women on PMTCT in order to gain 
more insight on factors influencing their participation. These experiences will be a base for 
recommendations for improving programme performance, which is crucial for refining 
practice and predicting outcome as the programme fully rolls out. The findings and 
recommendations will influence policy change on HIV care in pregnancy to ensure that 
programme implementation meets women’s needs. The recommendations will also be of 
service to educators in curriculum development for learning institutions and the study’s 
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findings will contribute to the body of knowledge on the phenomena and serve as a baseline 
for future research. 
1.5 Operational definitions 
HIV and AIDS 
HIV is the human immunodeficiency virus. It is the virus that can lead to acquired immune 
deficiency syndrome, or AIDS (CDC, 2012). AIDS is the late stage of HIV infection, when a 
person’s immune system is severely damaged and has difficulty fighting diseases and certain 
cancers (CDC, 2012). HIV is spread through having unprotected sex with HIV-infected 
person and through babies being born to an HIV-infected mother whereby the virus can be 
passed from mother to child during pregnancy, birth, or breastfeeding.  
Option A strategy 
Option A is a WHO-advised PMTCT intervention that aims to provide longer antiretroviral 
(ARV) prophylaxis for HIV-positive pregnant women with relatively strong immune systems 
who do not need ART for their own health. This is believed to reduce the risk of HIV 
transmission from mother to child (WHO, 2010). In this study, Option A strategy refers to 
maternal antepartum AZT starting as early as 14 weeks gestation; intrapartum single-dose 
NVP and first dose of AZT/3TC, and daily AZT/3TC through 7 days postpartum, including 
daily NVP for the infant from birth until 1 week after cessation of all breastfeeding; or, if not 
breastfeeding or if mother is on treatment, through age 4–6 weeks (WHO, 2010). 
Option B+ strategy 
Since the publication of revised guidelines by the WHO in 2006, important new evidence has 
emerged on the use of antiretroviral (ARV) prophylaxis for the prevention of mother-to-child 
transmission of HIV (PMTCT), and on safe feeding practices for HIV-exposed infants. 
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Option B+ strategy is a PMTCT intervention that provides universal lifelong ART for all 
HIV-infected pregnant and breastfeeding women regardless of clinical or immunological 
stage (MOH, 2011). This is a basis for effective PMTCT interventions that will virtually 
eliminate the number of new paediatric HIV infections in resource-limited settings. In this 
study Option B+ refers to the provision of triple ARVs to HIV-positive, pregnant and 
breastfeeding women starting as soon as diagnosed, continued for life including daily NVP or 
AZT from birth through age 4–6 weeks regardless of infant feeding method (MOH, 2011). 
PMTCT 
PMTCT (prevention of mother-to-child transmission of HIV) are global interventions to 
minimise the risk of HIV infection from an infected mother to an infant. HIV is transmitted 
from a mother to an infant before, during, and after labour; MTCT of HIV can therefore be 
prevented by antiretroviral therapy, obstetric interventions, and changes in breastfeeding 
practices. ART is considered a priority for pregnant and breastfeeding women for effective 
reduction of mother-to-child transmission of HIV (MOH, 2008). In this study PMTCT refers 
to the primary interventions with voluntary testing and counselling of pregnant women in 
antenatal clinics, the use of antiretroviral drugs and adoption of appropriate infant feeding 
options (Department of Health [DOH], 2008). 
HIV-Positive women 
In this study HIV-positive women refers to women tested for HIV where antibodies against 
the virus were detected on a blood test. 
Lived experiences 
Lived experience is an individual’s expression of how she views the everyday world, 
conveyed in words, personal feelings, attitudes, and behaviours (Colaizzi, 1978). This term 
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will be used to describe individuals who have lived through the experience of being HIV-
positive and participating in the PMTCT Option B+ strategy. 
1.6 Conclusion 
In an overview of HIV and women, this chapter highlighted the situation in Malawi in 
relation to PMTCT. The efforts to minimise maternal and child morbidity and mortality in 
Malawi through the adoption of Option B+ strategy and other related issues were briefly 
indicated, and the aims and objectives of the study were identified as being to seek 
understanding and interpretation of the lived experiences of HIV-positive women on Option 
B+ strategy in order to inform changes in practice, policy, education and research.  
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Chapter 2  Research methodology 
2.1 Introduction 
In the previous chapter, the world, regional and country HIV and AIDS statistics in relation 
to women were discussed with the aim of putting a context to the research problem and 
objectives. This chapter therefore outlines the approach used in the research in seeking to 
answer the research questions for the purpose of gaining understanding of, and providing 
meaning to, the lived experiences of HIV-positive women receiving care on PMTCT Option 
B+ strategy. It indicates the research paradigm that informed the research approach and how 
it was applied in relation to the study setting, sampling and data management. 
2.2 Research paradigm 
This research study was based on the constructivist paradigm. Within this worldview, the 
qualitative approach was applicable. Constructivism as the mode of inquiry offers the 
possibility for a researcher to examine the unique experience of humans as they live and 
make sense of their social worlds, and paradigms for human inquiry are in turn characterised 
according to the ways in which they respond to certain primary philosophical assumptions: 
ontological assumptions, relating to the study of being; epistemological, assumptions, 
relating to how we know what we know, and axiological assumptions, concerning the role of 
values in the inquiry (Crotty, 1998). 
The ontological nature of constructivist enquiry lies in the way that social reality is 
approached as the product of processes by which social actors together negotiate the 
meanings for action and situations (Crotty, 1998); on this premise, reality is considered to be 
multiple and mentally constructed by individuals. Constructivists thus take the position of 
relativism that assumes that different worlds constitute people with diverse ways of knowing, 
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distinguishable sets of meanings and separate realities (Crotty, 1998). This implies that reality 
is subjective and is the ontological assumption from which this study sets out to explore the 
lived experiences of HIV-positive women receiving care on PMTCT Option B+. 
Epistemologically, constructivists assume that meaning is not discovered, but constructed. 
According to Crotty (1998), knowledge is maximised when we engage with phenomena and 
make sense of them directly and immediately. The lived experiences of women on Option B+ 
will therefore be explored through an interaction between the researcher and the participants; 
hence, the findings will be the creation of this interactive process. In other words, the 
research will be conducted subjectively and in a value-laden context, this then representing 
the axiological dimension of the research project. 
In this study, the ontological assumption was that HIV-positive women have individual 
unique experiences on Option B+ strategy, the meaning of which is constructed as they 
receive care. Epistemologically, these meanings were explored and understood by interacting 
with the women directly without prior assumptions, thoughts or feelings (axiologically), 
which was useful as a way of identifying and interpreting their experiences. 
2.3 Philosophical framework 
A phenomenology approach was chosen as the philosophical framework for this study, which 
also had an exploratory dimension in view of the paucity of existing research that could 
provide information on the lived experiences of HIV-positive women receiving care on 
PMTCT Option B+ strategy. Crotty (1998) discusses phenomenology, which is rooted in a 
philosophical tradition developed by Husserl and Heiddeger, as an approach to discovering 
the meaning of people’s life experiences. Phenomenologists investigate subjective 
phenomena in the belief that critical truths about reality are grounded in people’s lived 
experiences. According to Polit and Beck (2004), the four aspects of lived experiences that 
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are of interest to the phenomenologist are: lived space, referring to the external environment 
of the subject (home, clinic, hospital, etc.); lived body, referring to the physiological or 
psychological changes that affect the individual (feelings, emotions); lived time, referring to 
the period of sickness or care (the period of pregnancy); and lived human relations, referring 
to the way a person relates to  friends, family and community members. 
The goal of phenomenological inquiry is to fully describe the lived experience, and the 
perceptions to which it gives rise, through prolonged engagement with a small group of 
participants which enables patterns and relationships to emerge (Creswell, 2009). Two 
schools of phenomenology which have been described are descriptive phenomenology and 
interpretive (hermeneutic) phenomenology. 
2.3.1 Descriptive (transcendental or eidetic) phenomenology 
Descriptive phenomenology was first developed by Husserl (1835-1938), and his philosophy 
emphasised descriptions of the meaning of human experience. Husserl’s belief was that 
causal relationships cannot in themselves explain phenomena; there has to be a person to 
experience the phenomena, and the phenomena need to be described within the context in 
which they occur (Burns and Grove, 2001). Descriptive phenomenology thus asks, “what do 
we know as persons” with the emphasis on describing the experience. According to Crotty 
(1998), Husserlian phenomenologists believe that although self and worlds are mutually 
shaping; it is possible to bracket oneself from ones beliefs in order to let the experience of 
phenomena speak first hand. Polit and Beck (2004) describe bracketing as a “process of 
identifying and holding in abeyance any preconceived beliefs and opinions about the 
phenomena”. This study proposed to explore the experiences of the participants going beyond 
Husserl’s approach by understanding and interpreting the lived experiences; the descriptive 
phenomenology approach was therefore not considered appropriate. 
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2.3.2 Interpretive (hermeneutic) phenomenology 
Interpretive (hermeneutic) phenomenology is based on the work of Husserl’s student and 
critic, Heidegger (1889- 1976), who moved away from Husserl’s philosophy into interpretive 
philosophy. Hermeneutics moves beyond the description or core concepts of the experience 
and seeks meanings that are embedded in everyday occurrences (Crotty, 1998). It uses lived 
experiences as a tool for better understanding of the social, cultural, political or historical 
context in which those experiences occur. Heidegger believed that people are shaped by the 
world in which they live; the world of each person is different and can thus only be 
understood in the context in which that person lives (Crotty, 1998). Differing from 
Husserlians, hermeneutic investigators do not believe bracketing can be achieved in totality; 
hence bracketing is seen not as a subtractive process of removing ones presuppositions but 
instead as a positive process, a way of seeing. Interpretative phenomenology asks “what is 
being”, with the emphasis on understanding and interpreting, rather than not just describing 
the experience (Polit and Beck, 2004). This approach matched the study’s aim and objectives 
in providing interpretation and meaning to the lived experiences of women on Option B+ 




Table 2-1 Comparison of phenomenological schools of thought 
 Husserl (1859-1938): 
descriptive phenomenology 
Heidegger (1889-1976): 
interpretive phenomenology  
Research question Descriptive Interpretive 
Assumptions Epistemology 
“what do we know as persons” 
Ontology 
“what is being” 
Bracketing Bracket biases to ensure neutrality Eliminate bracketing- personal 
awareness is intrinsic to 
phenomenological research 
Credibility Member checking No member checking 
Data analysis 
approach 
Colaizzi developed a method that 
involves observing human behaviour 
within its environment to examine 
experiences that cannot be 
communicated 
(Burns and Grove, 2009) 
Giorgi considers it important to 
identify the relationships of the units to 
each other and to the whole 
“Hermeneutic circle”  
(Burns and Grove, 2009) 
Data analysis 
process 
1. Read all the subjects’ description 
to acquire a feeling for them 
2. Return to each protocol and 
extract significant elements 
3. Spell out the meaning of each 
significant element 
4. Organise the formulated meanings 
into clusters of themes 
5. Results are integrated into an 
exhaustive description of the 
phenomena under study 
6. Formulate the exhaustive 
description into statements of 
identification 
7. Final validating step by returning 
to each subject 
1. Reading the entire disclosure of the 
phenomenon straight through to obtain 
a sense of the whole. 
2. Re-reading the same disclosure again 
in a purposeful manner to delineate 
each time that a transition in meaning 
occurs. 
3. Examining the previous determined 
meaning units for redundancies, 
clarification, or elaboration by relating 
meaning units to each other and to a 
sense of the whole. 
4. Reflecting on the meaning units and 
extrapolating the essence of the 
experience for each subject.  
5. Formalising a consistent description 
of the structure of the phenomenon 
across subjects by synthesising and 
integrating the insights achieved in 
previous steps. 
Source: Pallikkathayil and Morgan (1991); Burns and Grove (2009) 
2.4 Research approach  
The objectives of this research were to describe and interpret the lived experiences of HIV-
positive women on PMTCT Option B+ strategy, adopting a Heideggerian hermeneutic 
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approach. Hermeneutics is a qualitative research tradition, drawing on interpretive 
phenomenology that focuses on the lived experiences of humans and on how they interpret 
those experiences. Heideggerian phenomenology takes an ontological approach, asking the 
question, “what is the essence of these phenomena as experienced by these people?” 
According to Crotty (1998), this philosophy regards reality as subjective, which means there 
is no single reality because each individual has his or her own unique reality; 
correspondingly, the Heideggerian concept of “being in the world” acknowledges peoples’ 
physical ties to their world, and their personal context will be integrated into the way they 
experience the world and provide meaning to their experiences. 
As noted previously, the process of bracketing is not supported by Heideggerian 
phenomenologists because they regard it as impossible for the researcher to negate his or her 
own experiences related to the phenomenon under study (Crotty, 1998); presupposing prior 
understanding on the researcher’s part, they accordingly identify beliefs, assumptions and 
preconceptions about the research topic which are put in writing at the beginning of the study 
for self-reflection and external review.  
Interpretive phenomenology is used when the research question asks for the meaning of the 
phenomenon – hence its use in this study. Heidegger’s process of understanding (also known 
as the historicality of understanding) and the hermeneutic circle are the two essential 
components of Heideggerian phenomenology, as outlined below. 
2.4.1 Background 
Heidegger emphasises the historicality of understanding of one’s background or situatedness 
in the world. According to Koch (1995) and Laverty (2003), a person’s history or 
background, includes what a culture gives a person from birth and is handed down, 
presenting ways of understanding the world. Through this understanding, one determines 
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what is ‘real’, yet Heidegger also believed that one’s background cannot be made completely 
explicit. In the context of this study, participants were asked ‘background’ questions relating 
to their demographics, such as marital status and HIV diagnosis, which assisted in applying 
meaning to their experience on Option B+ strategy. 
2.4.2 Pre-understanding 
Pre-understanding is the meaning or organisation of a culture that is present before we 
understand and become part of our historicality of background (Laverty, 2003), and is not 
something a person can step outside of or put aside, as it is understood as already being with 
us in the world. According to Heidegger, pre-understanding is a structure for being in the 
world and he goes on to argue that nothing can be encountered without reference to a 
person’s background understanding. In this study, the researcher’s knowledge and experience 
working with HIV-positive women on Option B+ strategy was enhanced by understanding 
and interpreting their experiences. Koch (1995) and Laverty (2003) concur, arguing that 
meaning is found as we are constructed by the world, while at the same time we are 
constructing this world from our own background and experiences.  
2.4.3 Co-constitution 
According to Patterson and Williams (2002), co-constitution, as the term is used in 
hermeneutics, refers to a mutually defining inter-relationship between the persons and their 
world. It is thus impossible to separate the individual from his/her world. The authors go on 
to explain that co-constitution comprises activity from two sources, the individual orienting 
itself to the world, and the world revealing itself to the individual, thus co-constituting each 
other. Individuals therefore both construct their world and draw meanings from their 
experiences. During the interview process, data was collected through a series of co-created 
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questions, with main questions followed by probes that were influenced by preceding 
responses; in the context of PMTCT, common meanings will exist.  
2.4.4 Interpretation 
Heidegger describes a situation where nothing exists without reference to the background 
understanding, and claims that to be human is to interpret, because every encounter involves 
an interpretation influenced by an individual’s background or historicality. According to 
Laverty (2003), interpretation is seen as critical to the process of understanding, and this 
interpretive process is achieved through a hermeneutic circle which moves from the parts of 
experience, to the whole experience and back and forth again and again to increase the depth 
of engagement with and the understanding of texts. 
2.4.5 The hermeneutic circle 
Hermeneutic circle theory posits that it is not possible to really understand any one part of a 
work until you understand the whole, but it is also not possible to understand the whole 
without understanding all of the parts. The researcher’s pre-understanding of the phenomena 
is crucial in the context of hermeneutic approach to phenomenological research because it 
provides the background and frame of reference that provides meaning and understanding of 
the phenomena. Once interviews have been conducted and transcribed, an interpretive 
process of continuously relating a part of a text (transcribed interview) to the whole of the 
text known as hermeneutic circle or “circle of understanding” begins (Burns and Grove, 
2009). In this study, my preconceptions in terms of experiences and emotions were 
acknowledged and recorded during the interview process by keeping a reflective journal 


















Figure 2-1 The hermeneutic circle 
Source: Dummer, Brodwolf and Erath (2001) 
Despite the major contribution it makes in illuminating details of seemingly trivial aspects of 
human experience that might be taken for granted in seeking creating meaning and achieving 
a sense of understanding, phenomenological inquiry nonetheless faces criticism. One 
objection is that phenomenology abandons the scientific procedures of verification which 
means that research findings cannot be generalised to other situations, putting the overall 
benefit of the research in question (Mack, 2010). The phenomenological approach is also 
criticised for its ontological assumption which is subjective in nature; critics argue that not 
using a hypothesis, and involving oneself in the research, may yield biased results. 
2.5 Study setting 
Lincoln and Guba (1985) mandate that a naturalistic study must be carried out in a natural 
setting, arguing that this increases subjectivity of the study and promotes engagement. For the 
purpose of this study, one district hospital in the central region of Malawi was selected. The 










district covers an area of 3,356 km² and had a population of 511,792 as of 2012. It is the only 
government hospital in the district, is a referral hospital for 17 community health centres, and 
is conveniently situated within informal settlements. Services offered at the hospital include, 
but are not limited to, HIV and AIDS counselling and testing (HCT), an ARV clinic, and 
PMTCT. 
 
Figure 2-2 Malawi and its districts 
Source: Malawi Demographic Health Survey (MDHS, 2010) 
2.6 Study participants 
The target population for the study was HIV-positive women, pregnant or breastfeeding, who 
were receiving care under the PMTCT Option B+. The selected district hospital serves an 
average of 190 women attending maternal and child health clinics each day.  
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2.7 Sampling  
Purposive sampling was used in the study to invite participants on the basis of their being 
knowledgeable and informative about the phenomenon under study. According to Lincoln 
and Guba (1985), purposive sampling aims to detail the many specifications that give the 
context its uniqueness. Since very little is known about the lived experiences of women on 
Option B+, purposive sampling was ideal for this study in seeking insight into the new 
phenomena from selected information-rich cases. Babbie and Mouton (2001) acknowledge 
that “sometimes it is appropriate for a researcher to select his/her sample based on the 
knowledge of the population, its element and the nature of the research aims”. 
2.7.1 Inclusion criteria 
 HIV-positive women (pregnant or breastfeeding) within the district, , who were on 
the PMTCT Option B+ strategy  
 HIV-positive women willing to participate in the study and have their interviews 
digitally recorded 
2.7.2 Exclusion criteria 
 HIV-positive women on their first antenatal visit because they are introduced to 
Option B+ strategy on the same day, hence not considered to be experienced with 
the phenomena 
 HIV-positive women who did not want their interviews digitally recorded 
2.8 Initial participant sample 
The participant sample may be large or small, but it is considered sufficient when the amount 
of new information is scarce (Lincoln and Guba, 1985) – also known as data saturation. The 
study comprised five participants and data saturation was achieved.  
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2.9 Data collection process  
Ethical clearance to conduct this research was obtained from the Research and Ethics 
Committee of the University of KwaZulu-Natal and Malawi, and permission to conduct the 
study was obtained from the District Health Office of the selected research setting. 
Prior to the commencement of data collection for the study, the District Health Officer 
(DHO) and District Nursing Officer (DNO) of the selected district hospital was contacted in 
order to gain access to the Maternal and Child Health unit services. When permission was 
granted, an appointment was made to introduce myself to the clinic staff and explain my 
study purpose, objectives and procedures to the clinic in-charge, with whom I worked closely 
in identifying potential participants. Convenient days for the interviews were properly 
planned and coordinated with the clinic staff to avoid disturbing their routine work and 
patient flow.  
Women on Option B+ were identified during registration process through documentation in 
their health cards, if they met the inclusion criteria they were approached individually in the 
consultation rooms informed about the research, its purpose, and confidentiality issues in 
order to obtain their informed consent. Since each interview took time to conduct, they were 
scheduled in between waiting times for women in the clinic and an arrangement was made 
with the clinic staff so that when a woman was taken out of the queue to complete an 
interview she returned to her position in the queue to avoid any delay in her management. 
Women who completed their interviews after they had attended their clinic appointment were 
offered a drink and a snack during the interview as compensation for the extra time they spent 
at the clinic. The length of interview varied between participants, and the interviews were 




2.10 Data collection techniques 
2.10.1 In-depth interviews 
Data collection for this study relied primarily on in-depth interviews using an interview guide 
translated into the local language (Chichewa). Lincoln and Guba (1985) mention that 
collecting rich description of human experience is the researcher’s responsibility, to be done 
through intensive interviews with a small number of people. In this study, the respondents 
were fully aware that they were being interviewed, and they understood the purpose of the 
interview and how the information would be used (i.e., overtly). All verbal data was collected 
in Chichewa, in a relaxed atmosphere, and sufficient time was provided to enable complete 
description of phenomena. Since it had been anticipated that the interviews would be lengthy, 
they were digitally recorded to avoid memory bias and error in written notes during verbatim 
transcription; women who agreed to participate in the research but refused to be recorded 
were therefore excluded from the study. Polit and Beck (2004) strongly encourage recording 
of interviews rather than written notes, if only to minimise bias from the interviewer’s 
memory and personal views. This technique was chosen for the study to capture the detailed 
account of phenomena as lived by participants. This being my first qualitative research, two 
practice interviews were conducted to familiarise myself with the interview guide for more 
effective data collection; these two interviews have not been included in the analysis. 
2.10.2 Participant observation 
This form of unstructured data collection, according to Lincoln and Guba (1985), permits the 
researcher to use self as a data source (Polit and Beck, 2008) and see the world as the 
participant sees it. Participants’ non-verbal cues during interview were observed to assess for 
affective responses. This technique helped to provide more insight into the participants’ 
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world that would not have otherwise be described; these observations were recorded in field 
notes to enable meaningful interpretation of participants’ experiences. 
2.11 Data analysis 
Data collection and analysis in this study occurred simultaneously so that the search for 
themes and concepts began from the moment data collection commenced (Lincoln and Guba 
1985). Only one interview was conducted in a day to allow data analysis of each interview to 
identify emerging themes that were used in the proceeding interviews. In this study, the 
collected Chichewa information was translated back to English for analysis which also 
included language interpretation. Using the recorded interviews and written notes, translation 
and transcription verbatim, and analysis was done using Giorgi’s approach (Pallikkathayil 
and Morgan, 1991): 
 Reading the entire disclosure of the phenomenon straight through to obtain a sense of 
the whole. 
 Re-reading the same disclosure again in a purposeful manner to delineate each time 
that a transition in meaning occurs. This is done with the intention of discovering the 
essence of the phenomenon under study. The end result is a series of meaning units or 
themes. 
 Examining the previous determined meaning units for redundancies, clarification, or 
elaboration by relating meaning units to each other and to a sense of the whole. 
 Reflecting on the meaning units and extrapolating the essence of the experience for 
each subject. Systematic interrogation of each unit is undertaken for what it reveals 
about the phenomena under study for each subject. During this process each unit is 
transformed into the language of psychological science if relevant. 
 Formalising a consistent description of the structure of the phenomenon under study 




2.12 Data management 
All recordings were downloaded on a computer protected by a password and labelled using 
participants’ pseudo-details and interview date, with back-up copies stored on a memory 
stick. Data analysis is the systematic organisation and synthesis of research data (Polit and 
Beck, 2004). The data collection tools were stored under lock and key in the School of 
Nursing at the University of KwaZulu-Natal where they will be held for a period of 5 years, 
and only the researcher and research supervisor will have access to the data. 
2.13 Trustworthiness  
The criteria used in this study are outlined by Lincoln and Guba (1985), and have been 
described by Polit and Beck (2004) as the gold standard for qualitative research. 
Trustworthiness is the degree of confidence in qualitative research data which is assessed 
using the criteria of credibility, transferability, dependability and confirmability. 
2.13.1 Credibility 
According to Lincoln and Guba (1985) credibility involves carrying out the study in a way 
that makes the study findings believable and taking steps to demonstrate credibility to 
consumers. It refers to the confidence in the truth of the data and its interpretation. Due to the 
likelihood of participants discussing the study questions with others in the waiting queue, 
only one interview was conducted in a day therefore minimising the possibility that a person 
who already knows about the study would be sampled, hence preventing data contamination. 
Member checking 
Lincoln and Guba (1985) regard member checking as a crucial technique for establishing 
credibility of qualitative data but Giorgi argues against validation by the participants 
(Reiners, 2012). Giorgi regards it as inappropriate to ask participants or external judges for 
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validation since the researcher has not bracketed their biases, and according to Heidegger’s 
philosophy, the depth of involvement of researchers confirms credibility. In this study, my 
personal engagement and reflection during the study and the interpretive nature of the data 
analysis method did not necessitate confirmation. 
2.13.2 Transferability 
Phenomenologists cannot specify the external validity of an enquiry (Lincoln and Guba, 
1985) but the researcher can provide a thick description of the findings to enable someone 
interested to conclude whether to make a transfer. Transferability in this study was achieved 
by providing a rich and thorough description of study processes, in harmony. The authors 
note that the responsibility of the researcher is to provide a data base in the research report 
that makes transferability judgements to other contexts possible. 
2.13.3 Dependability 
Lincoln and Guba (1985) acknowledge that there is no credibility without dependability; this 
implies that it is possible to use techniques outlined in relation to credibility to demonstrate 
dependability. In this study dependability was also achieved through scrutiny of relevant 
supporting documents by an external reviewer. 
2.13.4 Confirmability  
In this study, inquiry audit was used to support dependability and credibility. Confirmability 
is the objectivity and neutrality of the data which ensures congruent opinions between two 
independent people about the data’s accuracy, relevance or meaning. Collection of research 
materials and documentation such as raw data and reflexive notes were undertaken to allow 
an independent audit (Lincoln and Guba, 1985). 
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2.14 Ethical issues 
Ethics is defined as a system of moral values concerned with the degree to which research 
procedures adhere to professional, legal and social obligations to the study participants (Polit 
and Beck, 2004). This study was conducted ethically with due consideration given to the 
protection of the rights of human subjects; according to Brink (2006), a researcher is 
responsible for conducting research in an ethical manner and must pay attention to all such 
requirements.  
The three main principles that helped guide this study were: beneficence, respect for persons, 
and justice. 
Beneficence: Beneficence is a fundamental ethical principal in research which protects 
participants from physical and psychological harm (Polit and Beck, 2004). HIV and AIDS 
being a sensitive issue, inquiries in this study may lead women to reveal sensitive personal 
information that may have psychological consequences. To minimise this harm, questions 
were fully phrased and women were allowed to ask questions at the end of a session. The 
hospital’s counsellor also arranged for a follow-up session to help the women deal with 
possible emotional discomfort, but none of the participants opted to take this opportunity. 
According to Polit and Beck (2004), the risks and benefits of participating in a research study 
should be communicated, and since the study aims to make recommendations that will inform 
education, practice and research in the care of HIV-positive women on Option B+ strategy, 
detailed information was provided to participants in advance. 
Respect for persons: This principle is the foundation of the participant’s right to self-
determination and full disclosure (Polit and Beck, 2004). Participation in this study was 
voluntary and no incentives were given for participating. Participants were free to withdraw 
from the study at any point without penalty or risk to the treatment they were entitled to. 
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Information regarding this research study was offered to the participants in the study both 
verbally and in form of a document, and consent was obtained in writing or by thumb print 
for illiterate participants.  
Justice: All participants in the research study were selected according to research 
requirements, and treated equally and fairly throughout their participation. According to Polit 
and Beck (2004), fair treatment includes access for participants to professional assistance and 
honouring of agreements between researcher and participant, all of which were taken into 
consideration. The right to privacy and anonymity was maintained by using pseudonyms in 
the data collection tool, not real names, so that information cannot be traced back to 
individuals. 
2.15 Dissemination of results 
Copies of the research findings are disseminated to the institution where the study was 
conducted, the Malawi Ministry of Health, for use in practice, policy making and education, 
the University of Kwazulu-Natal Library and the University of Kwazulu-Natal Nursing 
department. The findings will also be presented at conferences and be published. 
2.16 Conclusion 
This chapter outlined the methodology used for the study to seek understanding of, and 
provide meaning to, the lived experiences of HIV-positive women receiving care on PMTCT 
Option B+ strategy. It indicated the research paradigm that informed the research approach 
and its application in relation to the study setting, sampling and data management.  
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Chapter 3  Literature review 
3.1 Introduction 
The methodology discussed in the preceding chapter outlined the research approach used in 
the study, and this chapter, highlights the review of literature in relation to the phenomena. 
Literature review is a survey of what is known and what is not known about the research 
problem. The timing of a literature review in qualitative research varies (Burns and Grove, 
2009); some phenomenologists believe that literature should not be reviewed until after the 
data have been collected and analysed so that the literature will not influence the researchers 
openness (Burns and Grove, 2009), while others prefer to review the literature at the outset of 
the study to seek out experiential descriptions of the phenomena and expand the researcher’s 
understanding of the phenomena from multiple perspectives (Polit and Beck, 2004). 
The review of literature for this study was done prior to data collection with the following 
purposes in mind: 
 to establish what is already known about the phenomena under study 
 to gain insight into what research has already been done in order to guide the 
research process 
 to identify gaps in literature for further enquiry 
The literature was sourced from databases such as Medline, Proquest, EBSCOhost, and 
Google scholar and from a number of text books. Very little literature was found which could 
provide information regarding the experiences of women on Option B+ strategy. 
The review of literature is organised as follows: 
 Global interventions to reduce MTCT and scaling-up of PMTCT 
 PMTCT in Malawi  
35 
 
 Process of PMTCT 
 Experiences on Option B+ strategy 
 Implications for policy change 
3.2 Global interventions to reduce MTCT and scaling-up of PMTCT  
HIV is the leading cause of mortality among women of reproductive age worldwide and is a 
major contributor to maternal, infant and child morbidity and mortality (WHO, 2009; 
UNAIDS, 2009), making PMTCT a global priority. PMTCT is a key component of overall 
HIV prevention efforts and represents an opportunity to stem the tide of the HIV epidemic 
through improved maternal health and infant HIV-free survival. According to the PEPFAR 
independent expert panel which reported in terms of Global Leadership Against HIV/AIDS, 
Tuberculosis, and Malaria Reauthorization Act of 2008 ( “Lantos and Hide United State 
Global Leadership,”  2008), comprehensive PMTCT involves a 4-pronged approach: 
1. Primary prevention of HIV infection among women of childbearing age 
2. Preventing unintended pregnancies among women living with HIV 
3. Preventing HIV transmission from women living with HIV to their infants, and 
4. Providing appropriate treatment, care and support to mothers living with HIV 
and their children and families. 
PMTCT has been the focus for the international HIV and AIDS response as reflected in the 
Declaration of Commitment on HIV and AIDS adopted at the United Nations General 
Assembly special session on HIV and AIDS in 2001 (UN General Assembly, 2001), the 
President's Emergency Plan for AIDS Relief (PEPFAR) in 2002 (AIDS Virus Education and 
Research Trust [AVERT], 2011), the Abuja Call to Action Towards an HIV-free and AIDS-
free generation in 2005 (Inter-Agency Task Team [IATT], 2012), the political declaration of 
the United Nations General Assembly high-level meeting on AIDS to work towards universal 
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access to HIV prevention, treatment, care and support in 2006 (UN General Assembly 
Special Session [UNGASS], 2008), and numerous other high-level statements by multilateral 
organisations (PEPFAR, 2010). Scale-up of PMTCT services as an important aspect of access 
also falls in line with the Obama administration’s strong support for empowerment of women 
and improving the health of women, children and families through the Global Health 
Initiative (GHI), and it contributes to Millennium Development Goal (MDG) 4 (Reduce 
Child Mortality), MDG 5 (Improve Maternal Health) and MDG 6 (Combat HIV and AIDS, 
Malaria and Other Diseases). 
There have been significant achievements in PMTCT in a number of countries, with 70 of 
123 reporting low- and middle-income countries having established a national PMTCT scale-
up plan for implementation of provider-initiated (‘opt-out’) HIV testing in antenatal care 
(ANC) settings (Access to Clinical and Community Maternal, Neonatal and Women’s Health 
Services [ACCESS] Report, 2010), with improved rates of HIV counselling and testing for 
pregnant women. According to the PEPFAR Independent Expert Panel report (PEPFAR, 
2010), in six of the ten countries estimated to have the largest numbers of pregnant women 
living with HIV (Kenya, Malawi, Mozambique, South Africa, Tanzania and Zambia), rates of 
counselling and testing for pregnant women have risen to 60–80%, including provision of 
ARVs for PMTCT. In resource-rich countries like the United States, there has been dramatic 
reduction of MTCT since 1994, with a 67% drop since the introduction of Zidovudine (AZT) 
during pregnancy, labour and to the newborn, as reported in clinical findings on the 
Paediatric AIDS Clinical Trials Group (PACTG) 076 protocol. Early identification of HIV 
infection among pregnant women through routine antenatal HIV testing, provision of 
antiretroviral treatment to HIV-infected pregnant women, elective caesarean delivery, and 
avoidance of all breastfeeding, have reduced the risk of HIV transmission to infants in the 
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United States and Europe, and in other countries with well-resourced health systems, to 
approximately 1–2% (Townsend et al., 2008; PEPFAR, 2010). 
In resource-limited countries, clinical trials have identified prophylactic antiretroviral drug 
regimens for use in treating pregnant women living with HIV infection and preventing HIV 
infections in infants. WHO (2010) guidelines emphasise the importance of providing ART 
for women who require it for their own health, and of regimens such as AZT plus single-dose 
intrapartum/newborn Nevirapine (SD-NVP) for PMTCT in women who do not require 
therapy for their own health. According to the WHO (2010), women who test positive must 
be assessed for treatment eligibility by CD4 test and clinical examination. Increased 
availability of CD4 tests in antenatal settings is critically needed but is not a reality for many 
countries, which is a serious challenge in efforts to extend PMTCT. Even though the majority 
of pregnant women are clinically well, many are likely to be eligible for treatment based on 
low CD4 count, which gives urgency to the need for intervention in provision of treatment or 
prophylaxis during the intrinsically limited time period of the pregnancy (PEPFAR, 2010). 
Implementation has nonetheless been slow. 
The PEPFAR Independent Expert Panel (PEPFAR, 2010) reported that reasons for low rates 
of PMTCT utilisation among pregnant women include lack of availability or access to 
antenatal and PMTCT services, and difficulties in integrating PMTCT interventions within 
existing antiretroviral treatment and maternal and child health (MCH) services, but according 
to the same report even if all of the programmatic challenges of making services available are 
met, agreeing to testing, accepting HIV-positive status and following through on the 
recommended interventions nevertheless places a tremendous burden on the individual 
woman. In addition to other social barriers (including stigma) that may be detrimental to 
women’s health, disclosure of HIV infection to a partner, family or community member can 
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be extremely daunting (and in some cases even dangerous) for a woman who culturally may 
have very little decision-making power or personal independence. 
3.3 PMTCT in Malawi 
In 2003, the Malawi Ministry of Health (MOH) set a target of at least 75% of women 
attending ANC with PMTCT services by the end of 2010 (MOH/NAC/UNICEF, 2003), and 
by 2007 PMTCT services were available in 64% of health facilities (MOH, 2008). Despite 
the expansion of the PMTCT services in the country in recent years, the efficiency and 
effectiveness of these interventions remain unknown (Van Lettow et al., 2011). In 2011, 
responding to the challenge of providing the requisite universal access to CD4 cell-count 
testing for successful implementation of either of the two WHO recommended options, the 
MOH proposed a modified Option B (called “Option B+ strategy”), in which all confirmed 
HIV-infected pregnant and breastfeeding women are offered lifelong ART regardless of CD4 
count or clinical stage (MOH, 2011). This massive scaling up of testing and treatment has, 
however, given rise to an ethical debate on how best to prepare pregnant and breastfeeding 
women (Hardon et al., 2012). Some argue that there should be comprehensive pre-test 
counselling to help clients in consciously opting for testing, so that they are better prepared 
for subsequent issues of disclosure and compliance should they be HIV-positive (Yeatman, 
2007). Advocates of comprehensive counselling believe that routine testing approaches 
expose HIV-positive women to severe stigma and discrimination, for which they are ill-
prepared.  
PMTCT studies in Malawi have shown very high rates of consent for HIV testing but attrition 
in follow-up continues to be a serious problem (Bwirire et al., 2008). Manzi et al. (2005) 
found that while 95% of pregnant women attending antenatal care in Malawi tested for HIV, 
only 45% of HIV-positive pregnant women and 34% of babies born to HIV-positive mothers 
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received ARV prophylaxis. These findings are similar to those from other African countries 
such as Côte d’Ivoire, where only 36% of 1,829 HIV-positive pregnant women in a PMTCT 
programme in Abidjan received prophylaxis (Coulibalyet al., 2005), and the question remain, 
why are so few HIV-positive women and their infants receiving ARVs? One especially 
notable reason for low uptake of PMTCT revealed in a qualitative study in Malawi by 
Bwirire et al. (2008) is that women visiting the antenatal clinic are unprepared beforehand for 
HIV testing and its implications. In Kenya (Delva, Mutunga, Quaghebeur  and Temmerman, 
2006), low quality of PMTCT counselling has been noted, with only haphazard attention to 
crucial topics such as partner involvement and follow-up support: in Botswana, post-testing 
counselling also neglected the psycho-social needs of HIV-positive women (Creek et al., 
2007).  
Option B+ strategy’s process of ART initiation has the potential to improve maternal health, 
facilitate access to PMTCT and ART, reduce HIV transmission risk to uninfected male 
partners, and provide protection against vertical HIV transmission in future pregnancies 
(Schouten et al., 2011;  Cohen at al., 2011), however the government’s efforts in realising 
these goals would be in vain if HIV-positive women are not utilising the service; this leaves 
the researcher to wonder whether the lived experiences of these women would provide 
answers to its optimal provision and uptake. Is anyone listening to the HIV-positive women? 
3.4 Process of prevention of mother-to-child transmission 
This section outlines the PMTCT process as provided in maternal and child health care units, 
beginning with antenatal care, and continuing through labour and delivery services to 




3.4.1 Antenatal  
All pregnant women presenting for antenatal care receive HIV counselling and testing (HCT) 
with an “opt-out” option. For women who agree to be tested and are HIV-positive, a 
confirmatory HIV test is done to rule out any possibility of mix-up in results or fraudulent 
access to ART (MOH, 2011); individual post-test counselling then follows, with emphasis on 
adherence, disclosure, feeding options and follow-up care. HAART (Tenofovir/Lamivudine/
Efavirenz), Cotrimoxazole preventive therapy (CPT), and NVP syrup for the baby are 
prescribed on the same day and given right in the ANC for HIV-positive women from 14 
weeks’ gestation, irrespective of CD4 count. Unlike other persons starting ART, pregnant and 
breastfeeding women do not undergo the pre-ART readiness classes (known as literacy 
classes) which are intended to promote compliance. Each woman has a master card that is 
kept in the clinic to be used whenever she reports for follow-up; the ANC staff also records 
all new clients in the ART register. Integrated guidelines for HIV services provision also 
encourage women to bring sexual partners to attend HTC (MOH, 2011). 
3.4.2 Labour and delivery 
HIV status is confirmed from their antenatal records for all women presenting in labour ward. 
A labour ward resident HIV counsellor offers HIV counselling and testing for all women with 
unknown HIV status depending on the stage of labour; the women take prescribed HAART 
immediately as per protocol, and the next appointment date is given. If the woman is already 
on Option B+, she is then asked whether she took the day’s dosage before coming to the 
hospital. If she did not, she is reminded to do so or she is given the dose from the hospital 
supply. Women initiated on ART in labour ward are recorded in the ART register and also 
have a master card. Infant feeding method is discussed with the woman, together with other 




HIV testing is offered for women whose HIV status is still unknown after delivery and ARVs 
are prescribed for mother and infant. The infant receives the first dose of NVP syrup after 
birth in the labour room and will continue for six weeks (MOH, 2012) regardless of infant 
feeding method. The next appointment date is recorded in the woman’s antenatal card and 
she attends postnatal care at her nearest health facility. The woman and child continue 
receiving ARVs in the MCH unit until such time as they meet the relevant criterion for 
transfer to the national ART programme in which the mother will continue for the rest of her 
life. The interventions go beyond breastfeeding and the mother’s commitment is thus crucial. 
3.5 Experiences on Option B+ strategy 
There are so far no research studies in the literature that consider the lived experiences of 
women themselves on Option B+ strategy; this section accordingly outlines Malawi’s 
experience at national level in the implementation of Option B+. At the July 2012 
international AIDS conference in Washington attention was given to Option B+ strategy and 
there was considerable discussion about a rapid scale-up of this programme. However, 
according to Thyssen, Lange, Thyssen, and Reddi (2013), studies on clinical and economic 
feasibility have yet to be done, and additional studies investigating adherence and resistance 
to ART are also needed before a global scale-up of Option B+ strategy is implemented. The 
study by Chimbwandira et al. (2013) is the first to summarise Malawi’s experience in 
implementing Option B+, drawing on data collected through routine programme supervision 
under the direction of the MOH and supported by the office of the global AIDS coordinator 
(OGAC) through PEPFAR. Their report revealed that 8,877 (83%) of 10,734 women started 
under Option B+ strategy were retained at 6 months after ART initiation. Only 1% of those 
not retained were known to have stopped ART, 4% were known to have died, and the 
majority of the 1,762 women classified as lost to follow-up are likely to have stopped or 
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interrupted ART, giving an exceeding high 83% retention rate. This is a good result for the 
first quarterly cohort of women starting on Option B+ in Malawi, considering that there had 
been no previous experience at any of the sites with ART initiation from ANC and maternity 
(MOH, 2012).  
Table 3-1 Six-month outcomes of women initiated on Option B+ strategy 
ART cohort registration group outcomes 
Total alive on ART 8,877 83% 
Total not retained 1,857 17% 
Defaulted 1,762 95% 
Stopped ART 22 1% 
Died 73 4% 
 
Source: Chimbwandira et al. (2013) 
Under the new policy, of the 2,949 women who started ART under Option B+ in the third 
quarter of 2011 and did not transfer care, 2,267 (77%) continue to receive ART at 12 months; 
this indicates that the number of pregnant and breastfeeding women started on ART has 
increased and the retention rate has remained similar to the rate for adults continuing to 
receive ART at 12 months before Option B+ strategy implementation. 
 
Figure 3-1 Twelve-month outcomes for women initiated on Option B+ strategy 
Source: Chimbwandira et al. (2013) 
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According to MOH report (2012), the removal of the barrier represented by CD4 cell count in 
Option B+ strategy also minimised other barriers to ART provision for pregnant women, 
such as distance between ANC sites where HIV diagnosis is made and ART sites where 
treatment was started, transportation costs, and human resource constraints that lead to long 
waiting times and scheduling difficulties (Chi et al., 2012). Decentralisation of ART into all 
ANC sites, combined with training of nearly all nurses and clinical officers on the new 
integrated PMTCT/ART guidelines, helped to bring about a 748% increase in the number of 
pregnant and breastfeeding women started on ART (Chimbwandira et al., 2013). 
Implementation of Option B+ in Malawi has led to women receiving ANC and ART in the 
same clinic and by the same provider, a move that is believed to promote retention. This ART 
scale-up has also resulted in a growing proportion of HIV-infected women who are already 
on ART when they become pregnant (MOH, 2012) Despite all the successes, important 
challenges and questions nonetheless remain: the cost-effectiveness of this approach needs to 
be evaluated, and although 12-month retention rates are reassuring, lifelong ART adherence 
will need to be maintained (Chimbwandira et al., 2013), informed by lessons learnt from the 
women’s own experiences. 
3.6 Implications for policy change 
As a result of the policy change, the total numbers of all patients initiating ART in the 
national programme increased by an astounding 88% after implementation of Option B+ 
strategy for only one quarter (MOH, 2012). According to the same report, the number of 
pregnant women started on ART is expected to increase in the next few quarters and 
subsequently fall once the system is stabilised, It is not certain however, whether the numbers 
on paper really represent the number of women utilising the programme. 
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Coutsoudis, et al. (2013) raise a number of ethical, medical, programmatic and economic 
concerns in relation to the implementation of Option B+ strategy: 
 Is it ethical to give women with high CD4 count treatment for life without fully 
understanding the long-term benefits and risks? 
 Are the benefits for maternal health worth the potential increase in drug 
resistance? 
 Will the necessary levels of adherence be maintained? 
In its approval of Option B+ strategy, the WHO commented that even though the method 
demonstrates some clear benefits there is still a need to evaluate programme settings, systems 
and support requirements for an effective implementation. Actual experiences of women on 
Option B+ is one of the issues that need to be evaluated so that recommendations are made 
and programme modifications are done while the programme is still in its early 
implementation phase. 
3.7 Conclusion 
This chapter highlighted the global interventions to reduce MTCT in an effort to minimise 
maternal and child morbidity and mortality, and the scaling-up of PMTCT for improved 
maternal health and infant HIV-free survival. The current status of the PMTCT programme in 
Malawi with the introduction of Option B+ looks promising as discussed but loss to follow-
up of women has already been identified along the crucial steps in the PMTCT process. A 
review of women’s experiences on previous PMTCT strategy (Option A) and long-term ART 
programmes has been done and yet not conclusive to predict similar experiences in Option 
B+ strategy.  
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Chapter 4  Presentation of study findings 
4.1 Introduction 
The review of literature presented in the prior chapter accentuated the existing research 
studies on option B+, the PMTCT process and the experiences on the programme so far. The 
previous chapters overall broadened the scope of the study and guided the research process. 
This chapter sets out the study findings on the lived experiences of HIV-positive women on 
PMTCT Option B+ strategy and reflects the objectives of the study.  
4.2 Research findings 
The research findings are presented in two sections: participant profile data, followed by 
findings on views, thoughts and feelings expressed by the participants in the individual in-
depth interviews. 
4.2.1 Profile of participants  
Five participants were involved in the study. All five were HIV-positive women on PMTCT 
Option B+ strategy; one was pregnant and four had delivered. Their ages ranged from 19 to 
38, one participant was single, and the rest were married; the duration of their lived 
experiences on the PMTCT programme ranged from four months to four years. Their level of 




Table 4-1 Profile of participants 









Alinafe 24 Married 2 4 years Standard 4 
Been on Option A strategy 
before. Husband had 
unknown HIV status but 
believes to be HIV-positive. 
First child HIV-negative. 
Febbie 28 Married 1 4 months Form 4 
New mother, Shortest 
experience on Option B+, 
not disclosed HIV status to 
partner.  
Josephina 38 Married 3 2 years Standard 5 
Tested HIV-negative in two 
previous pregnancies. 
Physically abused by 
partner after HIV status 
disclosure. Partner HIV 
status unknown. 
Monica 19 Single 0 6 months Form 2 
Youngest participant, still 
pregnant. Discarded 
medications on first visit 
and reinitiated a month 
later. 
Rose 28 Married 2 1 year Standard 8 
Husband on ARV treatment 
already only disclosed when 
she was found HIV-positive. 
 
4.2.2 Research findings according to categories, themes and sub-themes 
This section presents the substantive findings of the study. The data were collected through 
in-depth interviews, and recorded, transcribed and analysed using manual data-analysis 
techniques. 
In this analysis, categories, themes and sub-themes emerged, and the views of the 
respondents are presented here as direct quotations to support the identified themes and sub-
themes. 
The following categories of information emerged during the data analysis: 
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A. Knowledge and understanding of Option B+ strategy  
B. Accepting the HIV-positive status  
C. Sociocultural factors affecting HIV-positive women on Option B+ strategy 
D. Adherence on Option B+ strategy 
These categories were then subdivided into common themes and sub-themes.  
Table 4-2 Categories, themes and sub-themes 
Category Theme Sub-theme 
Knowledge and 
understanding of Option B+ 
strategy 
Source of information  
To test or not to test Timing 
‘Opt-out’ an option? 
Moment of truth Terrifying 
Depressing 
Preparation and readiness Psychological readiness and 
Pre-treatment preparation 
Accepting the positive HIV 
status 
Silence best option?  
Breaking the news Who to tell 
The blame game 
Coping strategies Talking about the experience 
Detachment 
Rationalisation 
Sociocultural factors affecting 
HIV-positive women on 
Option B+ strategy 
Participating  on Option B+ 
strategy 
Motivators vs. Deterrents  
Quality care 
Privacy  
Playing the role  Our opinions should count 
Preventing further spread 
Challenges Attitudes of health care 
workers 
Distance to hospitals 
Availability of drugs 
Stigma and discrimination 
Men not going for testing  
Adherence on Option B+ 
strategy 
Till death do us part Experience vs. Inexperience 
Support system  Informal support 
Formal support  
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Category 1: Knowledge and understanding of option B+ strategy & process 
Theme 1: Source of information 
All participants said that they knew about Option B+ strategy when they first tested HIV-
positive, which happened either in the antenatal clinic, during labour and delivery, or during 
postnatal period. This was described as the beginning of the PMTCT process, which had 
different meanings for individual participants. It proved worthwhile to explore the theme 
incorporating the participant’s experiences from the first stages of HIV testing to get a sense 
of the whole process. 
Although they were broadly knowledgeable about HIV and details of its prevention and 
management, which is a routine education topic in the antenatal clinic, the study participants 
indicated that they had been much less well informed about the Option B+ strategy. During 
the interviews, all the participants said they were urged to go for testing when they attended 
the clinic, from which it can be concluded that HIV testing is available for all women 
receiving maternal and child health services in the hospital. The antenatal clinic was found to 
be the place where women first heard of Option B+ strategy and where it all began for them.  
According to Rose: 
When I came to start antenatal care for this baby’s pregnancy, they taught 
us about HIV and we were told that all those coming for antenatal for the 
first time will be tested for HIV. 
From the interviews it was noted that the issue of Option B+ was not discussed with all the 
women attending antenatal care; rather, the focus was on those coming for the first time, to 
whom HIV testing is also offered.  
The process is the same, however, for women who had already tested positive but had no 
documentation. When asked how she started on the Option B+ strategy, Alinafe said:  
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It was when I came to start antenatal care for this pregnancy, they said all 
those who came for the first time should go for HIV testing. I had already 
been tested in previous pregnancies and knew my HIV status to be positive 
so I never went for the test [sighs]. However, the nurse told me that since I 
had no document that confirmed my status I had to do it again, so I did. 
Another participant (Febbie) told a similar story: 
I had not attended antenatal care throughout my pregnancy [Clears 
throat]... I discovered my pregnancy late and I had travelled to the village 
which was far from hospital…. I came to the hospital for delivery and that 
is the first time I ever heard of Option B+ strategy.... Umm, I had reported 
in labour ward with pains and guess what I got. 
These are some of the statements made by participants which suggested that knowledge about 
Option B+ began when they presented themselves at the hospital where routine HIV testing is 
done. All women had no prior knowledge of the Option B+ strategy until their own diagnosis 
of positive HIV status. The issue of access to Option B+ was also explored in this theme and 
it was established that pregnant and postpartum women are able to access the service once 
they visit the hospital. 
Theme 2: To test or not to test  
Sub-theme 2.1: Timing 
During the interviews it was obvious how the participants struggled with the decision 
whether to go through with the HIV testing or not. The participants felt that the HIV test was 
ill-timed, and that they needed to have been better prepared to go through with it. For 
Monica, a single woman with her first pregnancy, the decision was hard: 
The truth is, I was not ready… By that time I had never been tested for 




Some participants felt that they had not been given enough time to brace themselves for the 
possibility of a positive outcome as reported by Monica and Rose respectively.  
I could have made the decision at that time but the only problem is that it 
came as a surprise.   
If only there was a little more time to think about it, just some more time 
but there was none everything happened so fast.   
For Josephina, who had tested negative in previous pregnancies, timing was never an obstacle 
and the decision to get tested came easily, as she reported: 
Well I was tested for HIV with my previous pregnancies and I was found 
HIV-negative, that is why I did not think twice about testing this time, it felt 
normal. This time it was different and the results were shocking. 
The experience however was different for women who started the process after they had 
delivered. Febbie, aged 28, who missed antenatal care and only reported for delivery of her 
first child, gave a graphic account of her experience: 
 I reported in labour ward in pain and frustration since I was sent back 
twice already saying I was not in labour, then one nurse asked whether I 
knew my status which I knew to be negative tested a year previously. She 
called for someone else who took me to a private room talked about HIV 
and tested me  
Summing up, she expressed her frustration:  
They couldn’t have picked a better time.  
Participants were asked how they thought the HIV testing should be done and they all agreed 
that they needed to be introduced to the idea and given time to decide. Ideally, the timing (for 
some participants) would allow for going back home and consulting friends, family and 
partners. Women who had delivered their babies thought labour and delivery period should 
be spared from the stress of HIV testing. 
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These contributions prompted the inclusion of the next theme to determine the possibility of a 
participant declining HIV testing. 
Sub-theme 2.2: Opt-out an option? 
Opt-out in the context of PMTCT means that any woman who is offered HIV counselling and 
testing has a choice to refuse the test; however, women believed this was not how the 
possibilities had been presented to them. 
Rose, like some of the other participants, felt that she had not been given an option about 
whether to have the test. Asked to elaborate, she showed that she was upset:  
 I needed to get ready, it is not a decision you make in a rush, wish these 
people [health professionals] understood that. 
Likewise, for Monica, 
There was no choice, none whatsoever, not a chance. It was more like 
being told than asked. 
Knowing from the interview how Rose had struggled with the decision to consent to testing, 
the interviewer wanted to find out if she could have gone for testing voluntarily: 
 [Laughed]…Yes I could have gone for testing voluntarily, someday. 
Despite their ambivalence about going through with HIV testing, they all in the end did so, 
for a variety of reasons; some felt hopeless and knew that it was the only way out, others 
believed they would not get the necessary obstetric care if they declined the test, as in this 
statement: 
Do you think there is a chance for someone to say I don’t want to be 




and some participants just decided to brave the test and get done with it. 
Theme 3:  Moment of truth 
In describing their feelings after receiving their positive HIV results, words such as 
“disappointed”; “anger”; “grief”; “fear” often recurred in the participants’ accounts; 
“terrifying” and “depressing” were expressions used by all the participants. Reviewing the 
whole process through exploration of this theme of moment of truth, two sub-themes 
emerged: 
Sub-theme 3.1: Terrifying 
Febbie repeatedly described her experience as “terrifying”, more than three times in the 
course of the interview. These emotional terms, combined with the concerned look on their 
faces, showed what the impact had been for them of a positive HIV status: 
 The hardest part was receiving the results. 
The same issue was therefore also explored with the other participants, from which terrifying 
and depressing emerged as sub-themes in their emotional reactions to getting a positive HIV 
test result. Febbie expressed a profound emotional reaction to the news: 
Like I said, I was in labour pains when I was tested for HIV. It was my first 
child and everything else that was happening was new to me. I was highly 
anxious on the outcome of my labour and now that... Continued ... It was 
the worst feeling [gazing beyond the window] ... all I could think about 
was what my next move would be. All of a sudden the world seemed empty 
and my head grew bigger, it was terrifying. 
Monica avoided eye contact when she related her experience on receiving her positive HIV 
test result. Clearly emotional, she corroborated Febbie’s story: 
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There is no better word to describe the feeling, it’s almost unreal… terribly 
unreal. I though the nurse was playing a sick joke on me. 
…The terror came in as a realisation that life will never be the same again. 
For a moment my mind had a flight of ideas, almost getting me excited but 
none of it included curing the HIV… [Pause] … Felt like reaching a dead 
end. 
… I have seen HIV-positive patients before and that’s how I pictured 
myself in a few weeks ahead. The faces of those sick AIDS patients I saw 
flashed in my mind [Pause]… it was absolute terror.  
Sub-theme 3.2: Depressing 
Josephina’s experience on receiving the HIV test results was more depressive: 
All of a sudden it dawned to me that I would die soon, and I will not live to 
see my baby grow. It was a depressing feeling, I felt angry towards the 
counsellor for putting me through that. I cried...it could be described like 
an out of body experience, when you know you are there and yet you are 
not.  (Josephina) 
Likewise, for Monica, 
I was disappointed, I felt like I had disgraced my parents because there is 
no parent who wants to see their children suffering.  
The interviews with participants who had other children and longer experience on Option B+ 
revealed their views on the importance of interaction with the health professionals. They felt 
that health professionals needed to have time with them when revealing their positive HIV 
status, describing the situation of failure to ask questions and learn more about their condition 
as pathetic and depressing: 
There is not much time in the hospital to receive your HIV results and 
understand, no much time… [Pause] …everything happens so fast. 
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Josephina summed up her emotions by saying, 
It is like being given a death sentence. All plans, aspirations and goals 
crashed before your very eyes. 
Participants with less experience on Option B+ expressed stronger emotions on receiving the 
HIV-positive test results, suggesting how recently the diagnosis had been made. 
Theme 4: Preparation and readiness 
Preparation, defined by the Oxford dictionary (2010) as “the act or process of getting ready 
for an undertaking” proved inadequate for most of the participants. Even though the benefits 
of testing were laid out before the actual testing took place, the participants unanimously 
agreed that they were not sufficiently prepared for the process.  
Two sub-themes were used to explore the participant’s experiences with the theme: 
psychological preparation and pre-treatment education. These sub-themes were analysed 
concurrently in view of their mutual effect on one another. Participants believed that because 
they were not adequately prepared for their participation, it was psychologically taxing for 
them, and vice versa. 
Sub-theme 4.1: Psychological readiness and Pre-treatment preparation 
For Alinafe who had taken antiretroviral drugs for PMTCT in previous pregnancies under 
Option A, the preparation was more than adequate. She reported: 
Yes, the preparatory education was enough and I understood very well. 
They taught me how to be taking my medications and also the main aim of 
taking the medication. 
On the purpose of the taking the medications, she elaborated: 
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They said the main aim of taking my medication is that I have to protect my 
unborn child so that she should be born HIV-negative and also that I 
should still maintain my health and that I should not be getting sick often. 
It was a different experience, however, for the rest of the participants who had no prior 
experience with PMTCT: 
To tell the truth, the first time we were being educated on HIV and Option 
B+ strategy I had not tested for HIV so I was not paying much attention 
because I didn’t think it was relevant to me. The second time it was right 
after I received my positive HIV results and honestly I was not listening 
because there were a lot of things going on in my mind.  
(Monica) 
You can just imagine knowing that you are HIV-positive, being fed a lot of 
information at one goal and starting long life ARVs immediately. It is a lot 
to take for a day.   
(Rose) 
It is overwhelming, when I tested in labour ward I was given ARVs 
immediately and was told that they were for the rest of my life, soon after 
my baby was born she was also given ARV. It was hard to process but I 
had to go with the flow.   
(Febbie) 
For some, the preparation seemed adequate at the time because they had no expectations, but 
as time went on they had other suggestions: 
At the time it seemed adequate but later I needed more explanations and I 
had questions I couldn’t answer. There is need for more time to be 
dedicated when initiating the treatment because for me that is the crucial 




The women acknowledged that ARV initiation was extremely important and helpful but had 
reservations on timing. They believed the ARVs should not be administered as urgent, but 
that the women should rather give time to come back at a later date following a positive HIV 
test, for proper preparatory instruction with initiation of ARVs. The worst case scenario was 
Monica’s experience: 
I did not take it well, you can imagine I went to the hospital and I am 
coming back with these bottles of medications. I did not even want to go 
home that day to avoid questions and suddenly an idea hit me, it seemed 
the only option at the point [Giggles]… so I got rid of the medications 
along the way and went home like nothing happened... 
… I spent a month meditating on it until my next antenatal appointment. It 
all then sunk in, I realised the situation I was in and decided to act in the 
best interest of my baby. When I went back the next time I was more willing 
to start the medications, I was convinced I had made the right decision and 
I have not stopped ever since. 
The issue of taking ARVs for the rest of their lives seemed troubling for many. Even though 
Alinafe had received ARVs for PMTCT before, the issue was puzzling: 
I have received the ARVs for PMTCT before and I stopped sometime after 
giving birth to my child. That is what used to happen and my child was 
tested HIV-negative, so I really don’t know where this is coming from. I 
guess that’s why more time is necessary when the nurses communicate this 
you know 
Participants initially believed the preparation was adequate because they were still in shock 
and did not know what to expect, but as time went on the gaps were obvious. If only the pre-
treatment counselling took longer or scheduled on another day for initiation of treatment, they 
would be more prepared, they said. 
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Category 2: Accepting the positive HIV status  
During the interviews it was clear that accepting the positive status was a process rather than 
a step, influenced by both intrinsic and extrinsic factors that helped them to understand and 
cope with their positive HIV status.  
Theme 1: Silence the best option? 
Some participants referred to non-disclosure of HIV status as “silence”, as one participant put 
it when describing the emotional toll of the period immediately after receiving positive HIV 
results: 
It is an emotional bondage, you wonder if silence is the best option 
The issue of “silence” was further explored with other participants to discover its true 
meaning; hence the emergence of the theme. For Febbie it proved to be the only option as she 
reveals in an expression of despair: 
I cannot accept it, where do I start from? 
Febbie is a married woman with four months experience on Option B+ strategy; this 
knowledge, and the revelation that she had not accepted her HIV status, prompted the 
interviewer to probe more about her home situation: 
 When I took my baby home, it was the best time for me and my husband, 
we had received our long awaited gift and I never wanted to spoil the mood 
with my positive HIV news. 
… I am waiting to the best time to tell him, I know once I do that I will be 
relieved and in a way help me accept the diagnosis. [Sighs] As the days 
pass it is becoming harder and heavier on my heart but when I see his 
smiling face with our baby, that is all I want to see. 
… Since he is working it is easier to keep the secret because most of the 
things to do with PMTCT like medications are done while he is away 
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… For now it is working but I do not know for how much longer. I will 
burden myself with the news until I am ready. 
For some participants, the process is all about finding the inner strength, as summed up by 
Alinafe, the participant with the most years of experience on PMTCT:  
It is easier when you realise that you cannot change everything in life. 
Embrace life situations positively and with support from significant others, 
the bumps along the way are less high than they appeared to be. 
Theme 2: Breaking the news 
Some of the participants seemed to be having problems disclosing their HIV status to others; 
this was evidenced by one participant from previous discussion staying “silent” after four 
months of diagnosis. For the rest of the participants, breaking the silence was strategic, with 
more of them feeling comfortable disclosing to a sibling or parent rather than their own 
husband or partner; none felt the need to disclose to the community. The participants’ 
disclosure circumstances varied, as did their experiences, and two sub-themes were explored 
to understand the theme better. 
Sub-theme 2.1:  Who to tell 
When asked who they first told after being tested positive, Monica and others indicated that 
the decision did not come easy: 
I will tell you the truth, I was scared to go home to start with. In my mind I 
knew I had to tell someone, talk to someone… Uum, I did not know who. 
On my way home I kept thinking who would be the best person to talk to. I 
had not made the decision when I got home so I stayed for a week before 
confiding in my best friend of 11years and later I told my mum.  
(Monica) 
I told my mother first. She had escorted me to the hospital on the day I 
tested HIV-positive and on our way back I told her everything. I thought it 
was only appropriate to do so, we walked in silence back home and even 
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though she pretended not to have been affected, I knew she was hurt.  
(Rose) 
Probed further on what influenced her to tell her best friend first, Monica reported: 
I was single, still am. [Laughs] I knew my mum would be critical because 
she was not happy that I got pregnant in the first place, I knew it was only 
my best friend who would understand you know, and I considered my 
privacy also. I trusted my best friend to keep my secret better than anyone. 
Later on I realised that my mum would support me as much if she knew so I 
told her.  
The issue of difficulty in disclosing positive HIV status to the one’s partner comes out in 
Josephina’s experience: 
My husband is a difficult man, major decisions in the family I have to 
discuss with him and yet I went for HIV testing and initiated on 
medications without consulting him and this made me so worried, however 
I convinced myself that it was not my fault and believed he would 
understand. 
 … I regretted telling him for sure. He beat me so hard that I cried all 
night, he called me all sorts of ugly names and the following day he left the 
house. I had nowhere to go to because if I complained to the marriage 
counsellors it meant disclosing my HIV status and possibly making him 
angrier. After sometime he came back. We are still together but life is 
never the same. 
It came as a surprise during the interview to note that this dramatic reaction came from a 
partner who did not know his own HIV status, and the situation was similar with the other 
partners of the participants, with some actually refusing to be tested. Rose’s situation brought 
her closure, however: 
When I disclosed my HIV status to my husband he told me that he also 
tested HIV-positive few months before I delivered. He said he did not want 
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to worry me about it because of the pregnancy and he is already on ARVs. 
It was a shocking discovery, I was disappointed but what else could I have 
done.  
The participants believed that the decision about who to tell brought them closer to accepting 
their HIV status, because that is when they get the sense of reality that helps them to deal 
with the consequences. The decision to disclose to community members, however, proves to 
be further from everybody’s mind, as elaborated by Monica: 
Our neighbour is very talkative and I feel if she knew my status I would 
have no peace, she would tell everyone in the village and beyond. I do not 
know anyone else other than my family to know. If they ever know, it will 
not be from me. 
Sub-theme 2.2: The blame game 
Another issue that emerged throughout the interviews was the blame game between the 
partners after disclosure of HIV status. 
Josephina talked about her experience as follows in a sorrowful interview: 
He didn’t take it well as I explained before. He talked a lot, saying I am an 
ill-behaved person and it was me who brought the disease into our home. 
He left the house for a month now he is back but nothing has changed. He 
scolds me every chance he gets. 
In the same interview, Josephina concluded: 
 My husband told me that since I was the one who had been found with the 
disease I had no one to blame but myself. He believes I got what I 
deserved. I never asked for this and God know that I had been faithful and 
now this is what I get. 
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For the partners the blame is almost self-evident because they convince themselves that the 
reason for the HIV-positive status is that when they leave home for work their wives have 
extramarital affairs. This suggested to the interviewer that it would be worth exploring the 
possible source of HIV infection in the participants’ families.   
Josephina threw back the blame ball to her husband, putting it like this: 
Mmh, it is him, who else can it be. I always stay at home, he leaves me here 
and finds me when he comes back. I don’t move around as he says. How 
can I even have a sexual relationship with all his spies around [Laughs]. 
For Rose the answer was already at hand: 
After he confessed to me that he was also HIV-positive, it was obvious I did 
not look further for my answers… [Sighs]… I just don’t understand why he 
would keep something like this from me, how is it different from killing 
someone. 
The consequences of the blame game are far reaching; many participants commented that 
they lost a confidant and best friend: 
We cannot trust each other anymore, there is a lot of finger pointing and 
before long violence will set in. 
Theme 3: Coping strategies 
In previous discussion the concept of accepting one’s positive HIV status proved taxing for 
participants. Coping strategies that helped the participants to cope with their participation on 
PMTCT Option B+ strategy were identified as discussed in the sub-themes that follow. 
Sub-theme 3.1: Talking about the experience  
Monica described how she felt the decision to tell her mother and best friend about her HIV 
status had helped her to more fully accept her status; other participants agreed: 
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I feel good that I told my mother about my HIV status and participation in 
PMTCT Option B+. It gives me an opportunity to discuss with her issues 
that I would not have if she didn’t know my status. I am able to 
communicate when I have a problem, she takes good care of me. She is 
also my treatment partner because she reminds me to take medications on 
daily basis so I never forget.  
(Monica) 
I can’t imagine not telling anyone about my status up to this day, I would 
have gone insane. I couldn’t wait to get if off my chest and once I did I felt 
relieved. Now we talk openly about the disease with those who know. They 
help me a lot and I get encouragement and that keeps me going.  
(Josephina) 
I was in constant fear of what would happen to me but once I started 
talking about it, a weight lifted off my shoulder. They encourage me to talk 
about my feelings and emotions. I get a lot of emotional support because it 
becomes overwhelming sometimes and I know that the situation would not 
be the same if I did not disclose my HIV status.  
 (Rose) 
Febbie, who had not disclosed her HIV status to anyone as on the day of the interview, and 
had earlier in the interview described her conflict as to whether to disclose HIV status as 
emotional bondage, gave a controversial response: 
I cope just fine. Not telling anyone actually makes me feel safer and at 
peace. The secret is safe with me. You can never trust anyone and before 
you know it your HIV status is top story in the newspaper. I don’t have to 
be answerable to anyone and I can’t stand anyone feeling pity for me. 
Sub-theme 3.2: Detachment 
During the interviews it was apparent that some participants cope by separating themselves 
from reality. For Febbie the coping mechanism is very effective: 
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I know it, I do... but that is where you learn to detach yourself. I never 
knew but I guess it’s a trade you learn with time ... [Laughs]... I have learnt 
not to carry it everywhere with me, I bury it somewhere in my brain maybe 
and it stays there. 
And later in the interview: 
Even when I attend antenatal clinic and I hear the HIV and AIDS 
education, it seems as if am not there. It takes a while to click back in my 
head that I am HIV-positive... [Smiles]... I sound crazy I know, but you 
know what I mean. That’s the only way that keeps me sane I guess. 
Monica also shared her tendency to detach herself from reality: unlike Febbie, she became 
emotional when an HIV issue was brought up in her presence: 
It becomes so real when people are talking about it and you are thinking 
like, Hello I also have it here you know, but once the episode is over and I 
am home I am in a completely different set of mind. It doesn’t bother me 
much, it’s like I have switched off the power button for a while [makes a 
face] …it works! 
Other participants were not in consensus on this coping strategy, commenting that once you 
are diagnosed with HIV you can never take a break from the constant thoughts. It becomes a 
part of their lives. Rose experienced particular difficulty with suppressing her emotions: 
I am an emotional person, always been. I become emotional about 
everything [clears throat] ... With HIV sometimes I can’t stand people 
talking bad about HIV-positive people in my presence. I become emotional 
and once I am in the comfort of my home the memories come back. Asked 
how those feelings are dealt with she hesitated before responding ... I just 
keep myself busy and divert my concentration. 
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Sub-theme 3.3: Rationalisation 
Most of the participants gained solace from rationalising the whole process. Josephina had an 
unusual way of understanding her situation: 
It had to be me, who else? I mean if God planned for it to happen to me so 
let it be. I think it is selfish to be complaining why me, why me, you know,... 
[Pause]... if not you, then who? 
 Because come to think about it, everyone is working hard to help me and 
my baby to be healthy, so why should I sit down and cry. I am grateful that 
I am getting all the support I get and there is nothing to worry me at all. 
Alinafe agreed: 
It all happens for a reason and the earlier you realise that, the easier it 
becomes. I am receiving the best care for myself and my child and that is 
all I need, I do not let my heart be troubled by things I cannot change. 
 Category 3: Sociocultural factors affecting HIV-positive women on Option B+ strategy 
Theme 1: Participating on Option B+ strategy 
Although all the participants reported that they were happy participating on Option B+ 
strategy, it became clear during the interviews that utilising the services gave different 
meanings to the experience. Sub-themes that emerged helped to understand the women’s 
personal feelings as they receive care as discussed below. 
Sub-theme 3.1: Motivation or deterrence  
Participants’ decision to participate on Option B+ strategy was influenced by various factors 
and there were various reasons why they continued to participate despite obstacles. Some 




Josephina could not hide her happiness at inclusion in the programme: 
I feel it is benefiting me because had it been that I was not on the Option 
B+ strategy I could have died a long time ago ... She continued ... It is 
helpful because before I started my medication I was getting sick more 
often, it got me worried. I had not tested for HIV then but once I did and 
started PMTCT Option B+ it’s a whole new me. I wish I knew earlier I 
would be in perfect health now [Laughs]. 
Monica and Rose were equally ecstatic: 
I am very happy because I know that my life and that of my child is 
protected, I get all the care and advice I need.   
(Monica) 
As long as my baby is protected from the virus I am happy because she 
does not deserve to be infected.   
(Rose) 
Alinafe who had received PMTCT previously under Option A strategy was also very 
approving: 
It is all about protecting my child. I was found HIV-positive when I was 
carrying my first child, I did everything I was told from the hospital. It was 
my first experience so I was really sceptical but when my baby was tested 
negative I was thrilled, it was a good feeling.... and as if sensing the next 
question she continued... [Smiles]… well I thought I would not get 
pregnant again after that, but I got married later and he wanted my child, 
what would I have done? [Giggles]. I promise this is the last one. 
All the participants promised that it was their last child, which the interview was inclined to 
doubt, not least from the look on their faces.  
Making a comparison with the Option A strategy, Alinafe commented: 
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I like the attention I get, it is different from the previous strategy you know, 
at least I get to be included in the management other than the baby only. 
Desire for a HIV-negative baby seemed to be the biggest motivator in the women’s 
participation on Option B+ strategy, which made the interviewer curious as to whether they 
would continue on the strategy once their children stop breastfeeding. 
Sub-theme 3.2: Quality care 
The concept of quality care was explored from the participant’s point of view. The 
participants differed in their experiences in the hands of the health professionals.  The 
interviewer wanted to find out if they believe they receive quality care from the hospital and 
some participants had only kind words to say: 
To say the truth, yes, they treat us well, or maybe they treat me well … 
Paused as if waiting for a confirmation, then continued ...Well when you 
have a problem, they spend their time to help you and for me I come back 
satisfied.   
(Alinafe) 
Most definitely they are helpful, they go up and beyond to get the help that 
you need.  
(Febbie) 
One frequent issue, however, was timing of health services, as Monica complained: 
Sometimes the nurses and the doctors are late in attending to us, we come 
to the hospital very early but we return home late and sometimes they 
shout at us, without showing love and yet a doctor is supposed to be loving 
to us patients [smiles]... I wish they could be receiving patients with love so 
that we could also be coming here with open minds. 




It’s like they are adding on more stresses in my life. 
Since the timing issue appeared in all interviews, the interviewer wanted to establish whether 
the participants ever asked why they were kept waiting. Josephina was the only one who had 
an explanation: 
When you are looking for help you don’t ask questions... [Grins]... but 
sometimes we see that they start with a meeting that lasts long delaying the 
clinic since we use the same room.... and oh, there are a few nurses to help 
us so maybe that’s another reason. 
Rose had the same concern: 
To me I really feel the main problem is the time they start attending to 
patients. We arrive at the hospital early and spend most of the time 
waiting. Sometimes we sing songs followed by education session. By the 
time we start receiving treatment it’s almost 10:00 am which is too late so I 
feel if they can start treating us earlier it would be better so that we should 
reach home early too. 
The other issue that arose from this conversation was follow-up care for the women after 
delivery, on which point Rose had this to say: 
After I delivered I was not told where I should be getting my ARVs. So it 
was confusing you know what I mean, initially I was getting them from 
antenatal clinic but I wasn’t going to the antenatal clinic anymore. 
And following up her concern whether she got the necessary help: 




Sub-theme 3.3: Privacy 
The issue of privacy came earlier in the interviews because participants felt comfortable 
participating on Option B+ strategy when they felt their privacy was guaranteed – a point 
related to disclosure of HIV status to close family and friends only, as outlined previously. 
Participants did however express concern when privacy issues went beyond their control. 
You know there are a lot of people here in the hospital, you know, some 
from my own village. It is not easy to keep a secret for long you know what 
I mean. Soon they will start wondering why you go to the hospital so often 
or why you are treated differently.  
(Josephina) 
After a big sigh she continued: 
The clinic that we receive medications is just behind the antenatal clinic 
here and sometimes you are sent there for different reasons. Everyone 
knows around here that whoever goes there is HIV-positive or is a 
guardian to an HIV-positive patient but when you are alone the implication 
is obvious. I can’t control who sees me and it is frustrating sometimes 
Asked how that made her feel and how she dealt with the emotion, she skipped the first part 
and quickly commented: 
It is one of those things you tell yourself whatever you know, the most 
important thing is that I am receiving treatment and that’s what matters. 
Monica, who complained about her talkative neighbour earlier in the interview, thought that 
the neighbour suspected something because she might have seen her at the ARV clinic. 
Asked whether they felt the hospital maintained their privacy participants unanimously 
agreed that hospital personnel do maintain their privacy: 
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I don’t have any problems because I know they receive a lot of patients and 
they can’t remember everyone.   
(Alinafe) 
Absolutely, there is privacy here. But maybe since the counsellors come 
from the same communities we do... [Laughs] ... we can never be too sure, 
but really, I don’t think that is the case.   
(Monica) 
… unless you have a personal grudge with a health personnel but I don’t 
think they are allowed to be discussing patients with other people. 
 (Rose) 
Theme 2: Playing the role 
This theme was explored as a result of women feeling left out when participating in Option 
B+ strategy. They referred to the situation as a role play where they are used to fulfil a part 
without their emotional involvement. 
Sub-theme 2.1: Our opinions should count 
Febbie gave an interesting description of Option B+ strategy when her experiences on the 
sub-theme were explored: 
It’s a play that we are starring in, all the parts have been laid out already 
and we just follow the script as per director’s vision... [Laughs]... you are 
laughing? but seriously that’s how it feels. We are taken for a ride, 
destination unknown.  
Asked how that made her feel she hesitated for a while ... Powerless, it is 
the systems fault though not an individual... wish it was easy to change a 
system. 
Alinafe could not agree more: 
I was on PMTCT programme before, I leant about it from here then and 
when I came back with this child’s pregnancy, everything had changed. I 
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never knew anything about the change and it seems many more women 
didn’t. Aren’t we supposed to know when these changes are implemented? 
Who makes them anyway? Maybe am asking the wrong person… 
[Smiles]... and everything that happens during the PMTCT process from 
testing to medications, we do not have a say. It is all planned out, we are 
just playing the part. 
Febbie presented a different view altogether:  
It is too much about the baby, everyone focuses on the baby, your baby 
this, your baby that. Don’t get me wrong, I am concerned about my baby 
too… [gazing straight into interviewer’s eyes as she continued]...  but it 
seems that nobody realises that I am the one carrying the baby, she is my 
child and I am just as concerned. 
Probed on how she thought it would be done Febbie reported: 
I wish I could be involved, more like a partner and not like an invisible 
participant. Making the decisions for myself and my baby and not listening 
to them all the time. Because there is one thing they forget [Clears throat] 
...at the end of the day, I leave them here [referring to health professionals] 
... and I go home alone, u know what I mean. I can do whatever I want 
without them knowing so it only makes sense that I am happy with the 
management also. 
Participants felt that they could contribute to their own health and that of their children if they 
were involved more by health professionals and taken as mature individuals capable of 
making sound decisions pertaining to their health, while on the other hand a few participants 
felt that health professionals knew what was best and were more than willing to let them 
make all the decisions. 
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Sub-theme 2.2: Preventing further spread 
One role that the participants were happy playing was that of preventing further spread of 
HIV. They were more than happy to be on Option B+ for the sake of their husbands and 
children. For some it was one of the reasons they disclosed their status to their partners, 
because they believed they had a responsibility. 
I told him, I had to tell him. Not only did I want the weight off my shoulder 
but I knew that if I didn’t I would be putting my life, his life and our child’s 
life in danger. It took a lot of courage because I did not know how he 
would react but it had to be done. I am glad that we are all focussing on 
staying healthy and preventing further spread of HIV.   
(Alinafe) 
At the hospital the nurse told me to use a condom during the pregnancy to 
prevent re-infections since my husband’s HIV status is not known. She said 
that will help to minimise the risk of infecting my baby with the virus... 
[long pause] ... so you see the situation I was in, it was difficult to talk 
about condoms with my husband because we have never used them in our 
marriage not even as a contraceptive method, so talking about them could 
have brought suspicious on me… [Laughs] what would be the justification 
if I did not disclose my status? I told him, he was reluctant at first but we 
use sometimes.   
(Josephina) 
During an interview with Febbie, the interviewer was compelled to explore the sensitive sub-
theme to document her experience since she had not disclosed the HIV status to husband. 
Asked how she felt about keeping her husband in the dark, she said that she was only worried 
about her marriage and she gave these responses to follow-up questions: 
I feel sorry for him but I am afraid that my marriage will collapse if I tell 
him. 
For now we are not using any protection but soon we will, once I tell him. 
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At that point she brought the interview to a halt, visibly upset, and did not want to answer any 
further questions on the issue. 
Theme 3: Challenges 
Throughout the interviews, participants themselves raised what they regarded as challenging 
issues without being asked. Challenges faced by women on Option B+ strategy will be 
discussed in relation to five sub-themes: attitudes of health care workers distance to hospital, 
availability of drugs, stigma and discrimination, and men declining HIV testing. 
Sub-theme 3.1: Attitudes of health care workers 
Participants expressed concern over judgemental treatment they received from some of health 
care workers at the hospital. According to some participants it almost felt like they were 
being blamed for the infection, and worse, that they got pregnant while knowing their HIV 
status. 
For all participants except Alinafe who already knew her HIV status, this assumption left a 
bitter taste: 
I think it is unfair to judge, because they do not know how we became 
infected. I believe it can happen to anyone.   
(Febbie) 
If I knew my HIV status before I wouldn’t have gotten pregnant in the first 
place, but I knew after I was pregnant and there was no way out. They 
need to be more understanding.  
 (Monica) 
Probed further, the women failed to pinpoint a particular attitude or behaviour that validated 
the accusation but nonetheless persisted in this criticism:  
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I don’t know how to explain it you know, it is not a specific thing... [Silent 
gaze] ... it is general; the way they talk to you, look at you, behave in front 
of you, you know, you can clearly read their state of mind. 
Alinafe reported that she had more than twice been asked why she got pregnant when she 
knew her HIV status. She remorsefully narrated her story: 
 After I delivered my last child, she was my second child so really as a 
family we were prepared not to have any more children. I was on PMTCT 
Option A then and did all I could to protect my child. Luckily at 18 months 
she tested negative, anyway that was not the story... [Laughs]... When I 
delivered my child I wanted to put a permanent family planning method 
right away and I consulted the hospital and they inserted Norplant which 
was to be effective for five years. I had the Norplant for a year and 
suddenly I started menstruating heavily and I noticed that I was growing 
thinner, it don’t know whether it was related though... [Pause]... I was 
scared and then I came back to the hospital and the doctor gave me some 
family planning pills to be taking to control the bleeding. I was taking the 
pills everyday but it didn’t help. I came back to the hospital and the 
doctors said with the way things were they would give me some more pills 
but firstly to remove the Norplant for a while. Eventually when the 
bleeding was controlled the doctor asked me to choose another family 
planning method and I chose injections. Three months after starting the 
injections I found out that I was pregnant. 
After a long pause as if giving interviewer time to process she continued: 
So you see what I mean, even though I knew my status I did not plan this 
pregnancy you know, but they do not even want to listen to my story before 
they conclude. 
Asked how the particular experience made her feel, she said that she was frustrated but could 
do nothing about it so she let it pass. 
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Sub-theme 3.2: Distance to hospital 
All participants that were interviewed lived within the hospital catchment area but some were 
still a long distance from the hospital and had to use “Kabaza” [a bicycle taxi] or a minibus to 
get there. On whether distance to hospital hindered them from getting the necessary medical 
attention, Rose, who lived furthest from hospital provided an insight: 
 Yes it’s a bit far, it is about two hours or more of walking. I have walked 
before but now I can’t so I use a taxi. This means I have to have transport 
money all the time. 
Clarifying how she dealt with the issue, she added: 
I try to keep all my appointments but it is not easy. Sometimes I fail to go to 
the hospital to receive treatment for other ailments because am thinking 
there is an appointment coming that will also need money. So sometimes I 
just wait to do everything on the same day. 
Sub-theme 3.3: Availability of drugs  
In all the interviews it emerged that there was no problem with the availability of drugs at the 
hospital and no difficulty whenever anyone wanted to replenish her drug supply. 
Alinafe, Josephina, Monica and Rose all agreed that it had never happened to them that they 
went to the hospital for their medication and found that medication was out of stock: 
No it doesn’t happen or maybe it has not happened to me yet. 
Sub-theme 3.4: Stigma and discrimination 
Stigma and discrimination proved to be the chief obstacle in participants’ utilisation of 
Option B+ strategy. Contrary to the interviewer’s belief that stigma and discrimination no 
longer happened, the reality was very different.  
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Josephina said she worried most about fellow villagers knowing her status because she felt 
she would be stigmatised: 
 My fellow villagers, I feel they might be saying bad things about me and 
discriminate me. 
Asked if these things really happen in the village, she said: 
 Yes, sometimes it happens, like a certain woman in our village disclosed 
her HIV status and the whole village knows. She motivates people to go for 
testing in the village and visits the sick. But when she is not around people 
always talk about her ... [Pause]... it just makes me wonder if they don’t do 
the same with me when I turn my back. 
When asked whether this was mere talk or included acts of stigma and discrimination she 
elaborated further: 
 Of course it is more of the talk, they say she is an ill behaved person but I 
think it’s not like that, I am not ill behaved and yet I am HIV-positive. 
OK so the other time, the same lady I am talking about ... she is in our 
church, right? I sing in a choir and she also wanted to join the choir but 
the leaders did all they could to prevent her. In smaller groups people were 
discussing how she will not be attending most choir practices due to 
sickness. I did not say much because if they knew I was also HIV-positive I 
would be kicked out of the choir possibly or they would start avoiding me. 
Alinafe who has been HIV-positive for the longest time had not told anyone in the 
community, even though her suspicions were almost palpable: 
When you pass by people talking, you just know from the look on their 
faces that they are talking about you. Asked how she feels about other 
people knowing her status she said......There is nothing I can do, the only 
thing I have done is accepting my status and I hope those people will get 
used to the fact and stop talking about it. 
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Febbie and Monica had a different opinion; in their view it was not the community but they 
themselves who were to blame: 
Sometimes I feel like the problem is not them but us. Well I am talking in 
general because it has never happened to me but I get the feeling that 
people are talking about me sometimes. I become suspicious and 
eventually I withdraw myself, so it’s not anybody’s fault really. It’s more 
like discriminating yourself [Laughs]. 
Alinafe said that she wished she could help her community know more about HIV and 
motivate them to go for testing, but she felt that doing so would be disclosing her HIV status 
publicly and she was not ready to put her husband and children in that position yet. She 
believed that more HIV knowledge would mean less stigma and discrimination 
Sub-theme 3.5: Men not going for testing 
Male involvement was the hottest topic in all the interviews. Almost all the participants 
complained about their partners not being involved in the process of HIV testing, education 
and controlling HIV spread. It seemed as if the women had always wanted to share their 
opinions on this issue. 
Men should be on the fore front just like they head their families because 
they are the ones with the problem and yet they refuse to accept reality. 
They do not want to get tested, I don’t know whether they believe they 
cannot get the virus. 
And referring to her husband she continued ... He believes I infected him 
and yet he refuses to go for testing. It really makes me wonder whether he 






According to another participant: 
My husband believes he is already infected since I tested HIV-positive 
myself, for him, there is no point going for the test because it is obvious. 
How can you convince such a person? These men are cowards I tell you, 
they pretend to be tough but inside they are like babies... 
Participants do realise that the success of their own participation on Option B+ strategy is 
directly affected by their partners’ failure to get tested. 
It makes no difference being on PMTCT programme and the partners 
status is unknown because we still sleep [referring to sex] together as a 
family and most times are very reluctant to use protection. We are just 
infecting and re-infecting each other, it can’t work like that...  
Continued... I have tried my best to explain to him and make him 
understand that he needs to get tested but to no avail.   
(Josephina) 
Seeking to understand how the women saw the men’s behaviour, the interviewer asked if 
they felt the hospital set-up made men shun maternal and health care services. Josephina 
responded with a proverb: 
 [Laughing]  Mbewa ya manyazi inafela kuuna [literarily, Cowardice   
results in loss of opportunities] 
Enlarging on her comment, Josephine insisted that if men were truly concerned about their 
families they needed to take the initiative of going to the hospital to get tested for HIV. Asked 
how she felt men could be encouraged to go to hospitals she remained optimistic about 
leaving the responsibility to women who know their partners better. Speaking of the man as a 
“baby” she commented: 
You can pamper him, praise him, manipulate him or trick him if that’s 
what it would take to get him to the hospital for the HIV test. 
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Category 4: Adherence on Option B+ strategy 
When participants were asked to express their feeling regarding their adherence to Option B+ 
and factors affecting their adherence, the frequently occurring themes in this category were 
the impact of lifelong treatment and the support system. These themes and emergent sub-
themes were discussed. 
 Theme 1: Till death do us part 
Sub-theme 4.1: Experience and inexperience 
The notion “Till death do us part” was regarded with derision in participants’ reference to 
PMTCT Option B+ being a lifelong commitment like marriage. All participants showed 
anxiety when talking about the lifelong commitment, but there was a remarkable difference 
between those with longer HIV diagnosis and those with less experience. 
During interviews with Alinafe and Josephina who were more experienced that the rest of the 
participant, there was a sense of calmness when they talked about the lifelong commitment 
which comes through in their remarks: 
 I was told from the very beginning, Umm, I was told that once I started on 
the Option B+ strategy it will be for the rest of my life...  
Asked how she felt about it she continued.. it was not easy at first, I 
thought it was unrealistic but with time it sunk and I am ready for the 
commitment.   
(Josephina) 
 When I heard that I will be on the Option B+ strategy for the rest of my 
life my heart sunk. I was like, how can this be, I struggled at first but not 
anymore.  
 (Alinafe) 
Alinafe had an afterthought: 
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Mmh it is very different I must say, in Option A strategy I stopped the 
medication soon after I delivered my last child. It was only the baby who 
took medications for some time. I didn’t understand why it was happening 
that I had to take the medication for the rest of my life. During one of my 
visits to the hospital I asked the nurse about it she told me the process had 
changed but didn’t explain, I pressured on until I got closure and from then 
on I accepted Option B-plus strategy as my life partner [Giggles]. 
The less inexperienced participants regarded their commitment much more equivocally. They 
felt that it was unrealistic to demand this much from them, and some participants sounded 
more defeated than the rest. Monica, the single mother and the youngest participant, had this 
to say: 
Mmh it is difficult my sister, look at me now, just take a good look... 
[Pause] ... do I look sick? Perfectly healthy, Well is do understand that we 
need to protect the baby from the infection blah blah blah, I get that but 
why me? why do I have to take the medication for the rest of my life,... 
feeling the need to convince the interviewer she continued ... I am 19 years 
old I would want to get married later, Uum, I would surely disclose my 
HIV status to the future partner but telling him am on lifelong treatment 
too?  
And elaborating further: 
He will believe I am that sick that they had to put me on medications 
forever. No one would want to marry me. Option B+ may just as well be 
my partner for life.... Sensing lack of commitment, Monica was asked 
whether she will make it through to the end ... Mmh I don’t know for now, 
will see when I get there [Both laugh]. 
In the interesting case of Febbie not having disclosed her status to her partner, her 
experiences on the sub-theme were probed further, with careful rephrasing of the question to 
avoid upsetting her. She responded with a short unelaborated comment: 
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That has to be the hardest part in the whole process, knowing once you are 
in it is forever. 
Febbie and Rose’s sentiments were also shared by Monica, but none of them admitted the 
possibility of withdrawing from the programme any time soon, although they worried about 
their privacy. 
The frequent hospital visits, the procedures and the medications will get 
people suspicious... yes there is a chance that people might know about my 
status because the care is different from another mother who is HIV 
negative. 
Drug adherence 
Drug adherence was explored in the same sub-theme because participants expressed anxiety 
on this issue. The key element of Option B+ strategy is the medication, on which depends the 
health of mother and HIV-free status for the child. The women’s experiences with drug 
adherence, keeping in mind the lifelong commitment, took a variety of forms. 
For Alinafe it was an easy go: 
There are no major problems, I must say, only that, umm, at first after 
taking the medications I was feeling dizzy so the doctors told me to be 
taking the medications at night and go to sleep so at least now its better off 
Asked whether she understood the purpose of the medications, she explained: 
well I do like I said before, please don’t tell me to explain again [Laughed] 
... and sensing the response she continued... well I don’t know like specifics 
but what I know is that the medications will help to prevent the virus from 
multiplying that much and hence I won’t be getting sick so often and oh... if 
the virus is not multiplying there is a chance that I may not pass is to my 
child... [Pause]... Correct? See I can even teach you [Both laugh]. 
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Level of knowledge on medications varied among the participants, and taking a different 
position to Alinafe Rose brought up the issue of poor preparation at the initial stage of 
medication: 
There were a lot of things that were discussed that day but I only remember 
a few things like I said I wasn’t in the best state of mind and I wasn’t 
listening. They said will start ARV medication [Coughs] so that I should 
protect my unborn child from getting the disease and that I will take that 
medication for the rest of my life. 
Clarifying her point, she added: 
I can tell you that I did not start taking my medications right away because 
I did not even understand how I was supposed to take them... [Smiles]... I 
had to ask on the next visit and then I started.   
Taking these reservations further, Monica commented: 
I am worried at the thought that my life will depend on medications for the 
rest of my life, what kind of life is that? and I always think what would 
happen if I forgot to take the medication...  
Asked whether she meant forgetting to take her medication or stopping 
altogether she clarified... No, I can’t stop taking the medication because I 
want to protect my unborn child...  
Asked if she will stop when her child is born she hesitated... It’s not like 
that, but the child is my number one priority at the moment” 
Monica’s reasoning was shared by Rose and Josephina: 
I do not want my child to go through what I am going through now I will 
do everything in my power to save my baby. They [health professionals] 
explained everything to me and I thought it is better that my child should 




I feel blessed that I am benefiting from these medications, some months 
ago I met a friends who has been coming here and she told me that she 
gave birth to an HIV negative child so I feel it will also happen to me if I 
stick to what I have been advised.   
(Josephina) 
For some participants, however, it was the fear of consequences that drove them to drug 
compliance:  
I was told to take the medication for the rest of my life and that if I stop the 
viruses that were weak will become active and affect my immunity which 
can cause diseases or other problems and I may die earlier than expected, 
so I feel it’s good for me to continue taking my medication as  advised.  
(Alinafe) 
This revelation prompted the interviewer to find out whether participants are taking their 
drugs every day, as instructed at the hospital. Interestingly, Febbie was willing to share her 
experience. 
I definitely keep my medications in the house, where else can I keep them? 
[Laughs] …I just make sure I take my medications without my husband 
knowing. 
Asked her what would happen if he saw the medications, she responded 
with an unusual grin ... He saw them once before, I think it was the second 
month after delivering my baby, I was careless, I guess I was overwhelmed 
with the baby and all. 
Seemingly enjoying the conversation she continued: 
He asked me about the medications and I was scared, I told him they were 
vitamins I was given at the hospital. Luckily I had removed the prescription 
note from the bottles so he fell for it and you know, even if the prescription 
was there, he wouldn’t have known. They don’t know about these things. 
Later in the conversation she concluded ... I am more careful now. 
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Rose, on the other hand, admitted that she surprised herself in still taking the medications up 
to that day. She hadn’t thought she would make it that far, but time had helped her get 
stronger each passing day and she was hoping to continue for the rest of her life. Asked about 
their future plans almost all participants forgot that earlier in the interview they had said it 
was their last child – as evidenced by the following admission from Rose: 
I feel if this baby is HIV negative I will give birth to another one [Laughs] 
because they told me that the baby can be HIV negative,  if it really 
happens that she is negative I will give birth to another baby, just one 
more.  
Theme 2: Support system 
Provision of psychological support emerged strongly as an issue in the course of the 
interviews. Support systems that were explored were both informal and formal, along with 
their impact on the experiences of the participants on Option B+ strategy. 
Sub-theme 4.1: Informal support 
Important sources of support of informal support were family and friends. This was 
particularly the case where family and friends knew the participants HIV status but was also 
true in general. According to the women, this support needed to be present throughout the 
whole process, right from the initial HIV.  
Participants felt that absence of support systems at the hospital when they were diagnosed 
HIV-positive made their experience more unbearable than it need have been: 
 Yes the presence of my mother on that day helped me, I don’t know what I 
could have done if I was alone, she gave me strength in different ways and 
she encouraged me to start my medication and up to now I feel free and 
comfortable to discuss with her other things and problems that I face as I 
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am taking my medication.   
(Rose) 
A different scenario was recounted by other participants: 
I came alone to the hospital that day.  Much as it was my first time and my 
first experience I didn’t think it was a big deal. My mum wanted to escort 
me but I declined, anyway, I didn’t realise how much I would need her 
after the diagnosis, it was so heavy on me. I needed someone to be there 
and help me through.   
(Monica) 
Monica, who reported that she threw away the PMTCT medications she had been given on 
the first day, commented:  
If there was someone with me that time I wouldn’t have done what I did, 
am sure that someone would have talked sense into me. 
A participant who wished her partner had escorted her to the hospital said that in addition to 
the emotional support this would have given her it would also have been an opportunity for 
the partner to get tested, in this way both getting mutual support from one another: 
If I was with my husband that day he would have gotten tested to start with 
[Laughs] …but most importantly it could have been easier for him to hear 
the advice from the hospital personnel and their explanations about 
condom use and everything and it could have been easier for him to 
support me. Explaining further, she added: I told you at the beginning that 
I missed some information that day and I couldn’t really understand some 
of what they were saying so if we were together [Coughs] if we were 
together, we could be reminding each other where the other one has 





Josephina, who was physically abused by her husband after she disclosed her HIV status, 
thought that if her husband had escorted her to the clinic it wouldn’t have ended in violence. 
She commented later: 
I heard that in other hospitals like at the central hospital, I heard that 
women go with their husbands to the antenatal clinic. They talk about it 
here sometimes but it is not emphasised and I think I have never seen a 
husband doing that here. 
For some husbands and partners it was not that they failed to come to the clinic but that they 
did not want to get involved.  They took their wives by bicycle, dropping them at the hospital, 
waited outside the gate until they were finished and then headed home together. 
Taking a very different position, Febbie much preferred to be on her own: 
I am glad I was alone the day this happened [HIV testing] otherwise I 
wouldn’t have been able to keep the secret, now I make sure I go to the 
hospital alone for my follow-up post-delivery visits. 
Asked whether they felt they received necessary support from their friends and family 
participants commented as follows: 
We both know our HIV status now, we help each other because we have all 
accepted it. He gives me the support because he also needs it. I couldn’t 
have asked for more really...  
Asked if she feels the support could have been different had it been that her 
husband was HIV negative, she said, ... It could have probably been the 
same.   
(Rose) 
I do not receive the necessary support from him, but of course I haven’t 
told him so he wouldn’t know what I need and I can’t explain, if my 
marriage resolves I won’t be able to take care of myself that’s why I don’t 
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really get worried with such support.  
 (Febbie) 
Mmh sometimes but not always, the issue of the virus is always brought up 
and am just used to it now.   
(Josephina) 
Asked how she dealt with this Josephina said: 
I just leave him to be talking, after he gets tired he stops. At least the 
physical abuse stopped and I can stand the rest. I just feel sorry for him 
because he doesn’t know his HIV status. He could have been receiving 
proper care himself. 
During the discussions it was determined that all the participants truly valued informal 
support, and at least each one of them had a trusted friend or relative whom they could share 
their emotions and experiences. 
Sub-theme 4.2: Formal support 
Formal support as discussed represented structures within the hospital and the community 
that provide women on Option B+ strategy the opportunity for physical, social and 
psychological help as needed. 
One participant was unaware that there were any services of that sort and only realised during 
the interview of their possible availability. 
It also emerged in the interviews that there were community support groups to which none of 
the participants belonged, as reported by Monica: 
 I know there is a support group for HIV people in my community but I am 
not a member, I am not ready to disclose my HIV status to people who have 
nothing to do with it. Maybe time will tell. 
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One NGO that was familiar to all participants was the organisation that keeps a record of all 
women registered on PMTCT Option B+ strategy. Located on the premises of the hospital, 
the staff of the organisation meets all women who have been diagnosed and visit them in their 
homes if the women are willing. Alinafe was the only participant who had accepted the home 
visiting and she gave this account of her experience: 
 I did not have any problem for them to visit me at home so they do come 
by once in a while just to see how I am doing. 
The hospital also gives the women some food items if an assessment has revealed nutritional 
inadequacies in the mother or the child. Formal support is readily available but the women 
need to step out and access the services for their emotional support 
4.3 Conclusion 
This chapter reviewed and provided a discussion of the findings of the study in line with the 
objectives. The discussions focussed on HIV-positive women on different aspects, knowledge 
and understanding of Option B+ process, accepting their HIV status, utilisation and also 
adherence on Option B+ strategy. It looked at the overall lived experiences of HIV-positive 
women on PMCTCT Option B+ strategy.  
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Chapter 5  Discussion: study findings, conclusions, limitations 
and recommendations 
5.1 Introduction  
The lived experiences of the participants in the study as presented in the previous chapter are 
discussed herein, conclusions made and recommendations drawn. There are various research 
studies which have given an insight into experiences of women in ART programmes 
including PMTCT, both in Malawi and in Africa as a whole. Issues that have emerged and 
are outlined in this chapter may help to illuminate similar experiences on Option B+ strategy. 
The findings will be discussed according to the following four major categories and their 
themes and sub-themes that emerged in the course of the in-depth interviews with the 
participants (see Table 4.2) 
Knowledge and understanding of Option B+ strategy  
Accepting the HIV-positive status  
Sociocultural factors affecting HIV-positive women on Option B+ strategy 
Adherence on Option B+ strategy 
Study limitations will also be discussed at the end of the chapter. 
5.2 Knowledge and understanding of Option B+ strategy 
5.2.1 Source of information 
Knowledge of HIV and AIDS among women in Malawi stands at 99.4%, according to the 
Malawi Demographic Health Survey (MDHS, 2010). For pregnant and post-partum women, 
the source of such information is the hospital where they access maternal and child health 
services including antenatal care. Antenatal care includes all of the extra care going beyond 
medication and tests that women receive during pregnancy and preparation for child birth. 
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Since the introduction of routine HIV counselling and testing within antenatal care in 
Malawi, HIV and AIDS information assumes a greater proportion of the education offered to 
all women attending maternal and child health services in hospitals, and this is evidenced by 
all the participants in the study agreeing that they had some knowledge and understanding of 
Option B+ strategy irrespective of their level of education. 
The knowledge and understanding differed among the participants, with none demonstrating 
adequate knowledge of Option B+ strategy. This may be supported by an estimated 41% 
proportion of women with comprehensive knowledge of AIDS (MDHS, 2010) 
notwithstanding the 99.4% general knowledge of AIDS in the same population, or it may 
actually reflect how comprehensively the education is offered to the women. In Uganda, one 
of the countries implementing Option B+ strategy, similar findings were presented through 
focus group discussions concerning Option B+ strategy with communities living with HIV, 
which highlighted varied and limited understanding of what Option B+ entails (Ahmed, Kim 
and Abrams, 2013). Limited knowledge on Option B+ strategy may yield to the fact that 
women are exposed to comprehensive Option B+ education just once, when reporting to the 
ANC for the first time. Assuming this comprehensive education was offered to all the women 
accessing maternal and child health services at the hospital, many women would be 
conversant with Option B+ strategy before they even get pregnant, hence maximising their 
knowledge and understanding. 
Even though it was not feasible to determine access to HIV counselling and testing by all 
women in the population, since women in the study were already found in the hospital, it can 
be concluded that the service is offered to all women who come to the hospital. Option B+ 
strategy has promoted the target of universal access to HIV treatment for mothers in a setting 
where it is difficult to effectively distinguish between those mothers eligible for treatment 
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and those needing prophylaxis (Fasawe et al., 2013). Such knowledge and understanding is 
crucial to success however, and hence the need to increase exposure to comprehensive 
information through education and ongoing counselling. The first exposure to Option B+ 
strategy may be the same for all HIV-positive women, but their experiences differ from that 
point on. 
5.2.2 To test or not to test 
During the interviews it was obvious how the participants struggled with the decision to go 
through with the HIV testing. The emotional toll exacted on them was revealed in detail 
through the sub-themes that emerged during the analysis.  
5.2.2.1 Timing 
HIV counselling and testing should be an individual decision, but in settings like Malawi 
where there is a generalised epidemic all pregnant women are tested as early as possible in 
each pregnancy, with health providers recommending the testing as part of routine antenatal 
care. This means that it is the health provider who initiates the HIV test rather than the 
women themselves. The impact of this approach was evident throughout the interviews with 
participants feeling that the HIV testing was ill timed. This feeling was the same for women 
who were tested while pregnant and for those who had their first encounter with Option B+ 
strategy at labour and delivery. These encounters are consistent with WHO (2010) 
recommendations that women who test HIV-negative in their first or second trimesters of 
pregnancy should be re-tested in their third trimester of pregnancy, and if a woman does not 
return for testing during her third trimester, she should be recommended to test at labour or, if 
that is not possible, immediately after delivery. Despite the protocol, participants expressed 
concern that they were not given time to decide whether they wanted the HIV test or not. 
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The participants believed that they would have been in a position to make the decision 
independently only if they had been given adequate time to think it through, their fear being 
the outcome of an HIV-positive result. From the interviews it was noted that negative 
experiences on Option B+ strategy mostly arose from this uncontested HIV test. For some 
participants, the timing needed to include an opportunity to go home and consult with 
partners, as it could otherwise be a source of potential misunderstanding in their families. It is 
easy to say that women as self-determined individuals are capable of making their own 
decisions regarding their health, but it can also be argued that, with voluntary HIV testing 
criticised as overly simplistic (Lange, 2011) and potentially delaying early detection of HIV 
and initiation of ART, women need to be tested and treated on contact if the elimination of 
HIV infection is to become a reality.  
5.2.2.2  ‘Opt-out’ an option? 
The ‘opt-out’ HIV testing approach adopted in Malawi is meant to enable all pregnant 
women to be screened for HIV infection. Testing should be conducted after a woman is 
notified that HIV screening is recommended for all pregnant women and that she will receive 
an HIV test as part of the routine panel of prenatal tests unless she declines (WHO, 2007). 
This was found in the study to run counter to the preferences of the participating women, who 
felt strongly, and with a degree of hopelessness, that the ‘opt-out’ possibility had not been 
adequately available to them HIV testing. All participants expressed their concern that they 
were not given an opportunity to make a decision on whether to test or not. Test-and-treat 
models which allow health professionals to diagnose and treat HIV infection in pregnant 
women, minimise missed opportunities, and promote early initiation of ARVs, however 
reports have also shown an increased rate of loss to follow-up of mothers and their babies 
particularly after the first clinical visit (Coulborn et al.2013). It can be speculated that failure 
of women to ‘opt out’ of HIV testing results in initiation of women on Option B+ strategy 
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who are not  ready to commit to the process; hence the increase in drop-out. Some 
participants expressed fear that they would not receive the necessary care if they declined the 
test, which made the women feel vulnerable the health system and induced them to withdraw. 
5.2.3 Moment of truth 
“Moment of truth” was the point when women learnt that they were HIV-positive. It was 
described as the most difficult time throughout the whole process. With the global emphasis 
on ‘test and treat’ this step in the HIV testing process has become a critical component of the 
spectrum of HIV care (Corwin, 2013). The news was received in various ways by the 
participants, but the common emotions were anger, grief and fear. Some of the participants 
felt angry and disappointed at themselves, some directed their anger towards their 
partners/husbands, grieving at the realisation that life would never be the same, while others 
feared isolation from their friends and family facing the prospect of disease progression and 
death. The extreme emotions fell into the pattern reflected by the sub-themes. 
5.2.3.1 Terrifying and depressing 
Regardless of the person’s sex or behaviour, a diagnosis of HIV (or any chronic illness) is 
likely to be felt as a shock. Shock and disorientation are commonly reported reactions to life-
changing news of this nature, as are terror, sorrow, anger, fear, depression or shame – even 
for patients who already suspected that they were infected (Corwin, 2013). Human emotions 
are complex and varied, and while a small number of test providers indicated that they felt 
little or no impact when disclosing the HIV-positive result – because the diagnosis is ‘not the 
end of the world’ (Myers et al., 2007) – most indicated that it was difficult because they 
anticipated that the test recipient would (or did) find the news distressing, as was the case in 
the study. The psychological impact on the participants of HIV-positive results was explored 
and what came through from all the emotive words was that they felt terrified and depressed 
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at the prospects of dying. This impact abated, however, over time, with those less 
experienced exhibiting more extreme emotions than those with longer experience – an 
indication that the HIV diagnosis can become a lesser burden than it is at first. 
Participant responses indicated a need for health professionals to spend time with them in the 
initial stages to help them understand and have their concerns resolved which does not always 
happen. Participants complained that it all happened so fast, in disregard of the 
recommendation that disclosure of positive test result should be followed by time for patients 
to react and process the news before further information is thrust upon them (Corwin, 2013). 
Corwin (2013) also advises that even if the patient does not display negative reactions, too 
much information should not be given at this particular visit as she may still be unable to 
adequately process long explanations at this time – thus rendering the service ineffective. It is 
therefore no surprise that women failed to show adequately comprehensive knowledge of 
Option B+ strategy despite having been given the information. Health care workers need to 
understand the grieving process that women go through at this stage and provide the 
emotional and psychological support they need. 
5.2.4 Preparation and readiness 
5.2.4.1 Emotional preparation and pre-treatment education 
It is commonly acknowledged that being HIV-positive is difficult and stressful for anyone, 
but the experience of pregnant and postpartum women may have further dimensions. In 
prevention of mother to child transmission, the concern is not with the mother alone, but 
extends also to the unborn or newborn baby. The pregnant and postpartum mother is 
therefore in constant contact with the health professionals for management of the HIV 
infection – a task which in the view of the participants needed psychological preparation and 
comprehensive education. The focus of HIV counselling is to provide emotional support to 
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help the newly diagnosed patient cope with the diagnosis, access treatment and other care 
services, disclose status to sexual partners, remain safe during the initial phase of dealing 
with a new diagnosis, and prevent further transmission of HIV (Corwin, 2013). How much of 
this information is incorporated in the counselling of the participants is not known. A ground 
breaking presentation at the 7
th
 Annual AIDS conference by Tenthani, et al. (2013) 
substantiates the poor preparation and support of women on Option B+. It was established 
that patients who were lost to follow up started ART on the day of their diagnosis and never 
came back, unsurprisingly these women were less likely to return to clinics.  
Participants reported that there was information overload on the day of diagnosis; not only 
had they come unprepared for an HIV test but they also were found to be HIV-positive, 
counselled, and initiated on lifelong treatment, all on the same day. The participants 
questioned why the ARVs were administered as a matter of urgency, rather than making sure 
that they were ready first. Corwin (2013) agrees that risk behaviour assessment for the HIV-
positive should not be done in haste but rather when the patient is ready (for some, this may 
be the same day as receiving the test results, for others it may be the next visit after they have 
had a chance to process the diagnosis). For some participants this proved tragic, with one 
participant throwing away all the medications she had received for PMTCT on that day. This 
corresponds with the preliminary findings of a routine PMTCT Option B+ programme in a 
rural district in Malawi (Coulborn et al., 2013) which revealed that the mothers and babies 
who are lost to follow-up, particularly after first visit, are not necessarily defaulters but may 
actually have failed to start ARVs at all. Poor preparation may result in poor compliance, as 
shown by one participant who had previously been on PMTCT Option A strategy in an 
earlier pregnancy and was not convinced as to why she needed to take the ARVs for the rest 
of her life, since she had previously taken the same ARVs for a short period of time and her 
child then had tested HIV-negative. 
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The integrated guidelines for provision of HIV services in Malawi that were implemented 
from July 2011 replaced all earlier editions of the Malawi antiretroviral therapy programme 
and PMTCT guidelines which had previously functioned separately (MOH, 2011). Even 
though the services are thus integrated, the ART programme which initiates lifelong ARV 
treatment for HIV-positive men, women and children in the general population continues, 
independently of the PMTCT programme, to conduct ART preparatory classes which are 
prerequisite for ART initiation. These classes have a major influence on the outcome for 
clients because only those who understand the implications of treatment are initiated. Men 
and women undergo 2–3 class sessions on ART after initial diagnosis, accompanied by a 
guardian of their choice, to prepare them for the same task that pregnant and postpartum 
women embark on without formal preparation. The participants’ wish for better preparation 
may be valid, considering that this is provided for other HIV-positive people, but in the 
relatively inflexible ‘test and treat’ approach health professionals would be reluctant to let 
HIV-positive mothers come back later for education and initiation, for fear of missed 
opportunities should they fail to return. This may raise the question as to why only pregnant 
women are targeted for the ‘test and treat’ model and not the general population if the 
country’s aim is to eliminate HIV. 
5.3 Accepting HIV-positive status 
5.3.1 Silence best option? 
Whereas hearing about their HIV-positive result had been a single, dire step for them, 
participants regarded acceptance of the positive status as a long process that hinged on 
individual characteristics and environmental factors. Participants unanimously reported that it 
was only when they accepted their positive HIV status in their hearts that they started living a 
healthy life. Even though that may have been true for all of them, the realisation was not 
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necessarily enough to compel disclosure of HIV status, as some believed that silence was the 
best choice. Issues of HIV status disclosure need to be discussed during post-test counselling 
of an HIV-positive result, and if a patient is frightened or unwilling to notify the sexual 
partner of an HIV diagnosis, the reasons for this must be explored. Should there be real 
concern about abuse or harm to the patient, it is important to help them through those issues 
first (Corwin, 2013) and continue with ongoing counselling on disclosure. 
As “golden” as Silence may seem, it has been cited as a major culprit in continued HIV 
transmission and deficient care for people living with HIV and AIDS. This was borne out by 
one participant who – despite having known for over four months that she was HIV-positive, 
with an active sexual partner, and being in contact with health professionals – still remained 
silent. For this participant, efforts to save her marriage took precedence over the risk of 
infecting others. This projects a gloomy and pessimistic scenario for the war against AIDS 
since prevention efforts should offer us a window of hope for mitigation and curtailing of the 
pandemic. Another factor cited in the spread of HIV is low and inconsistent condom use in a 
sexual relationship where one partner is HIV-positive – an issue also acknowledged in the 
Malawi national response to HIV and AIDS (Malawi Government, 2012). This also emerged in 
the conversations with the study participant who failed to bring up the issue of condom use in 
the family for fear of suspicion, since she had not disclosed her HIV status to partner. 
Silence should not be encouraged in the era of HIV as it impedes the efforts in curbing the 
pandemic, not only does it put their sexual partners at risk but re-infections will prove 
detrimental to their own health and increase the risk of infecting their breastfeeding children. 
Women who are having difficulties in disclosing their HIV status should receive ongoing 
counselling and health professionals should be involved in bringing the woman to understand 
the consequences and help her with disclosure. 
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5.3.2 Breaking the news 
5.3.2.1 Who to tell 
For the participants who made the decision to disclose their HIV status, the circumstances 
and the experiences of disclosure varied. Decisions tended to be strategic, weighing the 
possible outcomes and in most cases influenced by other people’s thoughts and perceptions. 
Nor was it likely to be an easy decision, although participants agreed that disclosing the 
results to someone was advantageous in more ways than one – consistent with literature 
reporting that disclosure of HIV status to partners and family has many benefits, including 
decreased anxiety, increased social support, increased access to PMTCT and care, treatment 
and support programmes, ability to plan for the future, opportunity for partners to be tested, 
and opportunity to reduce risky behaviours (Medley, Garcia-Moreno, McGill and Maman, 
2004). In the study, women who believed they were infected by their partners were more 
likely to disclose their HIV status, and although barriers presented themselves to women, 
they did not match the actuality of disclosure experiences. Findings by Bobrow (2008) 
reported that even though majority of women reported positive responses to disclosing their 
HIV status to their partners, 14.6% of women experience a violent reaction to their disclosure 
(Medley et al., 2004) and this was reflected in the present study, with one participant being 
subjected to physical and verbal abuse after disclosure. 
One participant raised a persistent issue that is often ignored when it comes to disclosure, 
citing the problem of disclosing HIV status that she had discovered through being tested for 
HIV without her husband’s consent. In Malawi, the traditional value system, especially in 
rural settings, assigns limited power women within their marriages (Musopole, 2006; White, 
Kachika and Banda, 2005). In such cases women do not make independent decisions such as 
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choosing to be tested for HIV. Failure to include men in these matters therefore puts women 
in a difficult position when it comes to disclosure. 
5.3.2.2 The blame game 
The blame game sub-theme also arises in relation to the previous who to tell sub-theme, as 
women were more likely to disclose their HIV status to a partner if they felt they had been 
infected by that partner, thereby shedding some of the burden of self-blame. On closer 
analysis, these feelings could be interpreted as unacknowledged guilt. Participants indicated 
that it was more usually partners rather than family and friends who (they felt) blamed them 
unjustly, yet attempts to disclose were not always welcome.  Partner disclosure is a central 
concept in most PMTCT programmes. Studies on PMTCT often cite the problems associated 
with a mother’s voluntary or involuntary disclosure of HIV-positive status as an obstacle to 
minimisation, and the few studies that have specifically explored local experiences with 
partner disclosure in a PMTCT context tend to confirm the findings in the present study. 
Being the first in the partnership to be diagnosed HIV-positive was hard for women, yet 
reason enough for men to regard them as the source of the infection – regardless of their own 
unknown HIV status.  
In the instance of the participant who suffered physical and verbal abuse at the hands of her 
partner after HIV disclosure, the spousal reaction was consistent with literature that cites 
negative reactions from partners of HIV-positive women. A study by Njunga and Blystad 
(2010) mentions that a PMTCT programme was sometimes called the “divorce programme”, 
suggesting how the programme’s emphasis on partner disclosure played up fears among men 
facing accusations of infidelity from wives and relatives – a situation that sometimes led men 
to abandon their families. This puts the woman in a double-bind situation: potential 
transmission of the virus to the infant set against potential loss of income and support through 
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departure of the husband. Even though women may appreciate the social responsibility of 
disclosing their HIV status to partners, fears of blame still make disclosure a challenge.  
Since the present study focussed exclusively on women, men’s experiences on the sub-theme 
which could have been useful in understanding the situation were not solicited. Women’s 
need for support in disclosure is important, since feelings of blame may entirely defeat the 
purpose of disclosure so that the programme ends up causing more harm rather good to those 
it is meant to serve. Male involvement in PMTCT programme may be the solution to the 
dilemma, but men’s response to the programme needs to be analysed and this falls outside the 
scope of the study. 
5.3.3 Coping strategies 
Numerous studies have explored coping. The term refers to ‘constantly changing cognitive 
and behavioural efforts to manage specific external and or internal demands that are 
appraised as taxing or exceeding the resources of the person’ (Lazarus and Folkman, 1984). 
The stress associated with HIV disease has been found to be a major influence on quality of 
life as those who are infected try to find ways to buffer the impact of HIV. Participants in this 
study used a number of different coping mechanisms which they believed worked for them, 
such as talking about the experience, detachment and rationalisation, and, as pointed out by 
Lazarus and Folkman (1984), no one coping strategy emerged as inherently good or bad; 
coping can only be judged by its effectiveness in meeting the demands of the particular 
situation in each case. All participants realised that HIV was not curable and that Option B+ 
was a long-term commitment; they accordingly prepared themselves psychologically for the 
challenge one day at a time. 
100 
 
5.3.3.1 Talking about the experience 
All participants except for one who had not yet disclosed her HIV status found partners, 
family and friends as a major source of support in the form of informal discussions 
concerning their experiences. They emphasised that talking about what they were going 
through was a way to obtain encouragement and reassurance which helped them to cope with 
their feelings, and they deliberately chose to talk to those who would offer just that. One of 
the participants said that talking to her mother about her experiences brings her a sense of 
serenity, while for some the same comfort is obtained from talking to a health professional 
about issues of concern. This confirms the concerns of some participants who wanted health 
professionals to be more empathetic with them so that their interactions help them to cope 
rather than adding more stress. 
Talking about the HIV experience, and interpersonal relationships in general (to prevent 
social isolation), have been reported in literature. It has been found that mothers living with 
HIV who did not have social support were significantly more likely to have high 
psychological distress than those who had social support (Blaney et al., 2004). Hence the 
need to encourage women on Option B+ strategy to maintain social bonds. 
5.3.3.2 Detachment 
Coping is cited as an important aspect of adaptation outcomes such as psychological well-
being, especially in the long term (Lazarus and Folkman, 1984). Some coping strategies such 
as detachment, also referred to as avoidance coping mechanisms, are indicators of passive 
coping as opposed to active coping. Active coping strategies focus on managing the illness, 
seeking social support, and spiritual activities, whereas avoidance coping strategies result in 
negative emotions such as depression and anxiety (Degenova, Patton, Jurich, and McDermid, 
1994; Fleishman and Fogel, 1994). The findings in the study suggest however that while 
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avoidance may not be positively protective it may also not necessarily be harmful in terms of 
giving rise to emotional distress, since none of the participants who used this coping strategy 
exhibited such emotions. These findings are consistent with an extensive body of literature, 
but since none of the participants had been on Option B+ strategy for long it was difficult to 
determine what the long-term effects would be of the coping mechanism. 
5.3.3.3 Rationalisation 
Confirming that living with HIV has serious psychological and social ramifications in 
addition to being a physiological and medical concern, participants sought to rationalise the 
psychological stresses of being on Option B+ strategy. It was apparent from their responses 
that the psychological resources they drew upon were linked to issues of meaningfulness and 
psychological resilience. As with the detachment response, concealing their real emotions 
through attempts to rationalise their situation was a coping response through which they 
sought to establish a more stable emotional environment, avoiding more direct confrontation 
with the stressor. 
The findings in relation to this sub-theme confirmed that coping is not something static and 
needs to be understood as a lifelong process in which individuals resort to different coping 
strategies for different situations. This provides an understanding of the role of coping in the 
outcomes of women with HIV disease and suggests possibilities for designing interventions 
in support of psychological adaptation to the illness. The evidence on adaptational outcomes 
for active or passive coping strategies suggests that avoidance coping may be more effective 
during the earlier stages of HIV disease, whereas active strategies may be more effective 
when the disease becomes physically manifest (Kotze, 2011) and should at that stage be 
emphasised as the recommended coping strategy for women on Option B+. 
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5.4 Sociocultural factors affecting women on Option B+ strategy  
Issues of Option B+ participation and utilisation by HIV-positive women in Malawi are 
becoming more critical as a measure of programme success in view of the huge increase in 
the numbers being initiated on the programme, in relation to which a number of sociocultural 
factors come into play that are explored in this theme. No generalisable studies have been 
done to determine women’s experiences on Option B+ strategy in Malawi, but if retention on 
the programme is taken to be a direct indicator of their satisfaction then the outcomes, 
according to statistics, are not promising. A study conducted in one of the district hospitals in 
Malawi by Coulborn et al. (2013), showed an approximated 16.5% of women lost to follow-
up at month three and 21.5% lost at month six, including breastfeeding women.  The study 
was based on patient charts and hospital records but its recommendations took no account of 
any input by the patients themselves; hence the need, as previously indicated, to focus more 
directly on the affected women’s own experiences for deeper understanding of patient 
continuation (and continuation challenges) on Option B+ strategy. Contrary to the statistics, 
participants in the study expressed gratitude for the benefits they derived from the strategy, 
although it also emerged that various sociocultural factors affected them in one way or 
another – as highlighted further in the related sub-themes.  
5.4.1 Participating on Option B+ strategy 
5.4.1.1 Motivators and deterrents  
Motivators, as deduced from the participants’ experiences, were factors that promoted 
continued participation on Option B+ strategy while deterrents did the opposite. All the 
participants agreed that the strategy was helpful because their own health and that of their 
unborn or newborn children were taken care of and because the risk of HIV transmission to 
partners was reduced. This assessment by them is consistent with the goal set out in the 
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Malawi Integrated Guidelines for Clinical Management of HIV (MOH, 2011) of optimal 
protection for HIV-positive women during pregnancy, delivery, breastfeeding and subsequent 
pregnancies, taking account of the high fertility rates in Malawi, and with reduction of 
transmission to sexual partners being a further objective in the strategy. Participants’ 
responses indicated, however, that the overriding incentive for them was the prospect of 
having an HIV-free child – persuasive enough, as they saw it, for them to adhere to the 
strategy recommendations whatever obstacles they might encounter. One woman who gave 
birth to an HIV-negative child seemed to prove the point. 
The reasoning did not necessarily play out in the same way for all participants. Belief that 
PMTCT was exclusively for the child drove some women to the edge because they thought 
that their own need was being ignored. In a qualitative study by Bwirire et al. (2008), a 
woman declared that PMTCT was too much about the baby and not enough about the mother, 
echoing the feelings of some of the participants in the present study. In Option A strategy the 
focus was primarily on preventing HIV infection in the child, and women therefore stopped 
taking ARVs once the child was born; managing the child took priority over helping the 
mother. With Option B+ strategy the scenario is different: lifelong ART benefits the mother, 
with a substantive possibility of improvement to health, as in the case of one woman who 
reported being sick before being initiated on Option B+ and then responding positively to 
treatment. It has been suggested that recent trends to reposition start of ART at higher CD4 
counts than previously might have a beneficial effect on the programme’s acceptability to 
mothers (Braithwaite et al., 2008). Women who see Option B+ as advantageous for their own 
health may have a more positive overall experience than those who do not. Sadly, it is still 
the same poorly prepared women who are need to understand these complexities. 
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Feelings of guilt on the part of the interview participants were evident in the way they 
stressed their responsibility for protecting their child from the infection. The focus on the 
child was almost disturbing, inviting some doubt that the women would be equally motivated 
to remain on the programme once breastfeeding had ended. The one participant who had 
come to the end of breastfeeding insisted that she was continuing with the programme, so the 
possibility of some women discontinuing with Option B+ strategy could not be established. 
5.4.1.2 Quality care  
Although there was consensus among the participants that the care they received from the 
health professionals had been a significant incentive in persuading them to participate on 
Option B+, there was much more variation as to which individual factors or programme 
characteristics had the greatest influence on their experiences. Most of the participants felt 
satisfied with the care, with no bias against Option B+ strategy, and they commended health 
professionals in some cases for going out of their way to help them, although this could 
unfortunately not be said for all. The attitude of health care workers which emerged under 
this theme was also an issue under the challenges theme, where it is discussed in further 
detail.  
Timing of health care services also drew reaction from the participants. They complained that 
the clinic starts operating late, making patients wait even longer to receive care, a problem 
also recorded by Bwilire et al. (2008), who reported long waiting times at the ANC as one 
factor in poor PMTCT programme participation. Some participants mentioned worry about 
having to leave other children at home while they spent hours waiting at the clinic. In the 
researcher’s experience, this is a fair reflection of many ANC clinics which handle huge 
numbers of PMTCT women (as many as 200) with only two or three midwives on duty. 
These complaints were already being made in the Option A period when nurses only needed 
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to document ANC activities in client’s health book; now, with Option B+, there has been a 
huge increase in the number of women started on ART, and with record keeping a vital 
element in the programme a lot more time is spent on documentation and lengthy 
counselling. With this increased workload it is no surprise that waiting times have also 
increased, and a way needs to be found to reduce the waiting times so that women are not 
eventually discouraged from coming to the clinic. 
Despite mounting evidence that women on Option B+ will benefit from early treatment 
(Hargrove and Humphrey, 2010) and with less likelihood of negative consequences from 
treatment interruptions, some participants expressed anxieties about the programme that 
might ultimately affect their participation. They were troubled both by the prospect of 
lifelong treatment and by the idea of a drug-dependent existence which was hard to reconcile 
with their idea of quality life. Retention rates for long-term treatment programmes in Malawi 
remain unsatisfactory, and this is likely due to late ART initiation in the early stages of ART 
scale-up; Option B+ is also in the early stage of scale-up, but early initiation of ART would 
reduce the mortality rate significantly and possibly enhance participation. 
A particularly important point that emerged from the interviews was that health care workers 
need to be familiar with protocols and procedures of Option B+ at all levels of care, 
especially nurses who are in constant contact with the patients, so that they give proper care, 
advice and guidance. One participant complained that health care workers failed to tell her 
where she needed to go for the next Option B+ services following delivery. Health care 
worker training sessions were prioritised ahead of Option B+ strategy implementation, so 
with time it can be expected that all health workers will deliver the same message in helping 




One reason frequently adduced in literature as a hindrance to PMTCT participation is fear 
related to HIV status disclosure and its consequences. Chinkonde, Sundby and Martinson 
(2009) note that fear of involuntary HIV disclosure and negative community reactions 
discourages women from participating fully in PMTCT. This corresponds with the findings 
from this study that women were fearful that Option B+ participation would automatically 
reveal their HIV status, mainly because of the medications and the point of care location. 
Women felt at ease with Option B+ when they thought their privacy was guaranteed and they 
all agreed that the fear had nothing to do with mistrust of the health professionals, with whom 
they felt their privacy was secure, but rather with the wider environmental circumstances. 
The integration of ART and PMTCT in Option B+ strategy meant that ARVs are dispensed to 
the HIV-positive women during their routine antenatal care, using the same consultation 
rooms as any antenatal woman, and fear of being treated differently, thereby arousing the 
suspicions of curious neighbours, does not arise; the problem, however, was that sometimes 
they were required to visit the adjacent ARV clinic to see the doctor there, and this gave rise 
to anxiety about who would see them and what they would think. This concern for privacy 
may affect women’s attendance on Option B+ strategy, and indicates a need for better design 
of management arrangements that would instil confidence. 
Postpartum women are faced with a dilemma when it comes to privacy and feeding options 
for their children. Breastfeeding poses a major risk for MTCT; it is reported that 5–20% of 
babies born to HIV-positive women will become infected during this time (De Cock et al., 
2000), but PMTCT Option B+ postnatal women found themselves having to juggle protection 
for their child with protection of their privacy. One woman reported failing to maintain 
formula feeding her baby in fear of people’s reactions. Breastfeeding is accepted as a norm in 
Malawi and failure to breastfeed so raises eyebrows; hence HIV-positive women who choose 
107 
 
to formula feed waver between the two feeding options depending on the situation, a practice 
that has been reported to increase MTCT in the long run. Option B+ women are expected to 
frequently come to the hospital for health monitoring, drug supply and routine care, hence 
they need to be treated in an environment where they can feel safe and protected for their 
continued participation. More importantly, ongoing feeding counselling for HIV-positive 
mothers need to be emphasised and women need to be supported as necessary with their 
feeding option to avoid mixed feeding that increases the chance of HIV transmission to the 
child. 
5.4.2 Playing the role  
5.4.2.1 Our opinions should count 
This sub-theme proved to be emotionally taxing for the participants. In their participation on 
Option B+ strategy, participants saw themselves more as invisible partners than as active 
partners in care. Women equated themselves to actors in a movie where they fulfil a role with 
a laid-out script. The women had troubling questions about their involvement in their own 
care, and this supports the need for patients to be included in decision making so that they 
become more visible and empowered. This theme is not found in the Malawian literature, but 
a report on focus group discussions in Uganda concerning Option B+ strategy with 
communities living with HIV highlighted varied and limited understanding of what Option 
B+ entails, concerns about side effects, and a general feeling of lack of participation in their 
country’s decision-making process in the adoption of Option B+ (Ahmed et al., 2013). This 
scenario mirrors the situation in Malawi, where the participants cited both failure of 
government to consult them on the adoption of Option B+ and failure of the programme to 
cater for their opinions. 
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Issues on which the participants felt they had been ignored included choice to get tested, 
recruitment on Option B+ strategy without preparation, initiation of lifelong treatment 
without being offered alternatives, and the expected follow-up route for their infants. The 
question on participants’ minds was why it is called ‘Option’ when there is no option – a 
concern that is not clearly addressed in literature. Health workers and women on Option B+ 
need ongoing interaction focussed on what is working and what is not with regard to practical 
measures that could ensure sustained programme participation, where failure could render the 
programme ineffective. Having had no opportunity for input, participants expressed a sense 
of hopelessness in the face of the scenario of being tested without a choice, started on ART 
and left to deal with the community that still stigmatises the HIV-infected. MMWR (2002, 
cited in Bwirire et al., 2008) noted that women perceive HIV testing as an obligatory 
procedure. Although ‘opt-out’ may result in a high rate of HIV testing, if women are not 
involved at this early stage and perceive it as obligatory it might adversely influence 
participation. 
Participants who believed the programme is all about the baby were particularly concerned 
that health professionals fail to realise that they cannot target the baby without the mother’s 
involvement, and felt that they should be the ones to make the final decision. Regardless of 
national policy, respect for individual choice and human rights require that for true informed 
consent the risks, benefits, and alternatives in a recommended course of treatment must be 
communicated to patients (IATT, 2012). Participants seemed to echo this in holding that their 
capacity for positive participation in their own care should be taken seriously – although for 
some, leaving the decisions to the health professionals was the best choice. 
The report by the interagency task team (IATT, 2012) on the implementation of Option B/B+ 
programmes emphasised that the success of transition to Option B/B+ is critically dependent 
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on its acceptability to women living with HIV. In cases where two options may have similar 
efficacy for an individual woman (e.g., Option B / Option B+), understanding the relative 
acceptability of the options becomes especially significant from a human rights perspective. 
It is important to hear at first hand from women living with HIV regarding their preferences 
and whether they would like to have the opportunity to choose between the two options. This 
implies that HIV-positive women would be given an opportunity to choose either unless they 
need treatment for their own health. Assuming women had the option to choose between 
Option B or Option B+ strategy it would mean that the treatment guidelines would not be 
standardised and there would be a crucial need for CD4 count to decide whether to 
discontinue ARVs on Option B – a long standing issue that was resolved with adoption of 
Option B+ strategy. Somehow Options B+ has cleared up the major potential area of 
confusion by employing one simplified regimen for all women so that each person can easily 
comprehend their role in the effort to reach an AIDS-free generation, but this may not be 
justification for not involving women in their care. 
5.4.2.2 Preventing further spread 
Participants exhibited a sense of social responsibility in dealing with their own emotional 
burden which was apparent in their willingness to take precautions to protect their partners 
and babies from the HIV infection. According to the Malawi government AIDS response 
report (2012), most new infections occur within long-term stable sexual relationships and the 
report identified the current drivers of HIV and AIDS epidemic in Malawi as low and 
inconsistent condom use and sub-optimal implementation of HIV prevention interventions, 
including the use of ARVs. Even for a participant not actively committed to preventing 
further spread, like the one who had not yet disclosed her status, the subject was excessively 
emotional – implying that with the right support she could be willing to join the race. 
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Failure to incorporate men in the care regime put women in a difficult situation however. 
Men expressed strong concerns that they might re-infect their partners, or might not bother to 
attend the clinic if they knew they will not be getting the same treatment (Ahmed et al., 
2013).  There is some evidence that these concerns have been alleviated in Malawi by 
sensitive approaches to disclosure and messaging, couples counselling, and support groups, 
giving some cause for optimism about active participation by men in Option B+ strategy and 
acceptance by them of their role in the preventing further spread of HIV. 
5.4.3 Challenges 
Although the lived experiences of pregnant women on Option B+ strategy seem positive, 
they are also faced with challenges and issues that affect their participation. HIV-infected 
women not only feel isolated and discriminated against by the community but they also have 
to contend with bad-attitude health care workers in the hospital, distance to hospital, 
availability of drugs, and men who fail to play their part in HIV prevention and decline 
testing – all of which gives unique and varied colouring to the experiences of each individual. 
5.4.3.1  Attitudes of health care workers 
The attitude of healthcare workers is not infrequently a cause of frustration for women on 
Option B+. As reported, judgemental behaviour by healthcare workers gave rise to 
helplessness, lack of confidence and loss of trust in the face of betrayal by those whom 
participants most relied upon for help, though this was not always the case; some participants 
had no problem in this regard, saying that healthcare workers gave them the information they 
needed, treated them well and kept their privacy. Bad attitude on the part of health care 
workers, especially nurses, is not uncommon in Malawi, and is often cited in platform 
discussions. The problem has also been reported from other African countries such as in 
South Africa where the Department of Health (DOH, 2011) has established National Core 
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Standards for Health as a benchmark of care quality against which delivery of services can be 
monitored to card the problem. Health care attitude being the priority, the Core Standards 
ensure that patients are respected and their rights upheld, including getting access to needed 
care and to respectful, informed and dignified attention as seen from the point of view of the 
patient. Service improvements to meet these standards could be achieved through patient 
satisfaction surveys and input form patient complaints. Malawi might learn from this 
programme to its advantage in seeking to promote positive attitudes that will attract women 
to participate on Option B+ strategy. 
Muula, Misiri and Tadesse (2007) found that in general attitudes of health workers towards 
HIV-infected women were favourable but that some of the nurses/midwives were themselves 
not sure what advice to give to HIV-positive antenatal women on Option B+ strategy. Lack 
of knowledge among health care workers can be stressful, especially when they have to deal 
with large number of patients as in Option B+ strategy. One participant put the blame for bad 
attitude on shortage of staff that makes nurses feel overwhelmed. Although Option B+ 
strategy is actually simpler to administer from a provider perspective, it may be reasonable to 
assume that nurses already providing PMTCT prophylaxis could switch to providing ART 
without additional human resources. However, nurses initiating pregnant women on ART 
may need more time to provide adherence counselling, which is lengthier for patients starting 
ART than for PMTCT (IATT, 2012). This should force the government to redefine strategies 
so that there are sufficient trained health care workers to manage the workload while at the 




5.4.3.2 Distance to hospitals 
In this study it emerged that distance to hospitals may significantly affect a patient’s access to 
Option B+ strategy. Although none of the participants specifically cited distance as 
hindrance, some who lived further from the hospital mentioned financial constraints but were 
quick to insist that this had nothing to do with missing any hospital appointments. 
Participants in this situation, always devised solutions that would allow them to receive the 
necessary care, which might include borrowing money or combining hospital visits.  
Successful implementation of Option B+ strategy usually requires initiation of ART by 
nurses and clinical officers in MNCH settings (IATT, 2012). In Malawi, this has ensured that 
the same unified and simplified ART regime is also administered in remote health care 
centres, thus bringing ART to the women and children who need it and giving support to 
extended ART access, as has been confirmed in the findings of this study. 
5.4.3.3 Availability of drugs 
A feasibility appraisal conducted by Malawi’s Ministry of Health, HIV and AIDS unit (2009) 
prior to Option B+ strategy implementation recommended that the proposed implementation 
be done in phases. But what happened instead was massive country-wide policy 
implementation that achieved total programme roll-out in less than one year. The projected 
increase of people to be started on ARVs yearly had major implications for the Malawi 
government’s capacity to sustain effective implementation of the initiative, not least in view 
of the obvious sharp increases in required quantities of drugs and supplies, numbers of health 
personnel, infrastructure, transport and logistics. Sustaining the increased number of women 
on lifelong treatment was a major concern at every level, especially for a donor-dependent 
country like Malawi. 
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Similarly in Uganda, serious concern was expressed that the country was not ready for 
Option B+ because the government could not sustain a secure supply of ARVs and was 
dependent on donor funding (Hsieh et al., 2013).  In focus group discussions with women on 
Option B+ strategy in Uganda and Malawi, less concern was expressed about drug shortage 
in the latter country, where treatment is “always available”. A few Malawians did however 
express concern that aid to the country might be cut off at some time in the future, or that 
newer, better ARV regimes might not be universally available as promised. This is consistent 
with the findings of the present study, where none of the participants had ever experienced 
drug stock-outs. 
5.4.3.4 Stigma and discrimination 
Stigma and discrimination proved to be the most significant challenge to utilisation of Option 
B+ strategy for the participants and was directly related to the unrequested disclosure to them 
of their HIV status. The women felt stigmatised by health professionals while they were 
accessing HIV care, and it also appeared that they were more likely to be targets of stigma 
and discriminatory practices from healthcare workers during labour and delivery. They also 
felt stigmatized by partners on assumptions about their moral integrity, such as accusations 
that they became infected with HIV because of risky behaviours, on top of which they also 
had to contend with community stigma and discrimination. In the end stigma and 
discrimination continue to undermine prevention treatment and care of people living with 
HIV, hinder those with the virus from disclosing their status to their partners, and threaten 
their access to health care. On the other hand, healthier appearance from being on treatment, 
and breastfeeding their children for longer, could also mean that Option B+ strategy would 
reduce the stigma and discrimination they have to contend with (Hsieh et al., 2013). 
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Stigma and discrimination exist in our societies in Malawi but evidence has shown that there 
is continuing decrease (Malawi government, 2012), supporting the picture that emerged in 
this study where it was roughly half of the respondents who reported being gossiped about 
and only a minority who suffered verbal and physical insults. Stigma and discrimination 
being a long-standing issue, collective effort is called for from politicians, policy makers, 
civil societies, opinion leaders and the general public, including PLWHIV, to eliminate 
stigma and discrimination if the Option B+ goal of eliminating HIV is to be realised.  
5.4.3.5 Men not going for testing  
Participants believed that their partners were part of the HIV problem and therefore needed to 
be part of the solution too. All participants mentioned that their partners did not accompany 
them when they went for HIV testing and even though they knew the women’s HIV status, 
none had gone for HIV testing. They realised however that their efforts to prevent further 
spread of the virus would not be effective if the HIV status of their partners remains 
unknown. One participant suggested that men choose not to get tested because they think 
there is no point if they have already been infected by the woman. These possibilities differ 
from reported reasons in the literature such as low perceived risk of infection and fear of 
being tested (MacKellar et al., 2011). ANC and PMTCT settings are an ideal entry point to 
offer HIV counselling and testing for partners and family members of pregnant women living 
with HIV. Inviting male partners to get tested for HIV can influence the uptake of PMTCT 
services by promoting communication and disclosure of HIV status and yet this doesn’t seem 
to happen. 
As heads of households men need to play an active role in PMTCT as was illustrated in the 
case of the study participant who considered consulting her husband about HIV testing. 
Targeting men with HIV and AIDS education, including instruction on PMTCT, and 
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encouraging them to become more involved in the health of their partners and children could 
bring about a dramatic improvement in the success of the strategy. It is also possible that 
some men do go for HIV testing but find disclosure as difficult as the women do. This proved 
the case for one participant, whose husband had been on ART without her knowledge and 
only disclosed when she did. Men may also be in desperate need of counselling to promote 
disclosure; hence the need to promote couple counselling in PMTCT. 
The benefits of testing heterosexual couples have also been highlighted by research: testing 
couples together facilitates mutual disclosure, can increase uptake and adherence with 
antiretroviral interventions for PMTCT, promotes condom use within the family (Farquhar et 
al., 2004), strengthens links with care facilities, and can increase the preventive benefits of 
testing. 
5.5 Adherence on Option B+ strategy 
Adherence among HIV-infected pregnant and postpartum women is probably the most 
challenging issue, and has significant implications for the success of the lifelong treatment 
(Besada et al., 2012) that is recommended with Option B+ strategy.  
5.5.1 Till death do us part 
5.5.1.1 Experience vs. Inexperience 
Option B+ strategy is a long process involving both medications and a cascade of 
interventions that include health monitoring for mother and child through CD4 count testing, 
WHO staging, HIV testing for the child at different stages, monitoring side effects of ARVs, 
changing ARVs from first line if need be, referrals, and ongoing counselling on nutrition. 
When women are recruited under the PMTCT Option B+ programme, they accept a lifelong 
partnership with the health professionals who take them through the whole process. “Till 
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death do us part” was derived as a theme in this study from the reference made by 
participants to PMTCT Option B+ strategy as being a lifelong commitment like marriage. All 
participants showed anxiety when talking about the lifelong commitment but there was a 
remarkable difference between those with longer experience of an HIV diagnosis (amounting 
to as much as four years in one case) and those with less experience (just a few months). 
There was a corresponding range in their experience of the treatment regime, with some 
having only recently been initiated on Option B+ strategy and some who also had prior 
experience on Option A.  
When the participants initially were told that Option B+ strategy was a lifelong commitment 
the meaning did not always sink in immediately, but as time went on the full implications 
aroused more and more emotional stress. Even those with more experience to draw on were 
not convinced that it had to be lifelong treatment. This confirms how poorly these women are 
prepared: despite their willingness to participate they lack vital information on Option B+ 
strategy. The less experienced women had a tougher time dealing with the reality; for one 
woman it was impossible to grasp the notion that she needed to go on lifelong treatment 
while she was still healthy. It is important to note that for patients in resource-limited settings 
like Malawi, there is radical departure in messaging where the previous advice to patients had 
been to wait until their CD4 cell count was low before they started ARVs (Ahmed et al., 
2013). Public consultation and education has not been sufficient in clarifying the need for this 
shift of strategy. 
Participants said that the hardest part of Option B+ adherence for them was accepting the 
notion of a drug dependent life. Most seemed to find this distressful, with one feeling she 
might have no chance of getting married if a man found out that she was on life-long ARVs. 
In Uganda most women on Option B+ revealed during focus group discussions that after the 
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birth of their children they would stop the medication because their only reason for agreeing 
to start ARVs had been to protect their children, while others planned to stop when their CD4 
cell count was sufficiently high (Hsieh et al., 2013). Although there is no literature supporting 
this finding for Malawi, adherence issues were obvious in the study and the current statistics 
on loss to follow-up may well point to the same conclusion. Reversing the situation will 
require adherence support mechanisms, including task shifting for ART initiation. 
5.5.2 Support systems  
Support systems are important in the coping strategies that participants use for handling the 
psychological stress of being on Option B+ strategy, as discussed previously, and also in the 
provision of necessary physical care and advice. It has been found that psychological distress 
can be associated with behavioural problems in children as well as impairment of physical 
and cognitive development (Avan, Richter, Ramchandan, Norris and Stein, 2010); in the 
context of HIV it has been suggested that support systems have a positive influence on health 
behaviour outcomes, adherence, and safer sexual behaviour. For this reason women should be 
encouraged to seek support in order to minimise the level of psychological distress they 
experience. Sources of support reported by participants included more informal support from 
partners, family and friends as well as formal support generated from the health care system. 
5.5.2.1 Informal support  
Most participants spoke in very positive terms about informal support, with broad consensus 
that friends and family gave them courage and strength to move on. Informal discussions and 
simply talking about their feelings and experiences were much valued. Family were a source 
of both psychological and physical support, which could be nutrition or it could be someone 
to remind them to take medications – although this could not always be said of participants’ 
partners. Some women reported that their husbands failed to provide for their basic needs 
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because of mistrust and overall disturbance in the family structure due to the infection. 
Participants who did not have support from partners exhibited more stress behaviour than 
their counterparts.  Contrary to the findings in this study, literature has also identified contact 
and interaction with other HIV-infected individuals as a valuable source of informal support 
(Moneyham et al., 1998) for combatting the isolation that often results from the stigmatising 
aspects of the disease. This form of support relies on individual women actively seeking the 
support from others; women in this study would consequently not appreciate this form of 
support, as disclosure of HIV status was their major concern. 
The participants stressed the necessity of a support system when they went for HIV testing, 
believing that more support would have made the experience less traumatic and would have 
helped them to absorb the education, instruction and advice from the hospital, much of which 
they had not understood. 
5.5.2.2 Formal support 
The presence of formal support structures in the hospital and in the community was 
confirmed from the study. What also emerged, however, was that even though participants 
craved support, they were not making use the already established sources of support within 
reach. Apart from the normal scheduled hospital visits where support was given by health 
professionals, not all participants knew that additional support structures existed. An NGO 
located on the premises of the hospital meets with women as soon as they are enrolled on 
Option B+ strategy but the continued support it offers depends on commitment by the patient, 
which was a problem for the women in the study. Community support groups to cater for 
their psychological, social and physical needs had also not been utilised by the women, and 
reluctance to access and utilise support services usually had at its root the problem of 
disclosure of HIV status. 
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Information about the range of support possibilities available within the hospital and 
community should be included in post-test counselling and ongoing counselling to HIV-
positive women with particular focus on help with disclosure. Failure to disclose HIV status 
has profound consequences and the importance of supporting women in the acute dilemma 
they often face in this regard cannot be overemphasised  
5.6 Conclusions of the study 
Data to explore the objectives of this study was obtained through in-depth interviews 
conducted with five HIV-positive women on Option B+ strategy. The challenges they faced 
and their coping strategies were revealed, and was most notably emerged was the emotional 
toll on women participating on Option B+ strategy. Participants identified the lifelong 
commitment as the most challenging part of the PMTCT Option B+ process, which made 
worse by failure (as they saw it) to involve them in their own care.  
This study indicated the importance of adequate knowledge and understanding of Option B+ 
strategy on the part of the women involved. Lack of knowledge seemed to be the biggest 
setback in the PMTCT process; the less the women understood about Option B+ strategy, the 
less likely they were to accept their HIV status, participate, adhere and cope throughout the 
process. The effectiveness of Option B+ strategy depended on how prepared the women were 
both psychologically and through education. The women in the study who had longer 
experience of PMTCT expressed less anxiety about the programme, which underlines the 
importance of knowledge, understanding, preparation and readiness for all women on Option 
B+ strategy. 
This study revealed that the ‘opt-out’ option in Option B+ strategy places women in a 
vulnerable position that significantly affects their participation. Provider-initiated HIV testing 
without preparation and choice on the side of the mothers brings with it issues of human 
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rights conflict and no real conclusion could be drawn regarding the approach to testing. 
Irrespective of problems associated with the approach to HIV testing, women nonetheless 
appreciated additional time spent with health professionals helping them to accept and cope 
with their participation on Option B+ strategy. 
Disclosure was found to be the major obstacle on Option B+ strategy. Not only did it 
determine whether the participants got the necessary psychological, social and physical 
support but it also affected efforts to minimise further spread of HIV. Fear of involuntary 
disclosure was indicative of failure on the part of the health care system to protect the privacy 
of women participating on Option B+ strategy. Lack of male involvement in PMTCT was an 
additional discouragement to disclosure, and gave rise to violence and blame within families. 
Particularly highlighted by the findings was women’s commitment to protecting their 
children from getting infected with HIV, but fixation on the children’s welfare as the sole 
motivator points yet again to a gap in their preparedness to deal with the phenomena and 
leaves room for doubt whether they would adhere on Option B+ strategy in long-term. 
Notwithstanding the sociocultural factors identified, women nonetheless gave proof of their 
sense of social responsibility in the endeavour to prevent further spread of HIV.  
Factors identified as affecting participation on Option B+ strategy included attitudes of health 
care workers, distance to hospitals, availability of drugs, men declining HIV testing, stigma 
and discrimination. 
Formal support within the hospital and community was not being utilised by participants on 
Option B+ strategy, who mostly relied on informal sources of support such as friends and 




The recommendations presented in this chapter are based on the findings from this study and 
other published studies in literature that informed the study discussion. The recommendations 
highlight gaps in education, practice and policy, as well as possible areas for future research. 
5.7.1 Knowledge and understanding of Option B+ strategy  
During the interview process, participants showed inadequate knowledge and understanding 
of Option B+ strategy. This was found to be partly because comprehensive education on 
Option B+ strategy is focussed on women attending antenatal care for the first time and 
targeted for HIV testing, meaning that women have just a single exposure to the rich 
information. Nurses need to make the comprehensive Option B+ strategy a routine education 
topic, so that all women accessing the hospital for other services too, such as family planning 
or under-five clinic, have an opportunity to learn about the new PMTCT option, thus 
disseminating generalised knowledge and understand of the Option B+ strategy within the 
community. Women on Option B+ strategy need ongoing counselling to address issues they 
are going through and there needs to be an emphasis on information-giving sessions for 
empowerment. 
The ‘opt-out’ approach in Option B+ strategy needs to be practised as per recommendations. 
The participants expressed concern that being tested for HIV without being given a choice 
was untimely and stressful. Nurses committed to the ‘test and treat’ model for preventing 
missed opportunities also need to respect the women’s choices and rights. With adequate 
information women will be in a better position to make an informed decision on getting 
tested, which may enhance adherence to the programme.  
Preparatory classes need to be considered in Option B+ strategy as is done for ART. Women 
who are tested for HIV need to be given a further date to return for comprehensive education 
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and initiation of ART. This will also give them more time to accept their HIV status and 
prepare themselves psychologically for the commitment. Women who come back for 
education and initiation would thereby show their commitment to start the medications and 
go through with the Option B+ process, creating greater confidence within the system that the 
women being recruited understand what the implications are. It can be recommended that as 
the Option B+ strategy programme rolls out, a principal target should be retention, otherwise 
women who are unwilling to participate will eventually default and be lost to follow-up, 
rendering the programme ineffective. 
5.7.2 Accepting the HIV-positive status  
Disclosure of HIV status by women on Option B+ strategy proved to be a challenge. There is 
need for disclosure education to be emphasised during post-test and ongoing counselling to 
women on Option B+ strategy. The culture of silence as far as HIV is concerned need to be 
discouraged because it challenges the efforts in HIV prevention. Disclosure for many women 
proved effective in obtaining the necessary support from friends and family, and those who 
did not disclose their status craved for support with disclosure highlighting the need for 
health professional to spend time with the women educating, counselling and supporting 
them with disclosure.  
Male involvement in Option B+ strategy is a very important component that needs to be 
critically analysed. National policies and procedures for testing and treatment of male 
partners of pregnant and lactating women should be clarified as part of the process of Option 
B+ strategy. Equal treatment of men and women on Option B+ strategy will encourage more 
partners to come to the hospital. If ‘test and treat’ is the approach for Malawi then it needs to 
be standardised to include both men and women, since men have an equal chance of re-
infecting their partner.  Partner counselling and testing should be emphasised for antenatal 
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women because it will encourage both disclosure and acceptance of HIV status, it will 
promote preventive strategies and it will minimise partner violence. 
Although adequate preparation of women on Option B+ strategy would help them in coping 
with their HIV status and participation, health professionals also need to promote active 
coping strategies such as seeking social support among women. Active coping mechanisms 
will also minimise psychological effects on the women and promote their health.  
5.7.3 Sociocultural factors affecting HIV-positive women on Option B+ strategy 
The lack of knowledge that women showed in the study suggests lack of knowledge on the 
part of the health care workers as well, since Option B+ strategy is a new phenomenon and 
in-service trainings are also needed for updating nurses, clinical officers and other cadres on 
ART management. Well-informed health professionals will be in a better position to support 
women on the programme, and the continuing professional development (CPD) programme 
in Malawi will promote this process. Other than the in-service training, new responsibilities 
related to ART management need to be included by educators in the nurses training curricula. 
ART initiation is a new task for nurses in Malawi and pre-service training curricula need to 
be updated to reflect Option B+ strategy guidelines, policies and protocols.  
The Ministry of Health may benefit from adopting South Africa’s National Core Standards to 
improve attitudes of healthcare workers dealing with women on Option B+ strategy. The 
National Core Standards, which is a benchmark of quality care against which delivery of 
services can be monitored, would ensure that patients are respected and their rights upheld, 
including access to needed care and to respectful, informed and dignified attention as seen 
from the point of view of the patient. The government can achieve this through patient 
satisfaction surveys and dialogue to establish what concerns they have for improvement of 
Option B+ strategy services. 
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The government needs to consider investing in additional human resources, especially nurses 
that would enable the PMTCT programme to deal with Option B+ strategy workload. It was 
discovered from literature that although the health professionals who were initially working 
on PMTCT initially easily switched to Option B+ strategy, the support that women require on 
Option B+ strategy may be more than for Option A. Lengthy counselling, ART initiation and 
ongoing support all require more human resources to eliminate long hospital waiting times 
that may eventually affect women’s participation. 
Participants’ concerns about not being involved in their own care poses a major challenge for 
Option B+ strategy. According to the participants, this began with Government’s initial 
failure to consult the service users before adoption of the service and it continues throughout 
the continuum of care. Even though Option B+ strategy is already in implementation, 
Government needs to engage with the community, consulting and educating them on Option 
B+ strategy. Targeting the community and its leaders will help to spread grass-roots 
awareness of Option B+ strategy and enhance acceptability. Women also need to be given an 
opportunity to evaluate the programme’s effectiveness in their own terms. Hospitals need to 
devise ways of seeking feedback from the women who are utilising the service, which could 
include surveys, anonymous comments and meetings with stakeholders. This would help to 
deal with women’s major concern: not being involved in their own care.  
Empowerment of communities and their leaders will motivate them to take action on issues 
such as reducing the stigma and stigmatisation reported in the study, motivating men to go for 
testing and be actively involved in PMTCT, promoting disclosure of HIV status, speaking 
against gender-based violence, and backing support for women on Option B+ strategy. 
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5.7.4 Adherence on Option B+ strategy 
Women on Option B+ strategy need to be introduced to formal support available within the 
hospital and community. Better linkage to support and care structures would enhance overall 
psychological, social and physical support for women as they cope with their participation on 
Option B+ strategy. 
5.8 Recommendations for further research 
This research was a small-scale study conducted in a single rural district hospital; a similar 
study in another setting could give a more extended picture of how widespread the views and 
experiences recounted here might be. 
Male involvement was found to be an important component on Option B+ strategy but men’s 
experiences with Option B+ strategy have never been explored. There is a strong case for 
further research targeting partners of women on Option B+ strategy to explore their 
knowledge, understanding and experiences with the Option B+ programme. 
All the women who were interviewed were still on the Option B+ strategy. A study would be 
recommended to follow those women classified as lost to follow-up to get experiences and 
reasons of dropping out of the programme. These results would give a true picture of the 
experiences that would eventually collapse the Option B+ strategy.  
5.9 Limitations 
This study reflects the experiences of only five volunteer participants. The data obtained from 
the interviews were limited to what the participants were willing to share about their 
experiences on Option B+ strategy. 
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The interviews were conducted within the hospital premises, which might have been a bit 
intimidating for some participants since their experiences involved criticising the healthcare 
workers and healthcare system as a whole while they were still receiving care. This fear may 
have influenced the responses from participants.  
The experiences in this study may therefore not be representative of all HIV-positive women 
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Annexure A: Participants’ Information Sheet and Informed Consent 
Greetings, 
My name is Aliko Mmanga; I am a student at the University of KwaZulu-Natal, undertaking 
a Master’s degree in Nursing (Maternal and child health). One of the requirements for the 
degree is to conduct a research project. 
This letter serves to ask consent from you to take part in this research. The purpose of the 
research is exploring the lived experiences of HIV-positive women on PMTCT Option B+ 
Strategy. This will help to understand the experiences that women go through while receiving 
PMTCT care on Option B+ strategy will the purpose of providing recommendations for 
improved programme performance.  
Your participation is completely voluntary and you are free to withdraw from the study at any 
point without any consequences. You will not be paid for your participation in the study and 
you will not be required to pay anything in order for you to participate. If you agree to 
participate you will take part in an in-depth interview lasting 30-45minutes, the interview will 
be recorded. Your privacy will be maintained at all times and only the researcher and 
supervisor will have access to the information you provide. The anonymity will be ensured 
by having pseudo identification on the data collection tool so that information cannot be 
traced back to you. The confidentiality will be guaranteed through secure storage of the filled 
in data collection tools in a safe and locked place for a period of 5 years, in the School of 
Nursing at the University of KwaZulu-Natal and only the researcher and research supervisor 
will have access to the data collected.  
If you do decide to participate there will be no direct benefits to you, however, your 
contribution will help the PMTCT programme in future. If there are any questions that you do 
not feel comfortable with, you are free to not answer. In addition, if after the interview any 
questions made you uncomfortable we will have a counsellor available to talk with you to 
help you through any stress you may have experienced. You will be required to sign two 
letters of declaration consent form if you agree to take part and you will keep one copy while 
I keep the other for my records. 
This study has been ethically reviewed and approved by the UKZN Biomedical research 
Ethics Committee (Protocol number BE260/13) and National Research Council of Malawi 
(Protocol number NHSRC 1186). 
In the event of any problems or concerns/questions you may contact the researcher or 
researcher at the following contact details:  
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Name of the researcher:  Aliko Mmanga 
Contact details:  School of Nursing, 5th Floor Desmond Clarence Building 
Howard College Campus, University of KwaZulu-Natal 
Faculty of Health Sciences,  
4041, DURBAN, SA 
Tel: +27748089722.  Email:alimmanga@gmail.com 
Supervisor:   Dr. Jennifer de Beer   
Contact details:  School of Nursing, 4th Floor Desmond Clarence Building 
Howard College Campus, University of KwaZulu-Natal 
Faculty of Health Sciences 
4041, DURBAN, SA 
Tel: +27312603311.  Email:debeej@ukzn.ac.za 
Research ethics:   Biomedical Research Ethics Administration 
Research Office, Westville Campus 
Govan Mbeki Building 
Private Bag X 54001  
Durban, 4000.  KwaZulu-Natal, SOUTH AFRICA 
Tel: +27 31 2604769 - Fax: 27 31 2604609 
Email: BREC@ukzn.ac.za  
National health sciences research committee  
P.O Box 30377 














DECLARATION OF CONSENT TO PARTICIPATE IN THE RESEARCH  
I __________________________________________ have been informed about the study 
entitled exploring the lived experiences of HIV-positive women on PMTCT Option B+ 
Strategy by Miss Aliko Mmanga. 
I understand the purpose and procedures of the study.  
I have been given an opportunity to answer questions about the study and have had answers 
to my satisfaction. 
I declare that my participation in this study is entirely voluntary and that I may withdraw at 
any time without affecting any treatment or care that I would usually be entitled to. 
I have given permission to the researcher to audiotape the interview. 
If I have any further questions/concerns or queries related to the study I understand that I may 
contact the researcher.  
If I have any questions or concerns about my rights as a study participant, or if I am 
concerned about an aspect of the study or the researchers then I may contact the researchers 
on the details provided. 
 
____________________      ____________________ 
Signature of participant                            Date 
_____________________  _____________________ 




Annexure B: Participant Interview Guide 
Participant demographics 
1. How old are you? 
2. Are you married? 
3. When did you know your HIV status? 
4. How long have you been on Option B+ strategy? 
5. Who else knows your HIV status? 
Essential questions 
Variations of the following questions will be used to solicit views and experiences from 
participants 
 Tell me about your experience related to prevention of mother to child transmission of 
HIV on Option B+ strategy 
 How do you feel about your participation in Option B+ PMTCT strategy? 
 What are some of the issues and concerns that you have on Option B+ strategy? 
Probes and prompts 
Probing questions and probes will be used during the interview process based on participant 
responses 
• How does that make you feel? 
• So how do you handle that? 




Annexure C: Mfundo zogwiritsa ntchito pokambirana ndiotenga nawo mbali 
Mbiri ya otenga nawo mbali 
1. Kodi muli ndi zaka zingati? 
2. Kodi muli pa banja? 
3. Kodi munadziwa liti kuti muli ndi kachirombo koyambitsa matenda a edzi? 
4. Kodi mwakhala nthawi yayitali bwanji pa ndondomeko ya mankhwala ama ARV? 
5. Pali wina amene akudziwa zoti muli ndi kachiromboka? 
Mafunso ofunikira 
Mafunso otsatirawa agwiritsidwa ntchito kufuna kudziwa zovuta  ndi zinthu zomwe otenga 
nawo mbali akukumana nazo? 
•  Tandiuzeni zomwe mukudziwa zokhudza njira zotetezera  mwana ku kachirombo  ka 
HIV zokhudza ndondomeko ya mankhwala ama ARV? 
 • Kodi inu mukunva bwanji pakutenga nawo mbali kwanu mu ndondomekoyi? 
• Nanga ndi zinthu ziti komanso zovuta zanji zomwe mumakumanazo pa 
ndondomekoyi? 
KUFUFUZA NDI KUFUNA KUDZIWA 
Mafunso ofufuza  ndi kufunsa zizagwiritsidwa ntchito kutengera ndi momwe otenga nawo 
mbali akuyankhira  
• Kodi zinthuzi zimakupangitsani kunva bwanji 
• Kodi nanga munachivomereza bwanji? 




Annexure D: Request letter for ethical clearance to Research Committee, University of 
KwaZulu-Natal 
The Research Committee 
University of KwaZulu-Natal 
May 2013 
APPLICATION FOR APPROBATION OF A RESEARCH PROPOSAL  
I hereby apply for an ethical clearance for my research proposal titled: 
“Exploring the lived experiences of HIV-positive women on PMTCT Option B+ 
Strategy in a selected district hospital in Malawi”. 
I am a Malawian student, undertaking studies to obtain a Master’s in Nursing: Advanced 
midwifery, maternal and child health at the University of KwaZulu-Natal in the School of 
Nursing and public health. One of the requirements for the degree is to conduct a research 
project. 
The district hospital was purposively chosen to be the setting for this study. Data will be 
collected from pregnant and breastfeeding women receiving care on PMTCT Option B+ 
strategy. Participants will be required to provide an account of their experiences through an 
in-depth interview with the researcher. This protocol will also be submitted foe ethical 
clearance in Malawi for approval and permission will be sought from the selected hospital.  
The research protocol, the data collection tools and the consent form for participants are 
enclosed herein. The informed consent for participants shows that participation is voluntary 
and how the rights and identity of the patients will be protected in the research process. The 
process will not interfere with daily work and flow of patients at the hospital. 





Research Supervisor: Dr. J. de Beer (University of KwaZulu-Natal)  





Annexure E: Letter of approval from Biomedical Research Ethics Committee, 





Annexure F: Request letter for ethical clearance to National Health Sciences Research 
Committee, Malawi 
The Chairman  
National Health Sciences Research Committee  
P.O Box 30377 
LILONGWE, MALAWI 
University of KwaZulu-Natal,  
Howard College Campus,  
School of Nursing and Public Health 
Desmond Clarence Building, 5th Floor  




APPLICATION FOR PERMISSION TO CONDUCT A RESEARCH STUDY 
Research Topic: Exploring the lived experiences of HIV-positive women on PMTCT 
Option B+ strategy in a selected district hospital in Malawi 
I wish to request permission to conduct a research project at Mchinji District Hospital. 
I am a 29 year old Malawian female who is currently studying Masters in Nursing: Maternal 
and Child Health –Coursework in South Africa. Part of the requirement for my studies 
requires that I conduct a research project in my area of my interest. 
Mchinji District Hospital was purposively chosen to be the setting for this study. Data will be 
collected from pregnant and breastfeeding women receiving care on PMTCT Option B+ 
strategy. Participants will be required to provide an account of their experiences through an 
in-depth interview with the researcher. This protocol has been submitted to the Research 
Ethics Committee of the University of KwaZulu-Natal and upon your approval permission to 
conduct the study will also be sought from Mchinji District Hospital. 
The research protocol, the data collection tools and the consent form for participants are 
enclosed herein. The informed consent for participants shows that participation is voluntary 
and how the rights and identity of the patients will be protected in the research process. The 
process will not interfere with routine work and flow of patients at the hospital. 
Your consideration will be greatly appreciated. 
Researcher: Miss Aliko Mmanga 
Cell: +2774 808 9722 
Email: alimmanga@yahoo.com 
Research Supervisor: Dr. Jennifer de Beer 
Tel: +27312603311 
Email: debeej@ukzn.ac.za  
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Annexure H: Request letter to conduct study at Mchinji District Hospital 
The District Health Officer 
Mchinji District Hospital 
P.O Box 36 
MCHINJI, MALAWI 
University of KwaZulu-Natal  
Howard College Campus, School of Nursing 
and Public Health 
Desmond Clarence Building, 5th Floor  
4041, DURBAN  
SOUTH AFRICA.  
May 2013 
Dear Sir: 
Application for approbation of a research proposal  
I hereby request the approbation of my research proposal by Mchinji district health office. 
I am a Malawian student, undertaking studies to obtain a Master’s in Nursing: Advanced 
Midwifery, Maternal and Child Health at the University of KwaZulu-Natal in the School of 
Nursing and public health. One of the requirements for the degree is to conduct a research 
project. 
The title of the research is “Exploring the lived experiences of HIV-positive women on 
PMTCT Option B+ Strategy in a selected district hospital, Malawi”. 
The district hospital was purposively chosen to be the setting for this study. Data will be 
collected from pregnant and breastfeeding women receiving care on PMTCT Option B+ 
strategy. Participants will be required to provide an account of their experiences through an 
in-depth interview with the researcher. This protocol has been submitted to the Research 
Ethics Committee of the University of KwaZulu-Natal and the Ministry of Health research 
unit for approval.  
The research protocol, the data collection tools and the consent form for participants are 
enclosed herein. The informed consent for participants shows that participation is voluntary 
and how the rights and identity of the patients will be protected in the research process. The 
process will not interfere with daily work and flow of patients at the hospital. 





Research Supervisor: Dr. J. de Beer (University of KwaZulu-Natal)  
Tel: +27312603311 
Email: debeej@ukzn.ac.za  
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Annexure I: Sample of in-depth interview with participant. 
Transcript for an in-depth interview with Monica 
Interviewer: Thank you for accepting to take part in this research, so feel comfortable 
because whatever we will discuss here will be private and confidential like I 
already said. So for the sake of this interview you will tell me a fake name that 
we should use. 
Participant: Monica  
Interviewer: OK Monica, How are you? 
Monica I am fine and you? 
Interviewer: I am also fine. How old are you? 
Monica:  I’m 19 years old 
Interviewer:  Are you married? 
Monica:  No, I am not married 
Interviewer: Boyfriend? 
Monica:  Mmmh no... [Laughs] no, I don’t. He disappeared. 
Interviewer:  After the pregnancy? 
Monica: Yeah, guess he was one of the irresponsible ones. We were together for 
8months, he was promising a lot and I thought we could build a family 
together but when this [pointing at the belly] happened he completely changed 
started acting up and disappeared later. Haven’t seen him since. 
Interviewer:  Is this your first pregnancy 
Monica: Yes it is and probably my last [smiles] 
Interviewer: Why do you say that? 
Monica: One is enough, isn’t it? [Laughs] 
Interviewer: [Laughing] Ok, so how far did you go with your education? 
Monica:  I dropped out in Form 2. 
Interviewer:  Form 2? Why did you drop out of school? 
Monica:  It was because of lack of financial support. My father died when I was in 
standard 8 and my mother managed to support me for two years, then later 
things became tough. I had to drop out of school and help her raise my 
siblings. It was the only choice. 
Interviewer: So who do you stay with at the moment? Who supports you? 
Monica: I stay with my mother, we support each other if I may say 
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Interviewer:   When did you know about your HIV status? 
Monica:  Uum, it was when I came here to start antenatal care almost 6months ago. 
Interviewer:  Take me through that day, what happened? 
Monica: Well I remember I came alone that morning, it was my first time so I was 
exceptionally early because I didn’t know how the clinic operated. The clinic 
started a bit late because we waited to some time. At the beginning of the 
clinic we were all placed in one room and we sang songs and then they taught 
about a lot of issues including HIV and AIDS. Then we were told that for 
those coming for the first time we will go through to another room while the 
rest were also directed somewhere else. I really didn’t have any expectations 
for this visit, it was after I went into the room that I realised that we will be 
tested for HIV. 
Interviewer: What happened in that room? 
Monica: It was a small group that went through and what happened was that they 
started by counselling us about HIV again but this time in detail, the 
advantages and disadvantages and how we would pass the virus to the baby 
and the issue of Option B+ strategy was brought in saying whoever is found 
HIV-positive will be put on ARVs for life. That was the very first time it 
downed to me that we will be tested for HIV. I did not pay much attention 
really because I thought it wasn’t relevant to me. Then blood samples were 
collected from each one of us and we were called one by one to receive our 
results. 
Interviewer: You are talking as if you had no choice 
Monica: Exactly, there was no choice, none whatsoever, not a chance. It was more like 
being told than asked. 
Interviewer: and what was going through your mind at that moment 
Monica: When I was waiting for the results outside that’s when I really thought about 
what just happened. I could see people coming out after receiving their results 
and I could tell who received bad news [clears throat]. A million things run 
through my mind at one point I thought of just abandoning the queue and go 
home. 
Interviewer:  What made you think that? 
Monica: The truth is, I was not ready. It is not easy I promise you. By that time I had 
never been tested for HIV, it was my first time and I was scared and yet there 
was nothing I could have done. There was no time to even get my head 
straight and prepare myself for a possibility of HIV-positive results. 




Monica: I could have made the decision at that time but the only problem is that it came 
as a surprise. 
Interviewer:  and how did that make you feel? 
Monica: Powerless I guess, I was just weak to my bones. Thinking I would have made 
the decision myself and yet I couldn’t. 
Interviewer: Then what happened next 
Monica: My name was called and I went in. Since they had already taught us how a 
positive HIV result would look like I saw it on the table but I convinced 
myself that it wasn’t mine until the counsellor spoke [She avoided eye contact 
and became emotional]. Then she picked the results from the table and 
showed me, it was a moment of truth. 
Interviewer:  How did you feel at that moment? 
Monica: [staring blankly] there is no better word to describe the feeling. It’s almost 
unreal you know, terribly unreal. I thought the nurse was playing a sick joke 
on me but of course not. 
Interviewer: What was the real reason for your worry? 
Monica: I was in shock I guess from thinking it can’t happen to me then reality struck. 
The terror came in as a realisation that life will never be the same again. For a 
moment my mind had a flight of ideas, almost getting me excited but none of 
it included curing the HIV. I realised there is no cure [pauses] felt like 
reaching a dead end. 
Interviewer: and how did that make you feel? 
Monica: I was disappointed, I felt like I had disgraced my parents because there is no 
parent who wants to see their children suffering. Yes my mind went that far. 
Interviewer: so after you received your results what happened? 
Monica: Then she talked about Option B+ strategy and medications and hospital 
delivery and preventing transmission and a whole lot. Its was just too much 
information and the next minute she gives me bottles of medications... ARVs 
and how I should be taking them, coming for refills and reporting sight effects 
[sighs]... phew it was too much. 
Interviewer: so in other words, she was preparing you for Option B+ strategy 
Monica: You could say that 
Interviewer: You don’t sound convinced, do you think the preparation was enough? 
Monica: To tell the truth, the first time we were being educated on HIV and Option B+ 
strategy I had not tested for HIV so I was not paying much attention because I 
didn’t think it was relevant to me. The second time it was right after I received 
my positive HIV results and honestly I was not listening because there were a 
lot of things going on in my mind. 
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Interviewer: How would you have liked the education or the preparation be done in general 
Monica: I believe preparation is very important for this strategy but my only problem is 
that it is not easy to understand the education when you are not in the right 
state of mind. From testing HIV-positive to lifelong treatment, it is a lot to 
take in. I wish there was time set aside for education, so that one has time to 
meditate, understand and make a decision. 
Interviewer: what other issues went through your mind then?   
Monica: I have seen HIV-positive patients before and that is how I pictured myself in a 
few weeks ahead, the faces of those sick AIDS patients I saw flashed in my 
mind [Pauses]... it was absolute terror. I was also thinking how I was going to 
tell my mother and how she would receive the news. 
Interviewer: Did you say you came alone to the hospital that day? 
Monica: Yes I came alone to the hospital that day, much as it was my first time and my 
first experience I didn’t think it was a big deal. My mum wanted to escort me 
but I declined, anyway, I didn’t realise how much I would need her after the 
diagnosis, it was so heavy on me. I needed someone to be there to help me 
through. 
Interviewer: Do you think it would have been different if you had someone?  
Monica: I believe so, if there was someone with me that time I wouldn’t have done 
what I did, am sure that someone would have talked sense into me. 
Interviewer:  What happened? 
Monica: [laughing] I did not take it very well, you can imagine I went to the hospital 
and I am coming back with these bottles of medications. I did not even want to 
go home that day to avoid questions and suddenly an idea hit me, it seemed 
the only option at the point [Giggles] so I got rid of the medications along the 
way and went home like nothing happened. 
Interviewer:    You mean you threw away the ARVs you were given at the hospital? 
Monica:          Yes I did, I just found a rubbish pit along the road and yes I threw them in and 
went home. 
Interviewer:  How were you feeling on your way home? 
Monica: I will tell you the truth, I was scared to go home to start with. In my mind I 
knew I had to tell someone, talk to someone… Uum, I did not know who. On 
my way home I kept thinking who would be the best person to talk to. I had 
not made the decision when I got home so I stayed for a week before 
confiding in my best friend of 11years and later I told my mum. 
Interviewer: So apart from your mum and best friend does anyone else know? What 
motivated you to tell your best friend other than your mum? 
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Monica: I was single, still am [Laughing] I knew my mum would be critical because 
she was not happy that I got pregnant in the first place, I knew it was only my 
best friend who would understand you know, and I considered my privacy 
also. I trusted my best friend to keep my secret better than anyone. Later on I 
realised that my mum would support me as much if she knew so I told her. 
Interviewer: So how was your mother’s reaction. 
Monica: Even though she pretended to be strong about it I knew that she was hurt and it 
made we feel sad. But coming back to your question there is no one else who 
knows I believe but I can never be sure. Our neighbour is very talkative and I 
feel if she knew my status I would have no peace, she would tell everyone in 
the village and beyond. I do not want anyone else other than my family to 
know. If they ever know, it will not be from me. 
Interviewer: How do you feel now that your mother knows your HIV status? 
Monica: I feel good that I told my mother about my HIV status and participation in 
PMTCT Option B+ strategy. It gives me an opportunity to discuss with her 
issues that I wouldn’t have if she didn’t know my status. I am able to 
communicate when I have a problem, she takes good care of me. She is also 
my treatment partner because she reminds me to take medications on daily 
basis so I never forget 
Interviewer:  Talking of medications let me take you back to the ARVs you threw away on 
the first visit. What happened next? 
Monica: I spent a month meditating on it until my next antenatal appointment. It all 
then sunk in, I realised the situation I was in and decided to act in the best 
interest of my baby. When I went back the next time I was more willing to 
start the medications, I was convinced I had made the right decision and I have 
not stopped ever since. 
Interviewer:  So how has your experience on Option B+ strategy been so far? 
Monica: So far, it has been good. I am very happy because I know that my life and that 
of my child is protected, I get all the care and the advice I need. 
Interviewer: do you have any worries or concerns? 
Monica: I am worried at the thought that my life will depend on medications for the 
rest of my life, what kind of life is that? And I always think what would 
happen if I forgot to take the medication or anything happens? 
Interviewer: Do you mean forgetting to take the medication? Or stopping. 
Monica: No, I can’t stop taking the medication because I want to protect my unborn 
child. I was told that once I stop, the chances of passing the virus to the baby 
may be high and I don’t want that to happen. 
Interviewer:  It seems you are more concerned about the baby than anything else. Will you 
continue the ARVs once the baby is born? 
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Monica: [hesitation]... It’s not like that, but the child is my number one priority at the 
moment. 
Interviewer: I know you told me about the disappeared boyfriend, you knew his HIV 
status? Where do you think the infection came from? 
Monica: We never went for HIV testing, I believe he is the one who infected me. I was 
young and naive I never thought such things do really happen. Not ever did I 
thought it necessary to go for testing and am sure wherever he is, he still 
doesn’t know and is busy spreading the virus. 
Interview: Do you think it would be useful to involve men in PMTCT programme? 
Monica: I think so, they would also be tested and know their HIV status and it would 
be easier for them to support their wives if they had adequate information 
about PMTCT or HIV in general. 
Interviewer:  Given the opportunity to change the hands of time what would you change? 
Monica: Well I regret getting pregnant, if I knew my HIV status I wouldn’t have gotten 
pregnant in the first place but I knew after getting pregnant and there was no 
way out. 
Interviewer: You wouldn’t have gotten pregnant... why do you say that? 
Monica: The whole Option B+ strategy is disappointing, we have no say [sighs] we are 
invisible in the system. Everything is laid out, like a play and we are in it. 
Interviewer: How does that make you feel? 
Monica: It’s disappointing and feels hopeless but what can I do? 
Interviewer: How do you deal with those feelings? 
Monica: There is no way of dealing with such feelings, u just wish u never got pregnant 
in the first place like I said, otherwise there is no solution. 
Interviewer: So what does it mean to you when you think that the ARVs are for the rest of 
your life? 
Monica: Mmh it is difficult my sister, look at me now, just take a good look... [Pauses] 
... do I look sick? Perfectly healthy, Well is do understand that we need to 
protect the baby from the infection blah blah blah, I get that but why me? why 
do I have to take the medication for the rest of my life? I am 19 years old I 
would want to get married later, Uum, I would surely disclose my HIV status 
to the future partner but telling him am on lifelong treatment too?  
Interviewer: What is your fear? 
Monica: He will believe I am that sick that they had to put me on medications forever. 
No one would want to marry me. Option B+ strategy may just as well be my 
partner for life. 
Interviewer: I sense lack of commitment, will you make it to the end? 
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Monica: Mmh I don’t know for now, will see when I get there [Both laughing]. 
Interviewer: Ok tell me about your experiences with the hospital do you think you are 
getting the necessary care? 
Monica:  Well, they try their best 
Interviewer: Explain more... 
Monica: Sometimes the nurses and doctors are late in attending to us, we come to the 
hospital very early but we return late and sometimes they shout at us without 
showing love and yet a doctor is supposed to be loving to us patients [Smiles] 
I wish they were receiving patients with love so that we could also be coming 
here with open minds. 
Interviewer: Do you think they treat you like that because you are HIV-positive? and how 
does the attitude make you feel? 
Monica: I don’t think so, that’s how some of them [referring to health professional] 
are, it’s not everyone I must say, just a selected few and it’s like they are 
adding on more stresses in my life you know. 
Interviewer: and how do you deal with it? 
Monica: Its one of those you know, I just convince myself that it is for a short period of 
time and I will be out of here. I don’t let it bother me. 
Interviewer:  Is there anything else that bothers you when you are receiving care here? 
Monica: Sometimes I feel like receiving care on Option B+ strategy is indirectly 
disclosing my HIV status 
Interviewer:  Do you feel that your privacy is not taken care of in the hospital? 
Monica: No not at all, there is privacy here [Clears throat]... Absolutely there is 
privacy here. But maybe since the counsellors come from the same 
communities we do... [Laughs] we can never be sure, but really, I don’t think 
that is the case. It is just the presence here, feels like someone can see through 
you. The Mwai clinic that gives ARVs is right behind the antenatal clinic and 
sometimes you are asked to go there for some reason and you already become 
conscious. Maybe its paranoia, but it’s a real feeling knowing that once people 
see me here they will speculate. 
Interviewer:  Have you ever felt like people are talking about you? How do you cope with 
all that? 
Monica: Not directly, but it becomes so real when people are talking about it and you 
are thinking like Hello I also have it here you know, but once the episode is 
over and I am home I am in a completely different set of mind. It doesn’t 
bother me much, it’s like I have switched off the power button for a while 
[makes a face] it works! 
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Interviewer: Do people still stigmatise and discriminates HIV-positive people in the 
community? Or it is just mere talk. 
Monica: Umh the stigma is not really there it’s more talk, you know women but you 
know what they say, words are sharper that an a double edged saw. Sometimes 
I feel like the problem is not them but us though. Well I am talking in general 
because it has never happened to me but I get the feeling that people are 
talking about me sometimes. I become suspicious and eventually I withdraw 
myself, so it’s not anybody’s fault really. It’s more like discriminating 
yourself [Laughs]. 
Interviewer: How far do you stay from the hospital? 
Monica: Not far, I walk 
Interviewer: Have you ever had run dry of medications because the hospital had drug stock 
out? 
Monica: No it has never happened 
Interviewer: Which means ARVs are always in stock when you need them. Do you receive 
any other support from the hospital or community other than friends and 
family? 
Monica: That is correct. Well, I know there is a support group for HIV people in my 
community but I am not a member, I am not ready to disclose my HIV status 
to people who have nothing to do with it. Maybe time will tell. There is also 
this group here in the hospital, I have forgotten their name but that are also 
willing to visit me at home. 
Interviewer:  Have they ever visited you? 
Monica:  No, I did not accept home visits so I just met them once or twice at their 
offices 
Interviewer: Do you think joining such support groups would help you in any way? 
Monica: I really don’t know what they do but yeah maybe, I will join someday when I 
feel comfortable enough to do so. 
Interviewer: So what are your plans, how many more children coming? 
Monica: Maybe one more [both laughing] 
Interviewer: Do you have anything else you would like to share with me concerning Option 
B+ strategy?  
Monica: No, nothing I have pretty much said everything [Smiles] 
Interviewer: Then that brings us to the end of the interview. Do you have any questions? 
Monica: Uum, there is no question 
Interviewer: Monica thank you so much for your time and I wish you all the best 
